<SEC-DOCUMENT>0001493152-25-013094.txt : 20250911
<SEC-HEADER>0001493152-25-013094.hdr.sgml : 20250911
<ACCEPTANCE-DATETIME>20250911165527
ACCESSION NUMBER:		0001493152-25-013094
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20250911
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250911
DATE AS OF CHANGE:		20250911

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Glucotrack, Inc.
		CENTRAL INDEX KEY:			0001506983
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				980668934
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41141
		FILM NUMBER:		251309136

	BUSINESS ADDRESS:	
		STREET 1:		301 RT 17 NORTH
		STREET 2:		SUITE 800
		CITY:			RUTHERFORD
		STATE:			NJ
		ZIP:			07070
		BUSINESS PHONE:		972 (8) 675-7878

	MAIL ADDRESS:	
		STREET 1:		301 RT 17 NORTH
		STREET 2:		SUITE 800
		CITY:			RUTHERFORD
		STATE:			NJ
		ZIP:			07070

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	GlucoTrack, Inc.
		DATE OF NAME CHANGE:	20220328

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Integrity Applications, Inc.
		DATE OF NAME CHANGE:	20101203
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8-k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:us-roles="http://fasb.org/us-roles/2024" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:GCTK="http://glucotrack.com/20250911">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02D_US%2DGAAP%2D2024 -->
<!-- Field: Set; Name: xdx; ID: xdx_036_GCTK_glucotrack.com_20250911 -->
<!-- Field: Set; Name: xdx; ID: xdx_04A_20250911_20250911 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DEntityCentralIndexKey_0001506983 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2025-09-11" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-09-11" id="Fact000004" name="dei:EntityCentralIndexKey">0001506983</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="gctk-20250911.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2025-09-11">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001506983</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-09-11</xbrli:startDate>
        <xbrli:endDate>2025-09-11</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 4pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>UNITED
STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>Washington,
D.C. 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>FORM
<span id="xdx_904_edei--DocumentType_c20250911__20250911_zAlFb5yDLHle"><ix:nonNumeric contextRef="AsOf2025-09-11" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CURRENT
REPORT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pursuant
to Section 13 or 15(d) of the</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Securities
Exchange Act of 1934</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date
of Report (Date of earliest event reported): <span id="xdx_908_edei--DocumentPeriodEndDate_c20250911__20250911_zxQ3DSiLKGo3"><ix:nonNumeric contextRef="AsOf2025-09-11" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">September 11, 2025</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b><span id="xdx_904_edei--EntityRegistrantName_c20250911__20250911_z4x3V1tJyDAd"><ix:nonNumeric contextRef="AsOf2025-09-11" id="Fact000011" name="dei:EntityRegistrantName">GLUCOTRACK,
INC.</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
name of registrant as specified in its charter)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_edei--EntityIncorporationStateCountryCode_c20250911__20250911_zJmGJD1oE7Zj"><ix:nonNumeric contextRef="AsOf2025-09-11" format="ixt-sec:stateprovnameen" id="Fact000012" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_edei--EntityFileNumber_c20250911__20250911_zBVDVO48aVch"><ix:nonNumeric contextRef="AsOf2025-09-11" id="Fact000013" name="dei:EntityFileNumber">001-41141</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_edei--EntityTaxIdentificationNumber_c20250911__20250911_zNckNnwWL4Sd"><ix:nonNumeric contextRef="AsOf2025-09-11" id="Fact000014" name="dei:EntityTaxIdentificationNumber">98-0668934</ix:nonNumeric></span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State or Other Jurisdiction</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(IRS Employer</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of Incorporation)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">File Number)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification No.)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 66%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_edei--EntityAddressAddressLine1_c20250911__20250911_zXaY5DEmApW9"><ix:nonNumeric contextRef="AsOf2025-09-11" id="Fact000015" name="dei:EntityAddressAddressLine1">301
    Rte. 17 North</ix:nonNumeric></span>, <span id="xdx_906_edei--EntityAddressAddressLine2_c20250911__20250911_zv0BVrC0Yoca"><ix:nonNumeric contextRef="AsOf2025-09-11" id="Fact000016" name="dei:EntityAddressAddressLine2">Ste. 800</ix:nonNumeric></span>, <span id="xdx_909_edei--EntityAddressCityOrTown_c20250911__20250911_znewwMSInh42"><ix:nonNumeric contextRef="AsOf2025-09-11" id="Fact000017" name="dei:EntityAddressCityOrTown">Rutherford</ix:nonNumeric></span>, <span id="xdx_908_edei--EntityAddressStateOrProvince_c20250911__20250911_z07F1ztpHi95"><ix:nonNumeric contextRef="AsOf2025-09-11" id="Fact000018" name="dei:EntityAddressStateOrProvince">NJ</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_edei--EntityAddressPostalZipCode_c20250911__20250911_z1iayBIgfXRj"><ix:nonNumeric contextRef="AsOf2025-09-11" id="Fact000019" name="dei:EntityAddressPostalZipCode">07070</ix:nonNumeric></span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address of principal executive
    offices)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Zip Code)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registrant&#8217;s
telephone number, including area code: <span id="xdx_90A_edei--CityAreaCode_c20250911__20250911_zyeAVwrFsYh8"><ix:nonNumeric contextRef="AsOf2025-09-11" id="Fact000020" name="dei:CityAreaCode">(201)</ix:nonNumeric></span> <span id="xdx_900_edei--LocalPhoneNumber_c20250911__20250911_zMlQaFTXq5t3"><ix:nonNumeric contextRef="AsOf2025-09-11" id="Fact000021" name="dei:LocalPhoneNumber">842-7715</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Former
name or former address, if changed since last report)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions (see General Instruction A.2. below):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_edei--WrittenCommunications_c20250911__20250911_zY2zlFczoN4g"><ix:nonNumeric contextRef="AsOf2025-09-11" format="ixt:booleanfalse" id="Fact000022" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written communications pursuant to Rule 425 under the
    Securities Act (17 CFR 230.425)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_edei--SolicitingMaterial_c20250911__20250911_zSIES3q7KTrh"><ix:nonNumeric contextRef="AsOf2025-09-11" format="ixt:booleanfalse" id="Fact000023" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting material pursuant to Rule 14a-12 under the
    Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_edei--PreCommencementTenderOffer_c20250911__20250911_zwzPU8mqRXAf"><ix:nonNumeric contextRef="AsOf2025-09-11" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement communications pursuant to Rule 14d-2(b)
    under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_edei--PreCommencementIssuerTenderOffer_c20250911__20250911_zAxIO6HAGk2c"><ix:nonNumeric contextRef="AsOf2025-09-11" format="ixt:booleanfalse" id="Fact000025" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement communications pursuant to Rule 13e-4(c)
    under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered pursuant to Section 12(b) of the Act:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 30%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title
    of each class</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 20%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trading
    Symbol(s)</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 46%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name
    of each exchange on which registered</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90D_edei--Security12bTitle_c20250911__20250911_zRbNb9vI9qrl"><ix:nonNumeric contextRef="AsOf2025-09-11" id="Fact000026" name="dei:Security12bTitle">Common Stock</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_901_edei--TradingSymbol_c20250911__20250911_zRQshrGOTzhi"><ix:nonNumeric contextRef="AsOf2025-09-11" id="Fact000027" name="dei:TradingSymbol">GCTK</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90B_edei--SecurityExchangeName_c20250911__20250911_zwJDY2Z4bf43"><ix:nonNumeric contextRef="AsOf2025-09-11" format="ixt-sec:exchnameen" id="Fact000028" name="dei:SecurityExchangeName">The Nasdaq Stock Market
    LLC</ix:nonNumeric></span></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 29.15pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR &#167;
230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR &#167; 240.12b-2).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
growth company <span id="xdx_908_edei--EntityEmergingGrowthCompany_c20250911__20250911_zT0HJXraN7xk"><ix:nonNumeric contextRef="AsOf2025-09-11" format="ixt:booleanfalse" id="Fact000029" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 4pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
1.01. Entry Into a Material Definitive Agreement.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Purchase
Agreement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 11, 2025, Glucotrack, Inc. (the &#8220;<span style="text-decoration: underline">Company</span>&#8221;) entered into a purchase agreement (the &#8220;<span style="text-decoration: underline">Purchase
Agreement</span>&#8221;) and a registration rights agreement (the &#8220;<span style="text-decoration: underline">Registration Rights Agreement</span>&#8221;), with Sixth Borough
Capital Fund, LP (the &#8220;<span style="text-decoration: underline">Investor</span>&#8221;), pursuant to which the Investor has committed to purchase up to $20.0 million of
the Company&#8217;s common stock, par value $0.001 per share (the &#8220;<span style="text-decoration: underline">Common Stock</span>&#8221;), subject to certain limitations
and satisfaction of the conditions set forth in the Purchase Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the terms and subject to the conditions set forth in the Purchase Agreement, the Company has the right, but not the obligation, to sell
to the Investor, and the Investor is obligated to purchase, up to $20.0 million of the Company&#8217;s Common Stock (the &#8220;<span style="text-decoration: underline">Purchase
Shares</span>&#8221;). Such sales of Common Stock by the Company, if any, will be subject to certain limitations specified in the Purchase
Agreement and may occur from time to time, at the Company&#8217;s sole discretion, during the 24-month period beginning on the &#8220;Commencement
Date.&#8221; The Commencement Date is the date on which all conditions to the Investor&#8217;s purchase obligation under the Purchase
Agreement have been satisfied, including the effectiveness of a registration statement filed by the Company with the U.S. Securities
and Exchange Commission (the &#8220;<span style="text-decoration: underline">SEC</span>&#8221;) covering the resale of shares issued or issuable to the Investor under the Purchase
Agreement, and the filing of the related final prospectus with the SEC, as required pursuant to the Registration Rights Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Regular
Purchases</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
and after the Commencement Date, the Company may, by written notice (each, a &#8220;<span style="text-decoration: underline">Regular Notice</span>&#8221;), direct the Investor
to purchase up to 20,000 shares of Common Stock (each such purchase, a &#8220;<span style="text-decoration: underline">Regular Purchase</span>&#8221; and, the day on which the
Investor receives the Regular Note, the &#8220;<span style="text-decoration: underline">Regular Purchase Date</span>&#8221;), subject to adjustment as described below (such maximum
number of Purchase Shares, as may be adjusted from time to time, the &#8220;<span style="text-decoration: underline">Regular Purchase Share Limit</span>&#8221;). The purchase
price for each Regular Purchase (the &#8220;<span style="text-decoration: underline">Regular Purchase Price</span>&#8221;) shall be equal to the lesser of ninety-seven percent
(97%) of: (i) the volume weighted average price (the &#8220;<span style="text-decoration: underline">VWAP</span>&#8221;) of the Common Stock on the Nasdaq Capital Market (the
&#8220;<span style="text-decoration: underline">Principal Market</span>&#8221;) on the date the Regular Notice is delivered to the Investor (the &#8220;<span style="text-decoration: underline">Regular Purchase Date</span>&#8221;);
or (ii) the average of the three (3) lowest closing sale prices for the Common Stock on the Principal Market (each, a &#8220;<span style="text-decoration: underline">Closing
Sale Price</span>&#8221;) during the ten (10) trading days prior to the Regular Purchase Date. The Regular Purchase Share Limit shall increase
to 25,000 Purchase Shares if the Closing Sale Price of the Common Stock on the applicable Regular Purchase Date is not less than $3.00,
and shall further increase to 30,000 Purchase Shares if the Closing Sale Price of the Common Stock on the applicable Regular Purchase
Date is not less than $5.00. The Investor&#8217;s committed obligation under any single Regular Purchase shall not exceed $500,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Add-On
Purchases</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the terms and conditions of the Purchase Agreement, in addition to directing purchases of Purchase Shares as pursuant to a Regular
Notice, the Company shall also have the right, but not the obligation, to direct the Investor to purchase a number of Purchase Shares
by delivering a written notice to the Investor (each, an &#8220;<span style="text-decoration: underline">Add-On Purchase Notice</span>&#8221;). Each Add-On Purchase Notice may
direct the Investor to purchase a number of Purchase Shares not to exceed the lesser of: (i) three (3) times the number of shares purchased
pursuant to the corresponding Regular Notice, or (ii) 30% of the trading volume of the Common Stock on the date of the Add-On Purchase
Notice (the &#8220;<span style="text-decoration: underline">Add-On Purchase Share Amount</span>&#8221;). The purchase price for each Add-On Purchase (the &#8220;<span style="text-decoration: underline">Add-On Purchase
Price</span>,&#8221; and each such purchase, an &#8220;<span style="text-decoration: underline">Add-On Purchase</span>&#8221;) shall be equal to the lesser of ninety-five percent
(95%) of: (i) the VWAP reported by the Principal Market for the period beginning at 9:30:01 a.m., Eastern time, on the applicable Regular
Purchase Date (the &#8220;<span style="text-decoration: underline">Add-On Purchase Date</span>&#8221;), or such other time publicly announced by the Principal Market as the official
open of trading, and ending 4:00:00 p.m., Eastern time, or such other time publicly announced as the official close of trading on such
applicable Add-On Purchase Date; and (ii) the average of the three (3) lowest Closing Sale Prices of the Common Stock during the ten
(10) business days immediately prior to the Add-On Purchase Date. The Company may deliver an Add-On Purchase Notice to the Investor only
if: (i) it has properly submitted a Regular Notice on the same Regular Purchase Date, providing for the purchase of a number of Purchase
Shares equal to or greater than the Regular Purchase Share Limit then in effect (including any automatic increases resulting from the
applicable Closing Sale Price or other adjustments under the Purchase Agreement); and (ii) the Investor has received all Purchase Shares
subject to all prior Regular Purchases (excluding the Regular Purchase made on such Regular Purchase Date), as well as all prior Add-On
Purchases and Intraday Purchases (as defined herein) initiated by the Company under the Purchase Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Intraday
Purchases</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to purchases of Purchase Shares as described above, the Company shall also have the right, on no more than three (3) occasions
during any business day, but not the obligation, to direct the Investor to purchase additional shares of Common Stock by delivering written
notice (each, an &#8220;<span style="text-decoration: underline">Intraday Purchase Notice</span>&#8221;) on such day (the &#8220;<span style="text-decoration: underline">Intraday Purchase Date</span>&#8221;). The total
number of shares of Common Stock set forth in each Intraday Purchase Notice, together with the number of shares specified in any other
Intraday Purchase Notices submitted on the same day, shall not exceed the lesser of: (i) 100% of the average daily trading volume reported
by the Principal Market during the five (5) business days preceding the business day prior to the Intraday Purchase Date; and (ii) the
Investor&#8217;s committed daily obligation of $1,000,000 (such maximum aggregate amount, the &#8220;<span style="text-decoration: underline">Intraday Purchase Share Amount</span>&#8221;).
The purchase price per share for each such transaction (the &#8220;<span style="text-decoration: underline">Intraday Purchase Price</span>,&#8221; and each such transaction,
an &#8220;<span style="text-decoration: underline">Intraday Purchase</span>&#8221;) shall be equal to the greater of ninety-five percent (95%) of: (i) the lowest transaction
price reported by the Principal Market during the period beginning at 9:30:01 a.m., Eastern time, on the applicable Intraday Purchase
Date, or such other time publicly announced by the Principal Market as the official open of trading, and ending 4:00:00 p.m., Eastern
time, on such applicable Intraday Purchase Date, or such other time publicly announced as the official close of trading on such applicable
Intraday Purchase Date; and (ii) the Closing Sale Price of the Common Stock on the business day immediately prior to the Intraday Purchase
Date. The Company may submit an Intraday Purchase Notice only if it is delivered to the Investor prior to 2:00 P.M. Eastern time on the
applicable business day, the notice specifies the number of shares to be purchased, and the Investor consents in writing to such Intraday
Purchase. The Company may submit up to three (3) Intraday Purchase Notices in a single business day provided that delivery of shares
by the Company pursuant to all prior Intraday Purchase Notices has been made.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Other
Terms</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company will control the timing and amount of any sales of Common Stock to the Investor pursuant to the Purchase Agreement. The Investor
does not have the right to require the Company to sell any shares of Common Stock, but is obligated to purchase shares as directed by
the Company, subject to the conditions set forth in the Purchase Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
actual amount and timing of any sales of Common Stock will be determined by the Company at its discretion and will depend on various
factors, including, among others, general market conditions, the trading price of the Common Stock, and the Company&#8217;s assessment
of appropriate funding sources for its operations. The net proceeds that the Company may receive under the Purchase Agreement will vary
based on the frequency of sales and the prices at which shares are sold to the investor. The Company currently intends to use any proceeds
from such sales for working capital and general corporate purposes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the case of Regular Purchases, Add-On Purchases and Intraday Purchases, the purchase price per share will be equitably adjusted for any
reorganization, recapitalization, non-cash dividend, stock split, reverse stock split or other similar transaction occurring during the
business days used to compute the purchase price.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
aggregate number of shares that the Company can sell to the Investor under the Purchase Agreement is limited and may not exceed 179,792
shares (subject to adjustment as described above), which is equal to 19.99% of the total shares of the Common Stock outstanding immediately
prior to the execution of the Purchase Agreement (the &#8220;<span style="text-decoration: underline">Exchange Cap</span>&#8221;), unless either of the following conditions is
satisfied: (i) the Company obtains stockholder approval to issue Purchase Shares in excess of the Exchange Cap; or (ii) the Average Price
(defined herein) equals or exceeds the lower of: (A) the official closing price of the Common Stock on the Principal Market on the trading
day immediately preceding the date of the Purchase Agreement; and (B) the average official closing price of our Common Stock on Nasdaq
for the five (5) consecutive trading days ending on the trading day immediately preceding the date of the Purchase Agreement. For purposes
of this determination, the &#8220;Average Price&#8221; will be calculated as the quotient of: (x) the aggregate gross purchase price
paid by the Investor for all shares of Common Stock purchased under the Purchase Agreement, divided by (y) the aggregate number of shares
of Common Stock issued to the Investor under the Purchase Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
all cases, the Purchase Agreement also prohibits the Company from directing the Investor to purchase any shares of Common Stock if those
shares, when aggregated with all other shares of Common Stock then beneficially owned by the Investor (as calculated pursuant to Section
13(d) of the&#160;Securities Exchange Act of 1934, as amended, and Rule 13d-3 thereunder), would result in the Investor beneficially
owning more than 4.99% of the then total outstanding shares of Common Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Purchase Agreement and the related Registration Rights Agreement impose no restrictions on future financings, rights of first refusal,
participation rights, penalties, or liquidated damages, except that while the Purchase Agreement remains in effect, the Company is prohibited,
without the prior approval of the Investor, from entering into any variable, reset, or otherwise adjustable equity or equity-linked transactions,
except for a future at-the-market offering facility with Dawson James Securities, Inc. (&#8220;<span style="text-decoration: underline">Dawson James</span>&#8221;). The Investor
has agreed not to engage in or effect, directly or indirectly, for its own principal account or for the principal account of any of its
affiliates, any short sales of the Common Stock or hedging transaction that establishes a net short position in the Common Stock during
the term of the Purchase Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
consideration for the Investor&#8217;s execution and delivery of the Purchase Agreement, the Company will pay the Investor a commitment
fee equal to 1.5% of the total Commitment Amount (the &#8220;<span style="text-decoration: underline">Commitment Fee</span>&#8221;). The Commitment Fee is payable in cash, shares
of Common Stock, or pre-funded warrants to purchase Common Stock (the &#8220;<span style="text-decoration: underline">Pre-Funded Warrants</span>&#8221;), or any combination thereof,
at the Company&#8217;s sole discretion. If paid in shares of Common Stock or Pre-Funded Warrants (such shares, including any such shares
issuable upon exercise of any Pre-Funded Warrants, collectively, the &#8220;<span style="text-decoration: underline">Commitment Shares</span>&#8221;), the number of shares issued
will be determined based on the lower of: (i) the official closing price of the Common Stock on the Principal Market on the trading day
immediately preceding the Commencement Date; and (ii) the average official closing price of the Common Stock on the Principal Market
for the five (5) consecutive trading days ending on the trading day immediately preceding the Commencement Date. The Commitment Fee will
be fully earned and payable on the Commencement Date, regardless of whether the Investor purchases any shares under the Purchase Agreement
or whether the agreement is later terminated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any portion of the Commitment Fee is paid in Commitment Shares, the Investor has agreed to hold all such shares and/or shares issued
upon exercise of Pre-Funded Warrants for a minimum period of three (3) months following the Commencement Date. After the expiration of
this initial three-month period, the Investor may sell up to fifty percent (50%) of the shares and/or shares issued upon exercise of
Pre-Funded Warrants. The remaining fifty percent (50%) may not be sold until six (6) months after the Commencement Date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has agreed to pay Dawson James a cash fee equal to 1.5% of the gross proceeds received by the Company from sales of securities
to the Investor pursuant to any Regular Purchase, Add-On Purchase, or Intraday Purchase, under an advisory agreement between the Company
and Dawson James.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Purchase Agreement contains customary representations, warranties, conditions and indemnification obligations of both parties. The Company
may terminate the Purchase Agreement at any time upon one business day&#8217;s notice without cost or penalty. Following the Commencement
Date, the Investor may not terminate the Purchase Agreement due to any suspension events (the &#8220;<span style="text-decoration: underline">Suspension Events</span>&#8221;)
specified therein, although the agreement will automatically terminate in the event of voluntary or involuntary participation, or threatened
participation, in insolvency or bankruptcy proceedings by or against the Company that are not discharged within 90 days. So long as a
Suspension Event has occurred and continues, the Company may not initiate any Regular Purchase or other purchase of shares by the Investor
until the Suspension Event is cured. In the event that (i) the Company fails to file the Registration Statement with the SEC within the
period specified by the Registration Rights Agreement, or (ii) the Commencement has not occurred on or before November 27, 2025, due
to the failure to satisfy certain conditions to the Investor&#8217;s purchase obligations, then, in the case of clause (i), the Purchase
Agreement may be terminated by the Investor at any time prior to the filing of the Registration Statement (defined herein) and, in the
case of clause (ii), either party may terminate the Purchase Agreement at the close of business on November 27, 2025, or thereafter,
without liability to the other party. However, that the right to terminate the Purchase Agreement pursuant to clauses (i) or (ii) is
not available to any party that is in breach of any covenant, agreement, or representation under the Purchase Agreement at the time of
such termination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 4 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Registration
Rights Agreement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the execution of the Purchase Agreement, the Company and the Investor entered into the Registration Rights Agreement.
Pursuant to the terms of the Registration Rights Agreement, the Company is obligated to: (a) file a registration statement on Form S-1
(the &#8220;<span style="text-decoration: underline">Registration Statement</span>&#8221;) with the SEC within fifteen (15) calendar days from the date of the Purchase Agreement,
covering (i) any shares of Common Stock issued as part of the Commitment Fee and (ii) the maximum number of Purchase Shares issuable
pursuant to the Purchase Agreement (collectively, the &#8220;<span style="text-decoration: underline">Registrable Securities</span>&#8221;); (b) use its reasonable best efforts
to have the Registration Statement any amendment thereto declared effective under the Securities Act of 1933, as amended (the &#8220;<span style="text-decoration: underline">Securities
Act</span>&#8221;), within forty-five (45) days after its filing date; and (c) use its best efforts to keep such Registration Statement
continuously effective under the Securities Act pursuant to Rule 415 promulgated under the Securities Act and available for the resale
by the Investor of all of the Registrable Securities covered thereby at all times until the date on which the Investor shall have resold
all the Registrable Securities covered thereby and no Available Amount (as defined in the Purchase Agreement) remains under the Purchase
Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing descriptions of the Purchase Agreement and the Registration Rights Agreement are summaries and are qualified in their entirety
by reference to the full texts of the Purchase Agreement and Registration Rights Agreement, which are filed as Exhibits 10.1 and 10.2,
respectively, to this Current Report on Form 8-K and incorporated herein by reference. The representations, warranties and covenants
contained in such agreements were made only for the purposes of such agreements and as of specific dates, were solely for the benefit
of the parties to such agreements and may be subject to limitations agreed upon by the contracting parties.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
current report on Form 8-K shall not constitute an offer to sell or a solicitation of an offer to buy any shares of Common Stock in any
state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the
securities laws of any such state or other jurisdiction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
3.02. Unregistered Sales of Equity Securities</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the extent required by Item 3.02 of Form 8-K, the information contained in Item 1.01 is hereby incorporated by reference into this Item
3.02 in its entirety.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the Purchase Agreement, the Investor represented to the Company, among other things, that it is an &#8220;accredited investor&#8221;
(as such term is defined in&#160;Rule 501(a)(3) of&#160;Regulation D&#160;under the&#160;Securities Act). The Commitment Shares and the
Purchase Shares will be issued and sold by the Company to the Investor in reliance upon the exemptions from the registration requirements
of the&#160;Securities Act&#160;afforded by Section 4(a)(2) of the&#160;Securities Act&#160;and&#160;Rule 506(b) of&#160;Regulation D&#160;thereunder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
9.01. Financial Statements and Exhibits</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Exhibits</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit<br/>

    No.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="ex10-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purchase
    Agreement, dated September 11, 2025, by and between Glucotrack, Inc. and Sixth Borough Capital Fund, LP.</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="ex10-2.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registration
    Rights Agreement, dated September 11, 2025, by and between Glucotrack, Inc. and Sixth Borough Capital Fund, LP.</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover Page Interactive
    Data File (embedded within the inline XBRL document)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 5 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNATURES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    September 11, 2025</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 45%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>GLUCOTRACK, INC.</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/ Paul
    Goode</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Paul Goode</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 6; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjd0KwjAMhZ9g7xB6LbpOJrg7HTrEKTJEvK0uk+LWjLT+PZJvad0QQyAk53w5QgxERktdI8NxXuSwx6atlUMosEJGc0bvSFfrBPws8KKtY2Vct/7AlDyDnpkM5cnfO+ddWywTCKcjKUdRDOE4kTHMNiL46imZSpdonFY1KFPCjqlljU7xq/+wV08y1Ly6pAOy1WQSkMOwl98QhTKCLd3Vg/hqIc9TEQy6CkTGdGu9a/F0aL4kLGpsfJzt6X8HH8LlSk0= -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>ex10-1.htm
<DESCRIPTION>EX-10.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.1</B></FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PURCHASE
AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PURCHASE
AGREEMENT</B> (the &ldquo;<U>Agreement</U>&rdquo;), dated as of September 11, 2025 (the &ldquo;<U>Effective Date</U>&rdquo;),
by and between <B>GLUCOTRACK, INC.</B>, a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), and <B>SIXTH BOROUGH CAPITAL FUND,
LP</B>, a Delaware limited partnership (the &ldquo;<U>Investor</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the terms and conditions set forth in this Agreement, the Company wishes to sell to the Investor, and the Investor wishes to buy from
the Company, up to Twenty Million Dollars ($20,000,000) of the Company&rsquo;s common stock, par value $0.001 per share (the &ldquo;<U>Common
Stock</U>&rdquo;). The shares of Common Stock to be purchased by the Investor hereunder are referred to herein as the &ldquo;<U>Purchase
Shares</U>.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOW
THEREFORE</B>, in consideration of the mutual covenants contained in this Agreement, and for other good and valuable consideration, the
receipt and adequacy of which are hereby acknowledged, the Company and the Investor hereby agree as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.</B></FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CERTAIN DEFINITIONS.</B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
purposes of this Agreement, the following terms shall have the following meanings:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
&ldquo;<U>Add-On Purchase Date</U>&rdquo; means, with respect to any Add-On Purchase made pursuant to <U>Section 2(b)</U> hereof, the
applicable Regular Purchase Date with respect to the corresponding Regular Purchase referred to in clause (i) of the second sentence
of <U>Section 2(b)</U> hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
&ldquo;<U>Add-On Purchase Notice</U>&rdquo; means, with respect to an Add-On Purchase made pursuant to <U>Section 2(b)</U> hereof, an
irrevocable written notice from the Company to the Investor directing the Investor to purchase the number of Purchase Shares specified
by the Company therein as the Add-On Purchase Share Amount to be purchased by the Investor (such specified Add-On Purchase Share Amount
subject to adjustment in accordance with <U>Section 2(b)</U> hereof as necessary to give effect to the Purchase Share amount limitations
applicable to such Add-On Purchase Share Amount as set forth in this Agreement) at the applicable Add-On Purchase Price on the applicable
Add-On Purchase Date for such Add-On Purchase.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
&ldquo;<U>Add-On Purchase Price</U>&rdquo; means, with respect to an Add-On Purchase made pursuant to <U>Section 2(b)</U> hereof, the
lesser of ninety-five percent (95%) of (i) the VWAP reported by the Principal Market for the period beginning at 9:30:01 a.m., Eastern
time, on the applicable Add-On Purchase Date, or such other time publicly announced by the Principal Market as the official open (or
commencement) of trading on the Principal Market on such applicable Add-On Purchase Date, and ending 4:00:00 p.m., Eastern time, on such
applicable Add-On Purchase Date, or such other time publicly announced by the Principal Market as the official close of trading on the
Principal Market on such applicable Add-On Purchase Date, and (ii) the average of the three (3) lowest Closing Sale Prices of the Common
Stock during the ten (10) Business Days immediately prior to the Add-On Purchase Date (in each case, to be appropriately adjusted for
any reorganization, recapitalization, non-cash dividend, stock split or other similar transaction that occurs on or after the date of
this Agreement).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
&ldquo;<U>Add-On Purchase Share Amount</U>&rdquo; means, with respect to an Add-On Purchase made pursuant to <U>Section 2(b)</U> hereof,
the number of Purchase Shares directed by the Company to be purchased by the Investor in an Add-On Purchase Notice, which number of Purchase
Shares shall not exceed the lesser of (i) three (3) times the number of shares purchased pursuant to such Regular Purchase Notice or
(ii) 30% of the trading volume on the date of the Add-On Purchase Notice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
&ldquo;<U>Available Amount</U>&rdquo; means, initially, Twenty Million Dollars ($20,000,000) in the aggregate, which amount shall be
reduced by the Purchase Amount each time the Investor purchases Purchase Shares pursuant to <U>Section 2</U> hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
&ldquo;<U>Average Price</U>&rdquo; means a price per Purchase Share (rounded down to the nearest tenth of a cent) equal to the quotient
obtained by dividing (i) the aggregate gross purchase price paid by the Investor for all Purchase Shares purchased pursuant to this Agreement,
by (ii) the aggregate number of Purchase Shares issued pursuant to this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
&ldquo;<U>Bankruptcy Law</U>&rdquo; means Title 11, U.S. Code, or any similar federal or state law for the relief of debtors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
&ldquo;<U>Base Price</U>&rdquo; means a price per Purchase Share equal to the Signing Market Price (subject to adjustment for any reorganization,
recapitalization, non-cash dividend, stock split, reverse stock split or other similar transaction that occurs on or after the date of
this Agreement).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
&ldquo;<U>Business Day</U>&rdquo; means any day on which the Principal Market is open for trading, including any day on which the Principal
Market is open for trading for a period of time less than the customary time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
&ldquo;<U>Closing Sale Price</U>&rdquo; means, for any security as of any date, the last closing sale price for such security on the
Principal Market as reported by the Principal Market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
&ldquo;<U>Confidential Information</U>&rdquo; means any information disclosed by either party to the other party, either directly or
indirectly, in writing, orally or by inspection of tangible objects (including, without limitation, documents, prototypes, samples, plant
and equipment), which is designated as &ldquo;Confidential,&rdquo; &ldquo;Proprietary&rdquo; or some similar designation. Information
communicated orally shall be considered Confidential Information if such information is confirmed in writing as being Confidential Information
within ten (10) Business Days after the initial disclosure. Confidential Information may also include information disclosed to a disclosing
party by third parties. Confidential Information shall not, however, include any information which (i) was publicly known and made generally
available in the public domain prior to the time of disclosure by the disclosing party; (ii) becomes publicly known and made generally
available after disclosure by the disclosing party to the receiving party through no action or inaction of the receiving party; (iii)
is already in the possession of the receiving party without confidential restriction at the time of disclosure by the disclosing party
as shown by the receiving party&rsquo;s files and records immediately prior to the time of disclosure; (iv) is obtained by the receiving
party from a third party without a breach of such third party&rsquo;s obligations of confidentiality; (v) is independently developed
by the receiving party without use of or reference to the disclosing party&rsquo;s Confidential Information, as shown by documents and
other competent evidence in the receiving party&rsquo;s possession; or (vi) is required by law to be disclosed by the receiving party,
provided that the receiving party gives the disclosing party prompt written notice of such requirement prior to such disclosure and assistance
in obtaining an order protecting the information from public disclosure.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
&ldquo;<U>Custodian</U>&rdquo; means any receiver, trustee, assignee, liquidator or similar official under any Bankruptcy Law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)
&ldquo;<U>DTC</U>&rdquo; means The Depository Trust Company, or any successor performing substantially the same function for the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)
&ldquo;<U>DWAC Shares</U>&rdquo; means shares of Common Stock that are (i) issued in electronic form, (ii) freely tradable and transferable
and without restriction on resale and (iii) timely credited by the Company to the Investor&rsquo;s or its designee&rsquo;s specified
Deposit/Withdrawal at Custodian (DWAC) account with DTC under its Fast Automated Securities Transfer (FAST) Program, or any similar program
hereafter adopted by DTC performing substantially the same function.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)
&ldquo;<U>Exchange Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p)
&ldquo;<U>Intraday Purchase Date</U>&rdquo; means, with respect to an Intraday Purchase made pursuant to <U>Section 2(c)</U> hereof,
the Business Day on which the Investor receives, prior to 2:00 p.m., Eastern time, on such Business Day, a valid Intraday Purchase Notice
for such Intraday Purchase in accordance with this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q)
&ldquo;<U>Intraday Purchase Notice</U>&rdquo; means, with respect to an Intraday Purchase made pursuant to <U>Section 2(c)</U> hereof,
an irrevocable written notice from the Company to the Investor directing the Investor to purchase the number of Purchase Shares specified
by the Company therein as the Intraday Purchase Share Amount to be purchased by the Investor (such specified Intraday Purchase Share
Amount subject to adjustment in accordance with <U>Section 2(c)</U> hereof as necessary to give effect to the Purchase Share amount limitations
applicable to such Intraday Purchase Share Amount as set forth in this Agreement) at the applicable Intraday Purchase Price on the applicable
Intraday Purchase Date for such Intraday Purchase, provided that the Intraday Purchase Notice complies with the provisions of <U>Section
5(m)</U> below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r)
&ldquo;<U>Intraday Purchase Price</U>&rdquo; means, with respect to an Intraday Purchase made pursuant to <U>Section 2(c)</U> hereof,
the greater of ninety-five percent (95%) of (i) the lowest transaction price reported by the Principal Market for the period beginning
at 9:30:01 a.m., Eastern time, on the applicable Intraday Purchase Date, or such other time publicly announced by the Principal Market
as the official open (or commencement) of trading on the Principal Market on such applicable Intraday Purchase Date, and ending 4:00:00
p.m., Eastern time, on such applicable Intraday Purchase Date, or such other time publicly announced by the Principal Market as the official
close of trading on the Principal Market on such applicable Intraday Purchase Date, and (ii) the Closing Sale Price of the Common Stock
on the Business Day immediately prior to the Intraday Purchase Date (in each case, to be appropriately adjusted for any reorganization,
recapitalization, non-cash dividend, stock split or other similar transaction that occurs on or after the date of this Agreement).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(s)
&ldquo;<U>Intraday Purchase Share Amount</U>&rdquo; means, with respect to an Intraday Purchase made pursuant to <U>Section 2(c)</U>
hereof, the number of Purchase Shares directed by the Company to be purchased by the Investor in an Intraday Purchase Notice, which number
of Purchase Shares together with the number of Purchase Shares set forth in any other Intraday Purchase Notices shall not exceed the
lesser of (i) 100% of the average daily trading volume reported by the Principal Market in the five (5) Business Days preceding the Business
Day before the Intraday Purchase Notice and (ii) the Investor&rsquo;s committed daily obligation set forth in <U>Section 2(e)</U> hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(t)
&ldquo;<U>Material Adverse Effect</U>&rdquo; means any material adverse effect on (i) the enforceability of any Transaction Document,
(ii) the results of operations, assets, business or financial condition of the Company and its Subsidiaries, taken as a whole, other
than any material adverse effect that resulted exclusively from (A) any change in the United States or foreign economies or securities
or financial markets in general that does not have a disproportionate effect on the Company and its Subsidiaries, taken as a whole, (B)
any change that generally affects the industry in which the Company and its Subsidiaries operate that does not have a disproportionate
effect on the Company and its Subsidiaries, taken as a whole, (C) any change arising in connection with earthquakes, hostilities, acts
of war, sabotage or terrorism or military actions or any escalation or material worsening of any such hostilities, acts of war, sabotage
or terrorism or military actions existing as of the date hereof, (D) any action taken by the Investor, its affiliates or its or their
successors and assigns with respect to the transactions contemplated by this Agreement, (E) the effect of any change in applicable laws
or accounting rules that does not have a disproportionate effect on the Company and its Subsidiaries, taken as a whole, or (F) any change
resulting from compliance with terms of this Agreement or the consummation of the transactions contemplated by this Agreement, or (iii)
the Company&rsquo;s ability to perform in any material respect on a timely basis its obligations under any Transaction Document to be
performed as of the date of determination.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(u)
&ldquo;<U>Maturity Date</U>&rdquo; means the first day of the month immediately following the twenty-four (24) month anniversary of the
Commencement Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
&ldquo;<U>PEA Period</U>&rdquo; means the period commencing at 9:30 a.m., Eastern time, on the fifth (5<SUP>th</SUP>) Business Day immediately
prior to the filing of any post-effective amendment to the Registration Statement (as defined herein) or New Registration Statement (as
such term is defined in the Registration Rights Agreement), and ending at 9:30 a.m., Eastern time, on the Business Day immediately following,
the effective date of any post-effective amendment to the Registration Statement (as defined herein) or New Registration Statement (as
such term is defined in the Registration Rights Agreement).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(w)
&ldquo;<U>Person</U>&rdquo; means an individual or entity including but not limited to any limited liability company, a partnership,
a joint venture, a corporation, a trust, an unincorporated organization and a government or any department or agency thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)
&ldquo;<U>Pre-Funded Warrant</U>&rdquo; means a warrant to purchase shares of Common Stock at an exercise price of $0.001 per share (or
such other nominal amount as may be permitted by the Principal Market), which is immediately exercisable and remains outstanding until
exercised in full.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(y)
&ldquo;<U>Principal Market</U>&rdquo; means The Nasdaq Capital Market (or any nationally recognized successor thereto); provided, however,
that in the event the Company&rsquo;s Common Stock is ever listed or traded on The Nasdaq Global Market, The Nasdaq Global Select Market,
the New York Stock Exchange, the NYSE American, the NYSE Arca, or The OTCQX Best Market or The OTCQB Venture Market operated by OTC Markets
Group, Inc. (or any nationally recognized successor to any of the foregoing), then the &ldquo;<U>Principal Market</U>&rdquo; shall mean
such other market or exchange on which the Company&rsquo;s Common Stock is then listed or traded.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(z)
&ldquo;<U>Purchase Amount</U>&rdquo; means, with respect to any Regular Purchase, any Add-On Purchase or any Intraday Purchase made hereunder,
as applicable, the portion of the Available Amount to be purchased by the Investor pursuant to <U>Section 2</U> hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(aa)
&ldquo;<U>Regular Purchase</U>&rdquo; means any purchase addressed in <U>Section 2(a)</U> hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(bb)
&ldquo;<U>Regular Purchase Date</U>&rdquo; means, with respect to a Regular Purchase made pursuant to <U>Section 2(a)</U> hereof, the
Business Day on which the Investor receives, after 4:00 p.m., Eastern time, but prior to 6:30 p.m., Eastern time, on such Business Day,
a valid Regular Purchase Notice for such Regular Purchase in accordance with this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(cc)
&ldquo;<U>Regular Purchase Notice</U>&rdquo; means, with respect to any Regular Purchase pursuant to <U>Section 2(a)</U> hereof, an irrevocable
written notice from the Company to the Investor directing the Investor to buy such applicable amount of Purchase Shares at the applicable
Regular Purchase Price as specified by the Company therein on the applicable Regular Purchase Date for such Regular Purchase.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(dd)
&ldquo;<U>Regular Purchase Price</U>&rdquo; means, with respect to any Regular Purchase made pursuant to <U>Section 2(a)</U> hereof,
the lesser of ninety-seven percent (97%) of: (i) the VWAP of the Common Stock on the Regular Purchase Date, or (ii) the average of the
three (3) lowest Closing Sale Prices of the Common Stock during the ten (10) Business Days prior to the Regular Purchase Date (in each
case, to be appropriately adjusted for any reorganization, recapitalization, non-cash dividend, stock split or other similar transaction
that occurs on or after the date of this Agreement).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ee)
&ldquo;<U>Sale Price</U>&rdquo; means any trade price for the shares of Common Stock on the Principal Market as reported by the Principal
Market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ff)
&ldquo;<U>SEC</U>&rdquo; means the U.S. Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(gg)
&ldquo;<U>Securities</U>&rdquo; means, collectively, the Purchase Shares, the Commitment Shares and the Pre-Funded Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(hh)
&ldquo;<U>Securities Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
&ldquo;<U>Signing Market Price</U>&rdquo; means the Nasdaq Minimum Price, as determined in accordance with Principal Market&rsquo;s rules
(to be appropriately adjusted for any reorganization, recapitalization, non-cash dividend, stock split or other similar transaction that
occurs on or after the date of this Agreement).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(jj)
&ldquo;<U>Stockholder Approval</U>&rdquo; shall mean the approval of the holders of a majority of the outstanding shares of Company&rsquo;s
voting Common Stock to ratify and approve all of the transactions contemplated by the Transaction Documents, including the issuance of
all of the Securities issued and potentially issuable to the Investor thereunder, all as may be required by the applicable rules and
regulations of the Principal Market (or any successor entity).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(kk)
&ldquo;<U>Subsidiary</U>&rdquo; means any Person the Company wholly-owns or controls, or in which the Company, directly or indirectly,
owns a majority of the voting stock or similar voting interest, in each case that would be disclosable pursuant to Item 601(b)(21) of
Regulation S-K promulgated under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ll)
&ldquo;<U>Transaction Documents</U>&rdquo; means, collectively, this Agreement and the schedules and exhibits hereto, the Registration
Rights Agreement and the schedules and exhibits thereto, and each of the other agreements, documents, certificates and instruments entered
into or furnished by the parties hereto in connection with the transactions contemplated hereby and thereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(mm)
&ldquo;<U>Transfer Agent</U>&rdquo; means VStock Transfer, LLC, or such other Person who is then serving as the transfer agent for the
Company in respect of the Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(nn)
&ldquo;<U>VWAP</U>&rdquo; means in respect of a Regular Purchase Date, Add-On Purchase Date and an Intraday Purchase Date, as applicable,
the volume weighted average price of the Common Stock on the Principal Market, as reported on the Principal Market or by another reputable
source such as Bloomberg, L.P.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.</B></FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PURCHASE OF COMMON STOCK.</B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the terms and conditions set forth in this Agreement, the Company has the right to sell to the Investor, and the Investor has the
obligation to purchase from the Company, Purchase Shares as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Commencement of Regular Purchase of Common Stock</U>. Upon the satisfaction of all of the conditions set forth in <U>Sections 7</U>
and <U>8</U> hereof (the &ldquo;<U>Commencement</U>&rdquo; and the date of satisfaction of such conditions the &ldquo;<U>Commencement
Date</U>&rdquo;) and thereafter, the Company shall have the right, but not the obligation, to direct the Investor, by its delivery to
the Investor of a Regular Purchase Notice from time to time, to purchase up to Twenty Thousand (20,000) Purchase Shares, subject to adjustment
as set forth below in this Section 2(a) (such maximum number of Purchase Shares, as may be adjusted from time to time, the &ldquo;<U>Regular
Purchase Share Limit</U>&rdquo;), at the Regular Purchase Price on the Regular Purchase Date (each such purchase a &ldquo;<U>Regular
Purchase</U>&rdquo;); provided, however, that (i) the Regular Purchase Share Limit shall be increased to Twenty-Five Thousand (25,000)
Purchase Shares, if the Closing Sale Price of the Common Stock on the applicable Regular Purchase Date is not below $3.00, and (ii) the
Regular Purchase Share Limit shall be increased to Thirty Thousand (30,000) Purchase Shares, if the Closing Sale Price of the Common
Stock on the applicable Regular Purchase Date is not below $5.00 (all of which share and dollar amounts shall be appropriately proportionately
adjusted for any reorganization, recapitalization, non-cash dividend, stock split or other similar transaction). The Investor&rsquo;s
committed obligation under any single Regular Purchase shall not exceed Five Hundred Thousand Dollars ($500,000). If the Company delivers
any Regular Purchase Notice for a Regular Purchase Amount in excess of the limitations contained in the immediately preceding sentence
or directing the Investor to purchase a specified number of Purchase Shares that exceeds the Regular Purchase Share Limit applicable
to such Regular Purchase, such Regular Purchase Notice shall be void <I>ab initio</I> to the extent of the amount by which the number
of Purchase Shares set forth in such Regular Purchase Notice exceeds the number of Purchase Shares which the Company is permitted to
include in such Regular Purchase Notice in accordance herewith, and the Investor shall have no obligation to purchase such excess Purchase
Shares in respect of such Regular Purchase Notice; <U>provided</U>, <U>however</U>, that the Investor shall remain obligated to purchase
the number of Purchase Shares which the Company is permitted to include in such Regular Purchase Notice. The Company may submit a Regular
Purchase Notice to the Investor as often as every Business Day after the market has closed (i.e. after 4:00 P.M. Eastern Time and prior
to 6:30 P.M. Eastern Time) so that the Regular Purchase Price is always fixed and known at the time the Company elects to sell shares
to the Investor pursuant to a Regular Purchase Notice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Add-On Purchases</U>. Subject to the terms and conditions of this Agreement, from and after the Commencement Date, in addition to
purchases of Purchase Shares as described in <U>Section 2(a)</U> above, the Company shall also have the right, but not the obligation,
to direct the Investor, by its delivery to the Investor of an Add-On Purchase Notice from time to time in accordance with this Agreement
and during the course of a Business Day, to purchase up to the applicable Add-On Purchase Share Amount at the applicable Add-On Purchase
Price (each such purchase, an &ldquo;<U>Add-On Purchase</U>&rdquo;). The Company may deliver an Add-On Purchase Notice to the Investor
only (i) on a Regular Purchase Date on which the Company also properly submitted a Regular Purchase Notice providing for a Regular Purchase
of a number of Purchase Shares not less than the Regular Purchase Share Limit then in effect on such Regular Purchase Date in accordance
with this Agreement (including, without limitation, giving effect to any automatic increase to the Regular Purchase Share Limit as a
result of the Closing Sale Price of the Common Stock exceeding certain thresholds set forth in <U>Section 2(a)</U> above on such Regular
Purchase Date and any other adjustments to the Regular Purchase Share Limit, in each case pursuant to <U>Section 2(a)</U> above) and
(ii) if all Purchase Shares subject to all prior Regular Purchases (excluding the corresponding Regular Purchase referred to in clause
(i) above), Add-On Purchases and Intraday Purchases initiated by the Company pursuant to this Agreement, as applicable, have theretofore
been received by the Investor as DWAC Shares in accordance with this Agreement. If the Company delivers any Add-On Purchase Notice directing
the Investor to purchase an amount of Purchase Shares that exceeds the Add-On Purchase Share Amount that the Company is then permitted
to include in such Add-On Purchase Notice, such Add-On Purchase Notice shall be void <I>ab initio</I> to the extent of the amount by
which the number of Purchase Shares set forth in such Add-On Purchase Notice exceeds the Add-On Purchase Share Amount that the Company
is then permitted to include in such Add-On Purchase Notice (which shall be confirmed in an Add-On Purchase Confirmation), and the Investor
shall have no obligation to purchase such excess Purchase Shares in respect of such Add-On Purchase Notice; <U>provided</U>, <U>however</U>,
that the Investor shall remain obligated to purchase the Add-On Purchase Share Amount which the Company is permitted to include in such
Add-On Purchase Notice. Within one (1) Business Day after completion of each Add-On Purchase Date for an Add-On Purchase, the Investor
will provide to the Company a written confirmation of such Add-On Purchase setting forth the applicable Add-On Purchase Share Amount
and Add-On Purchase Price for such Add-On Purchase (each, an &ldquo;<U>Add-On Purchase Confirmation</U>&rdquo;). Notwithstanding the
foregoing, the Company shall not deliver any Add-On Purchase Notices to the Investor during the PEA Period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Intraday Purchases</U>. Subject to the terms and conditions of this Agreement, from and after the Commencement Date, in addition to
purchases of Purchase Shares as described in <U>Section 2(a)</U> and <U>Section 2(b)</U> above, the Company shall also have the right,
on no more than three (3) occasions during any Business Day, but not the obligation, to direct the Investor, by its timely delivery to
the Investor of an Intraday Purchase Notice on an Intraday Purchase Date in accordance with this Agreement, to purchase the applicable
Intraday Purchase Share Amount at the applicable Intraday Purchase Price therefor in accordance with this Agreement (each such purchase,
an &ldquo;<U>Intraday Purchase</U>&rdquo;); provided that the Company delivers an Intraday Purchase Notice to the Investor prior to 2:00
P.M. Eastern Time on any Business Day, that such notice specifies the number of shares to be purchased, and the Investor consents in
writing to such Intraday Purchase pursuant to the provisions of <U>Section 5(m)</U> below. The Company may submit up to three (3) Intraday
Purchase Notices in a single Business Day provided that delivery of shares by the Company pursuant to all prior Intraday Purchase Notices
has been made. If the Company delivers any Intraday Purchase Notice directing the Investor to purchase an amount of Purchase Shares that
exceeds the Intraday Purchase Share Amount that the Company is then permitted to include in such Intraday Purchase Notice, such Intraday
Purchase Notice shall be void <I>ab initio</I> to the extent of the amount by which the number of Purchase Shares set forth in such Intraday
Purchase Notice exceeds the Intraday Purchase Share Amount that the Company is then permitted to include in such Intraday Purchase Notice
(which shall be confirmed in an Intraday Purchase Confirmation), and the Investor shall have no obligation to purchase such excess Purchase
Shares in respect of such Intraday Purchase Notice; <U>provided</U>, <U>however</U>, that the Investor shall remain obligated to purchase
the Intraday Purchase Share Amount which the Company is permitted to include in such Intraday Purchase Notice. Within one (1) Business
Day after completion of each Intraday Purchase Date, the Investor will provide to the Company a written confirmation of each Intraday
Purchase on such Intraday Purchase Date setting forth the applicable Intraday Purchase Share Amount and Intraday Purchase Price for each
such Intraday Purchase on such Intraday Purchase Date (each, an &ldquo;<U>Intraday Purchase Confirmation</U>&rdquo;). Notwithstanding
the foregoing, the Company shall not deliver any Intraday Purchase Notices to the Investor during the PEA Period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Payment for Purchase Shares</U>. For each Regular Purchase, the Investor shall pay to the Company an amount equal to the Regular Purchase
Amount with respect to such Regular Purchase as full payment for such Purchase Shares via wire transfer of immediately available funds
on the same Business Day that the Investor receives such Purchase Shares, if such Purchase Shares are received by the Investor before
1:00 p.m., Eastern time, or, if such Purchase Shares are received by the Investor after 1:00 p.m., Eastern time, the next Business Day.
For each Add-On Purchase and each Intraday Purchase, the Investor shall pay to the Company an amount equal to the Purchase Amount with
respect to such Add-On Purchase and Intraday Purchase, respectively, as full payment for such Purchase Shares via wire transfer of immediately
available funds on the second Business Day following the date that the Investor receives such Purchase Shares. If the Company or the
Transfer Agent shall fail for any reason or for no reason to electronically transfer any Purchase Shares as DWAC Shares in respect of
a Regular Purchase, an Add-On Purchase or an Intraday Purchase (as applicable) within two (2) Business Days following the receipt by
the Company of the Regular Purchase Price, Add-On Purchase Price and Intraday Purchase Price, respectively, therefor in compliance with
this <U>Section 2(d)</U>, and if on or after such Business Day the Investor purchases (in an open market transaction or otherwise) shares
of Common Stock to deliver in satisfaction of a sale by the Investor of such Purchase Shares that the Investor anticipated receiving
from the Company in respect of such Regular Purchase, Add-On Purchase or Intraday Purchase (as applicable), then the Company shall, within
two (2) Business Days after the Investor&rsquo;s request, either (i) pay cash to the Investor in an amount equal to the Investor&rsquo;s
total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased (the &ldquo;<U>Cover Price</U>&rdquo;),
at which point the Company&rsquo;s obligation to deliver such Purchase Shares as DWAC Shares shall terminate, or (ii) promptly honor
its obligation to deliver to the Investor such Purchase Shares as DWAC Shares and pay cash to the Investor in an amount equal to the
excess (if any) of the Cover Price over the total Purchase Amount paid by the Investor pursuant to this Agreement for all of the Purchase
Shares to be purchased by the Investor in connection with such Regular Purchase, Add-On Purchase and Intraday Purchase (as applicable).
The Company shall not issue any fraction of a share of Common Stock upon any Regular Purchase, Add-On Purchase or Intraday Purchase.
If the issuance would result in the issuance of a fraction of a share of Common Stock, the Company shall round such fraction of a share
of Common Stock up to the nearest whole share. All payments made under this Agreement shall be made in lawful currency of the United
States of America by wire transfer of immediately available funds to such account as the Company (or the Investor, as applicable) may
from time to time designate by written notice in accordance with the provisions of this Agreement. Whenever any amount expressed to be
due by the terms of this Agreement is due on any day that is not a Business Day, the same shall instead be due on the next succeeding
day that is a Business Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Daily Investor Purchase Commitment Limitation</U>. Notwithstanding anything in this Agreement to the contrary, the Investor&rsquo;s
committed obligation to purchase shares under any single Regular Purchase shall not exceed Five Hundred Thousand Dollars ($500,000),
and the Investor&rsquo;s aggregate daily committed obligation for all Intraday Purchases in a single Business Day shall not exceed $1,000,000.
If the Company delivers any Regular Purchase Notice or Intraday Purchase Notice that individually or in the aggregate exceed the limitations
contained in the immediately preceding sentence, such notice or notices shall be null and void <I>ab initio</I> to the extent of the
amount by which the number of Purchase Shares set forth in such notice(s) exceeds the number of Purchase Shares which the Company is
permitted to include in such notice(s) in accordance herewith, and the Investor shall have no obligation to purchase such excess Purchase
Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Compliance with Rules of Principal Market</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 91.6pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>Exchange Cap</U>. Subject to <U>Section 2(e)(ii)</U> below, the Company shall not issue or sell any shares of Common Stock pursuant
to this Agreement, and the Investor shall not purchase or acquire any shares of Common Stock pursuant to this Agreement, to the extent
that after giving effect thereto, the aggregate number of shares of Common Stock that would be issued pursuant to this Agreement and
the transactions contemplated hereby would exceed 179,792 (such number of shares equal to 19.99% of the shares of Common Stock issued
and outstanding immediately prior to the execution of this Agreement), which number of shares shall be (i) reduced, on a share-for-share
basis, by the number of shares of Common Stock issued or issuable pursuant to any transaction or series of transactions that may be aggregated
with the transactions contemplated by this Agreement under applicable rules of The Nasdaq Stock Market and (ii) appropriately adjusted
for any reorganization, recapitalization, non-cash dividend, stock split or other similar transaction that occurs after the date of this
Agreement (such maximum number of shares, the &ldquo;<U>Exchange Cap</U>&rdquo;), unless and until the Company obtains Stockholder Approval
of the issuance of Common Stock as contemplated by this Agreement, and the stockholders of the Company have in fact approved the issuance
of Common Stock as contemplated by this Agreement in accordance with the applicable rules of The Nasdaq Stock Market. For the avoidance
of doubt, the Company may, but shall be under no obligation to, request its stockholders to approve the issuance of Common Stock as contemplated
by this Agreement; provided, that if Stockholder Approval is not obtained in accordance with this <U>Section 2(e)(i)</U>, the Exchange
Cap shall be applicable for all purposes of this Agreement and the transactions contemplated hereby at all times during the term of this
Agreement (except as set forth in <U>Section 2(e)(ii)</U> below).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 91.6pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
<U>At-Market Transaction</U>. Notwithstanding <U>Section 2(e)(i)</U> above, the Exchange Cap shall not be applicable for any purposes
of this Agreement and the transactions contemplated hereby, solely to the extent that (and only for so long as) the Average Price shall
equal or exceed the Base Price (it being hereby acknowledged and agreed that the Exchange Cap shall be applicable for all purposes of
this Agreement and the transactions contemplated hereby at all other times during the term of this Agreement, unless the Stockholder
Approval referred to in <U>Section 2(e)(i)</U> is obtained). The parties acknowledge and agree that the Signing Market Price used to
determine the Base Price hereunder represents the lower of (i) the official closing price of the Common Stock on The Nasdaq Capital Market
(as reflected on Nasdaq.com) on the trading day immediately preceding the date of this Agreement and (ii) the average official closing
price of the Common Stock on The Nasdaq Capital Market (as reflected on Nasdaq.com) for the five (5) consecutive trading days ending
on the trading day immediately preceding the date of this Agreement (the &ldquo;<U>Nasdaq Minimum Price</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 91.6pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
<U>General</U>. The Company shall not issue any shares of Common Stock pursuant to this Agreement if such issuance would reasonably be
expected to result in (A) a violation of the Securities Act or (B) a breach of the rules and regulations of the Principal Market, and
any Purchase Notice relating to such shares shall be null and void to the extent of such number of shares and the Company shall pay cash
to the Investor at the Cover Price per share for such shares of Common Stock. The provisions of this <U>Section 2(e)</U> shall be implemented
in a manner otherwise than in strict conformity with the terms hereof only if necessary to ensure compliance with the Securities Act,
the rules and regulations of the Principal Market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>Beneficial Ownership Limitation.</U> Notwithstanding anything to the contrary contained in this Agreement, the Company shall not issue
or sell, and the Investor shall not purchase or acquire, any shares of Common Stock under this Agreement which, when aggregated with
all other shares of Common Stock then beneficially owned by the Investor and its affiliates (as calculated pursuant to Section 13(d)
of the Exchange Act and Rule 13d-3 promulgated thereunder), would result in the beneficial ownership by the Investor of more than 4.99%
of the then issued and outstanding shares of Common Stock (the &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo;). For clarity, the
4.99% limitation applies to each transaction and is not a daily limit. Upon the written or oral request of the Investor, the Company
shall promptly (but not later than 24 hours) confirm orally or in writing to the Investor the number of shares of Common Stock then outstanding.
The Investor and the Company shall each cooperate in good faith in the determinations required hereby and the application hereof. The
Investor&rsquo;s written certification to the Company of the applicability of the Beneficial Ownership Limitation, and the resulting
effect thereof hereunder at any time, shall be conclusive with respect to the applicability thereof and such result absent manifest error.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.</B></FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INVESTOR&rsquo;S REPRESENTATIONS
  AND WARRANTIES.</B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Investor represents and warrants to the Company that as of the date hereof and as of the Commencement Date:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Investment Purpose</U>. The Investor is acquiring the Securities as principal for its own account for investment only and not with
a view to or for distributing or reselling such Securities or any part thereof in violation of the Securities Act or any applicable state
securities law, has no present intention of distributing any of such Securities in violation of the Securities Act or any applicable
state securities law and has no direct or indirect arrangement or understandings with any other Persons to distribute or regarding the
distribution of such Securities in violation of the Securities Act or any applicable state securities law (this representation and warranty
not limiting the Investor&rsquo;s right to sell the Securities at any time pursuant to the Registration Statement described herein or
otherwise in compliance with applicable federal and state securities laws). The Investor is acquiring the Securities hereunder in the
ordinary course of its business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Accredited Investor Status</U>. The Investor is an &ldquo;accredited investor&rdquo; as that term is defined in Rule 501(a)(3) of
Regulation D promulgated under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Reliance on Exemptions</U>. The Investor understands that the Securities are being offered and sold to it in reliance on specific
exemptions from the registration requirements of United States federal and state securities laws and that the Company is relying in part
upon the truth and accuracy of, and the Investor&rsquo;s compliance with, the representations, warranties, agreements, acknowledgments
and understandings of the Investor set forth herein in order to determine the availability of such exemptions and the eligibility of
the Investor to acquire the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Information</U>. The Investor understands that its investment in the Securities involves a high degree of risk. The Investor (i) is
able to bear the economic risk of an investment in the Securities including a total loss thereof, (ii) has such knowledge and experience
in financial and business matters that it is capable of evaluating the merits and risks of the proposed investment in the Securities
and (iii) has had an opportunity to ask questions of and receive answers from the officers of the Company concerning the financial condition
and business of the Company and other matters related to an investment in the Securities. Neither such inquiries nor any other due diligence
investigations conducted by the Investor or its representatives shall modify, amend or affect the Investor&rsquo;s right to rely on the
Company&rsquo;s representations and warranties contained in <U>Section 4</U> below. The Investor has sought such accounting, legal and
tax advice from its own independent advisors as it has considered necessary to make an informed investment decision with respect to its
acquisition of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>No Governmental Review</U>. The Investor understands that no U.S. federal or state agency or any other government or governmental
agency has passed on or made any recommendation or endorsement of the Securities or the fairness or suitability of an investment in the
Securities nor have such authorities passed upon or endorsed the merits of the offering of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Transfer or Sale</U>. The Investor understands that (i) the Securities may not be offered for sale, sold, assigned, pledged, hypothecated
or otherwise transferred unless (A) registered pursuant to the Securities Act or (B) an exemption exists permitting such Securities to
be sold, assigned or transferred without such registration; (ii) any sale of the Securities made in reliance on Rule 144 may be made
only in accordance with the terms of Rule 144 and further, if Rule 144 is not applicable, any resale of the Securities under circumstances
in which the seller (or the Person through whom the sale is made) may be deemed to be an underwriter (as that term is defined in the
Securities Act) may require compliance with some other exemption under the Securities Act or the rules and regulations of the SEC thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>Validity; Enforcement</U>. This Agreement and the Registration Rights Agreement have been duly and validly authorized, executed and
delivered on behalf of the Investor and each is a valid and binding agreement of the Investor enforceable against the Investor in accordance
with its terms, subject as to enforceability to general principles of equity and to applicable bankruptcy, insolvency, reorganization,
moratorium, liquidation and other similar laws relating to, or affecting generally, the enforcement of applicable creditors&rsquo; rights
and remedies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
<U>Residency</U>. The Investor is a resident of the State of Florida.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>No Short Selling</U>. The Investor represents and warrants to the Company that at no time prior to the date of this Agreement has
any of the Investor, its agents, representatives or affiliates engaged in or effected, in any manner whatsoever, directly or indirectly,
any (i) &ldquo;short sale&rdquo; (as such term is defined in Rule 200 of Regulation SHO of the Exchange Act) of the Common Stock or (ii)
hedging transaction, which establishes a net short position with respect to the Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.</B></FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>REPRESENTATIONS AND WARRANTIES
  OF THE COMPANY.</B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company represents and warrants to the Investor that, except as set forth in the disclosure schedules attached hereto, which exceptions
shall be deemed to be a part of the representations and warranties made hereunder, as of the date hereof and as of the Commencement Date:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Organization and Qualification</U>. The Company and each of its Subsidiaries is an entity duly incorporated or otherwise organized,
validly existing and in good standing under the laws of the jurisdiction of its incorporation or organization, with the requisite corporate
power and authority to own and use its properties and assets and to carry on its business as currently conducted. Each of the Company
and its Subsidiaries is duly qualified to conduct business and is in good standing as a foreign corporation or other entity in each jurisdiction
in which the nature of the business conducted or property owned by it makes such qualification necessary, except where the failure to
be so qualified or in good standing, as the case may be, could not have or reasonably be expected to result in a Material Adverse Effect
and no proceeding has been instituted in any such jurisdiction revoking, limiting or curtailing or seeking to revoke, limit or curtail
such power and authority or qualification. The Company has no Subsidiaries required to be disclosed pursuant to Item 601(b)(21) of Regulation
S-K, except as set forth in Exhibit 21.1 (as applicable) to the Company&rsquo;s Annual Report on Form 10-K for its fiscal year ended
December 31, 2024 filed with the SEC on March 31, 2025 (the &ldquo;<U>2024 Form 10-K</U>&rdquo;). If the Company has no Subsidiaries,
all other references, except as set forth in this Section 4(a), to the Subsidiaries or any of them in this Agreement shall be disregarded.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Authorization; Enforcement; Validity</U>. (i) The Company has the requisite corporate power and authority to enter into and perform
its obligations under this Agreement, the Registration Rights Agreement and each of the other Transaction Documents, and to issue the
Securities in accordance with the terms hereof and thereof, (ii) the execution and delivery of the Transaction Documents by the Company
and the consummation by it of the transactions contemplated hereby and thereby, including without limitation, the issuance of the Commitment
Shares (as defined below in <U>Section 5(e)</U>) and the reservation for issuance and the issuance of the Purchase Shares issuable under
this Agreement, have been duly authorized by the Company&rsquo;s Board of Directors and no further consent or authorization is required
by the Company, its Board of Directors or its stockholders (except as provided in this Agreement), (iii) each of this Agreement and the
Registration Rights Agreement has been, and each other Transaction Document shall be on the Commencement Date, duly executed and delivered
by the Company and (iv) each of this Agreement and the Registration Rights Agreement constitutes, and each other Transaction Document
upon its execution on behalf of the Company, shall constitute, the valid and binding obligations of the Company enforceable against the
Company in accordance with their terms, except as such enforceability may be limited by general principles of equity or applicable bankruptcy,
insolvency, reorganization, moratorium, liquidation or similar laws relating to, or affecting generally, the enforcement of creditors&rsquo;
rights and remedies. The Board of Directors of the Company has approved the resolutions (the &ldquo;<U>Signing Resolutions</U>&rdquo;)
substantially in the form as set forth as <B><U>Exhibit B</U></B> attached hereto to authorize this Agreement, the Registration Rights
Agreement and the transactions contemplated hereby. The Signing Resolutions are valid, in full force and effect and have not been modified
or supplemented in any respect. The Company has delivered to the Investor a true and correct copy of minutes of a meeting of the Board
of Directors of the Company at which the Signing Resolutions were duly adopted by the Board of Directors or a unanimous written consent
adopting the Signing Resolutions executed by all of the members of the Board of Directors of the Company. Except as set forth in this
Agreement, no other approvals or consents of the Company&rsquo;s Board of Directors, any authorized committee thereof, or stockholders
(except as provided in this Agreement) is necessary under applicable laws and the Company&rsquo;s Certificate of Incorporation or Bylaws
to authorize the execution and delivery of the Transaction Documents or any of the transactions contemplated thereby, including, but
not limited to, the issuance of the Commitment Shares and the issuance of the Purchase Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Capitalization</U>. As of the date hereof, the authorized capital stock of the Company is set forth in the Company&rsquo;s Form 10-Q
for the quarter ended June 30, 2025 filed on August 14, 2025. Except as disclosed in the SEC Documents (as defined below), (i) no shares
of the Company&rsquo;s capital stock are subject to preemptive rights or any other similar rights or any liens or encumbrances suffered
or permitted by the Company, (ii) there are no outstanding debt securities, (iii) other than securities issued pursuant to the Company&rsquo;s
equity incentive plan, there are no outstanding options, warrants, scrip, rights to subscribe to, calls or commitments of any character
whatsoever relating to, or securities or rights convertible into, any shares of capital stock of the Company or any of its Subsidiaries,
or contracts, commitments, understandings or arrangements by which the Company or any of its Subsidiaries is or may become bound to issue
additional shares of capital stock of the Company or any of its Subsidiaries or options, warrants, scrip, rights to subscribe to, calls
or commitments of any character whatsoever relating to, or securities or rights convertible into, any shares of capital stock of the
Company or any of its Subsidiaries, (iv) there are no agreements or arrangements under which the Company or any of its Subsidiaries is
obligated to register the sale of any of their securities under the Securities Act (except the Registration Rights Agreement), (v) there
are no outstanding securities or instruments of the Company or any of its Subsidiaries which contain any redemption or similar provisions,
and there are no contracts, commitments, understandings or arrangements by which the Company or any of its Subsidiaries is or may become
bound to redeem a security of the Company or any of its Subsidiaries, (vi) there are no securities or instruments containing anti-dilution
or similar provisions that will be triggered by the issuance of the Securities as described in this Agreement and (vii) the Company does
not have any stock appreciation rights or &ldquo;phantom stock&rdquo; plans or agreements or any similar plan or agreement. The Company
has furnished to the Investor true and correct copies of the Company&rsquo;s Amended and Restated Certificate of Incorporation, as amended
and as in effect on the date hereof (the &ldquo;<U>Certificate of Incorporation</U>&rdquo;), and the Company&rsquo;s Amended and Restated
Bylaws, as amended and as in effect on the date hereof (the &ldquo;<U>Bylaws</U>&rdquo;), and summaries of the material terms of all
securities convertible into or exercisable for Common Stock, if any, and copies of any documents containing the material rights of the
holders thereof in respect thereto that are not disclosed in the SEC Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Issuance of Securities</U>. Upon issuance and payment therefor in accordance with the terms and conditions of this Agreement, the
Purchase Shares shall be validly issued, fully paid and nonassessable and free from all taxes, liens, charges, restrictions, rights of
first refusal and preemptive rights with respect to the issue thereof, with the holders being entitled to all rights accorded to a holder
of Common Stock. Upon issuance in accordance with the terms and conditions of this Agreement, the Commitment Shares (as defined in <U>Section
5(e)</U>) and any Pre-Funded Warrants issued as all or part of the Commitment Fee shall be validly issued, and, in the case of Commitment
Shares, fully paid and nonassessable and free from all taxes, liens, charges, restrictions, rights of first refusal and preemptive rights
with respect to the issue thereof, with the holders being entitled to all rights accorded to a holder of Common Stock. Each Pre-Funded
Warrant issued pursuant to this Agreement shall be duly authorized and validly issued, and the shares of Common Stock issuable upon exercise
of any such Pre-Funded Warrant shall, upon exercise and payment of the exercise price in accordance with the terms of the Pre-Funded
Warrant, be validly issued, fully paid and nonassessable, and free from all taxes, liens, charges, restrictions, rights of first refusal
and preemptive rights with respect to the issue thereof, with the holders being entitled to all rights accorded to a holder of Common
Stock. 20,000,000 shares of Common Stock have been duly authorized and reserved for issuance upon purchase under this Agreement as Purchase
Shares and for issuance as Commitment Shares or upon exercise of any Pre-Funded Warrants issued pursuant to this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>No Conflicts</U>. The execution, delivery and performance of the Transaction Documents by the Company and the consummation by the
Company of the transactions contemplated hereby and thereby (including, without limitation, the issuance of the Commitment Shares and
the reservation for issuance and issuance of the Purchase Shares) will not (i) result in a violation of the Certificate of Incorporation,
any Certificate of Designations, Preferences and Rights of any outstanding series of preferred stock of the Company or the Bylaws or
(ii) conflict with, or constitute a default (or an event which with notice or lapse of time or both would become a default) under, or
give to others any rights of termination, amendment, acceleration or cancellation of, any agreement, indenture or instrument to which
the Company or any of its Subsidiaries is a party, or result in a violation of any law, rule, regulation, order, judgment or decree (including
federal and state securities laws and regulations, the rules of the Principal Market applicable to the Company or any of its Subsidiaries)
or by which any property or asset of the Company or any of its Subsidiaries is bound or affected, except in the case of conflicts, defaults,
terminations, amendments, accelerations, cancellations and violations under clause (ii), which could not reasonably be expected to result
in a Material Adverse Effect. Neither the Company nor its Subsidiaries is in violation of any term of or in default under its certificate
or articles of incorporation, any certificate of designation, preferences and rights of any outstanding series of preferred stock of
the Company or bylaws or other organizational documents. <FONT STYLE="background-color: white">Neither the Company nor any Subsidiary:
(i) is in default under or in violation of (and no event has occurred that has not been waived that, with notice or lapse of time or
both, would result in a default by the Company or any Subsidiary under), nor has the Company or any Subsidiary received notice of a claim
that it is in default under or that it is in violation of, any indenture, loan or credit agreement or any other agreement or instrument
to which it is a party or by which it or any of its properties is bound (whether or not such default or violation has been waived), (ii)
is in violation of any judgment, decree, or order of any court, arbitrator or other governmental authority or (iii) is in violation of
any statute, rule, ordinance or regulation of any governmental authority, including without limitation all foreign, federal, state and
local laws relating to taxes, environmental protection, occupational health and safety, product quality and safety and employment and
labor matters, except in each case as could not have or reasonably be expected to result in a Material Adverse Effect.</FONT> Except
as specifically contemplated by this Agreement and as required under the Securities Act or applicable state securities laws and the rules
of the Principal Market, the Company is not required to obtain any consent, authorization or order of, or make any filing or registration
with, any court or governmental agency or any regulatory or self-regulatory agency in order for it to execute, deliver or perform any
of its obligations under or contemplated by the Transaction Documents in accordance with the terms hereof or thereof. Except as set forth
elsewhere in this Agreement, all consents, authorizations, orders, filings and registrations which the Company is required to obtain
pursuant to the preceding sentence shall be obtained or effected on or prior to the Commencement Date. Except as disclosed in the SEC
Documents, since one year prior to the date hereof, the Company has not received nor delivered any notices or correspondence from or
to the Principal Market, other than notices with respect to listing of additional shares of Common Stock and other routine correspondence.
Except as disclosed in the SEC Documents, the Principal Market has not commenced any delisting proceedings against the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>SEC Documents; Financial Statements</U>. The Company has filed all reports, schedules, forms, statements and other documents required
to be filed by the Company under the Securities Act and the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof, for the
twelve months preceding the date hereof (or such shorter period as the Company was required by law or regulation to file such material)
(the foregoing materials, including the exhibits thereto and documents incorporated by reference therein, being collectively referred
to herein as the &ldquo;<U>SEC Documents</U>&rdquo;) on a timely basis or has received a valid extension of such time of filing and has
filed any such SEC Documents prior to the expiration of any such extension. As of their respective dates, the SEC Documents complied
in all material respects with the requirements of the Securities Act and the Exchange Act, as applicable. None of the SEC Documents,
when filed, contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary
in order to make the statements therein, in the light of the circumstances under which they were made, not misleading. <FONT STYLE="background-color: white">The
consolidated financial statements of the Company included or incorporated by reference in the SEC Documents, together with the related
notes and schedules, present fairly, in all material respects, the consolidated financial position of the Company as of the dates indicated
and the consolidated results of operations, cash flows and changes in stockholders&rsquo; equity of the Company for the periods specified
and have been prepared in compliance in all material respects with the requirements of the Securities Act and Exchange Act, as applicable,
as in effect as of the time of filing and in conformity with generally accepted accounting principles in the United States as in effect
as of the time of filing (&ldquo;<U>GAAP</U>&rdquo;) applied on a consistent basis (except (i) for such adjustments to accounting standards
and practices as are noted therein and (ii) in the case of unaudited interim statements, to the extent they may exclude footnotes or
may be condensed or summary statements) during the periods involved; the other financial and statistical data with respect to the Company
contained or incorporated by reference in the SEC Documents, are accurately and fairly presented in all material respects and prepared
on a basis materially consistent with the financial statements and books and records of the Company; there are no financial statements
(historical or pro forma) that are required to be included or incorporated by reference in the SEC Documents that are not included or
incorporated by reference as required; the Company does not have any material liabilities or obligations, direct or contingent (including
any off balance sheet obligations), not described in the SEC Documents (including the exhibits thereto and documents incorporated by
reference thereto), which are required to be described in the SEC Documents (including the exhibits thereto and documents incorporated
by reference thereto); and all disclosures contained or incorporated by reference in the SEC Documents, if any, regarding &ldquo;non-GAAP
financial measures&rdquo; (as such term is defined by the rules and regulations of the SEC) comply in all material respects with Regulation
G of the Exchange Act and Item 10 of Regulation S-K under the Securities Act, to the extent applicable.</FONT> T<FONT STYLE="background-color: white">he
Company does not have pending before the SEC any request for confidential treatment of information.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>Absence of Certain Changes; No Undisclosed Events, Liabilities or Developments; Solvency</U>. Except as disclosed in the SEC Documents,
since June 30, 2025, <FONT STYLE="background-color: white">(i) there has been no event, occurrence or development that has had or that
could reasonably be expected to result in a Material Adverse Effect, (ii) the Company has not incurred any liabilities (contingent or
otherwise) other than (A) trade payables and accrued expenses incurred in the ordinary course of business consistent with past practice
and (B) liabilities not required to be reflected in the Company&rsquo;s financial statements pursuant to GAAP or disclosed in filings
made with the SEC, (iii) the Company has not altered its method of accounting, (iv) the Company has not declared or made any dividend
or distribution of cash or other property to its stockholders or purchased, redeemed or made any agreements to purchase or redeem any
shares of its capital stock and (v) the Company has not issued any equity securities to any officer, director or affiliate, except pursuant
to existing Company stock option plans and as may be issued and sold pursuant to this Agreement. Except for the issuance of the Securities
contemplated by this Agreement, no event, liability, fact, circumstance, occurrence or development has occurred or exists or is reasonably
expected to occur or exist with respect to the Company or its Subsidiaries or their respective businesses, prospects, properties, operations,
assets or financial condition that would be required to be disclosed by the Company under applicable securities laws at the time this
representation is made or deemed made that has not been publicly disclosed at least one (1) Business Day prior to the date that this
representation is made</FONT>. The Company has not taken any steps, and does not currently expect to take any steps, to seek protection
pursuant to any Bankruptcy Law nor does the Company or any of its Subsidiaries have any knowledge or reason to believe that its creditors
intend to initiate involuntary bankruptcy or insolvency proceedings. The Company acknowledges that this representation is made as of
the date of this Agreement only and makes no representation about future events or circumstances. The Company is financially solvent
and is generally able to pay its debts as they become due.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
<U>Absence of Litigation</U>. <FONT STYLE="background-color: white">Except as disclosed in the SEC Documents, there is no action, suit,
inquiry, notice of violation, proceeding or investigation pending or, to the knowledge of the Company, threatened against or affecting
the Company, any Subsidiary or any of their respective properties before or by any court, arbitrator, governmental or administrative
agency or regulatory authority (federal, state, county, local or foreign) (collectively, an &ldquo;<U>Action</U>&rdquo;), which (i) adversely
affects or challenges the legality, validity or enforceability of any of the Transaction Documents or the Securities or (ii) could, if
there were an unfavorable decision, have or reasonably be expected to result in a Material Adverse Effect. Neither the Company nor any
Subsidiary, nor, to the knowledge of the Company, any director or officer thereof, is or has been the subject of any Action involving
a claim of violation of or liability under federal or state securities laws or a claim of breach of fiduciary duty, which would, if there
were an unfavorable decision, have or reasonably be expected to result in a Material Adverse Effect. There has not been, and to the knowledge
of the Company, there is not pending or contemplated, any investigation by the SEC involving the Company or any current or former director
or officer of the Company. The SEC has not issued any stop order or other order suspending the effectiveness of any registration statement
filed by the Company or any Subsidiary under the Exchange Act or the Securities Act.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>Acknowledgment Regarding Investor&rsquo;s Status</U>. The Company acknowledges and agrees that the Investor is acting solely in the
capacity of arm&rsquo;s length purchaser with respect to the Transaction Documents and the transactions contemplated hereby and thereby.
The Company further acknowledges that the Investor is not acting as a financial advisor or fiduciary of the Company (or in any similar
capacity) with respect to the Transaction Documents and the transactions contemplated hereby and thereby and any advice given by the
Investor or any of its representatives or agents in connection with the Transaction Documents and the transactions contemplated hereby
and thereby is merely incidental to the Investor&rsquo;s purchase of the Securities. The Company further represents to the Investor that
the Company&rsquo;s decision to enter into the Transaction Documents has been based solely on the independent evaluation by the Company
and its representatives and advisors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
<U>No General Solicitation; No Integrated Offering</U>. Neither the Company, nor any of its affiliates, nor any Person acting on its
or their behalf, has engaged in any form of general solicitation or general advertising (within the meaning of Regulation D under the
Securities Act) in connection with the offer or sale of the Securities. Neither the Company, nor or any of its affiliates, nor any Person
acting on their behalf has, directly or indirectly, made any offers or sales of any security or solicited any offers to buy any security,
under circumstances that would require registration of the offer and sale of any of the Securities under the Securities Act, whether
through integration with prior offerings or otherwise, or cause this offering of the Securities to be integrated with prior offerings
by the Company in a manner that would require stockholder approval pursuant to the rules of the Principal Market on which any of the
securities of the Company are listed or designated. The issuance and sale of the Securities hereunder does not contravene the rules and
regulations of the Principal Market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
<U>Intellectual Property Rights</U>. <FONT STYLE="background-color: white">The Company and the Subsidiaries have, or have rights to use,
all patents, patent applications, trademarks, trademark applications, service marks, trade names, trade secrets, inventions, copyrights,
licenses and other intellectual property rights and similar rights necessary or required for use in connection with their respective
businesses as described in the SEC Documents and which the failure to so have could have a Material Adverse Effect (collectively, the
&ldquo;<U>Intellectual Property Rights</U>&rdquo;). None of, and neither the Company nor any Subsidiary has received a notice (written
or otherwise) that any of, the Intellectual Property Rights has expired, terminated or been abandoned, or is expected to expire or terminate
or be abandoned, within two (2) years from the date of this Agreement. Neither the Company nor any Subsidiary has received, since the
date of the latest audited financial statements included within the SEC Documents, a written notice of a claim or otherwise has any knowledge
that the Intellectual Property Rights violate or infringe upon the rights of any Person, except as could not have or reasonably be expected
to not have a Material Adverse Effect. To the knowledge of the Company, all such Intellectual Property Rights are enforceable and there
is no existing infringement by another Person of any of the Intellectual Property Rights. The Company and its Subsidiaries have taken
reasonable security measures to protect the secrecy, confidentiality and value of all of the Intellectual Property Rights, except where
failure to do so could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
<U>Environmental Laws</U>. <FONT STYLE="background-color: white">The Company and its Subsidiaries (i) are in compliance with all federal,
state, local and foreign laws relating to pollution or protection of human health or the environment (including ambient air, surface
water, groundwater, land surface or subsurface strata), including laws relating to emissions, discharges, releases or threatened releases
of chemicals, pollutants, contaminants, or toxic or hazardous substances or wastes (collectively, &ldquo;<U>Hazardous Materials</U>&rdquo;)
into the environment, or otherwise relating to the manufacture, processing, distribution, use, treatment, storage, disposal, transport
or handling of Hazardous Materials, as well as all authorizations, codes, decrees, demands, or demand letters, injunctions, judgments,
licenses, notices or notice letters, orders, permits, plans or regulations, issued, entered, promulgated or approved thereunder (&ldquo;<U>Environmental
Laws</U>&rdquo;); (ii) have received all permits licenses or other approvals required of them under applicable Environmental Laws to
conduct their respective businesses; and (iii) are in compliance with all terms and conditions of any such permit, license or approval
where in each clause (i), (ii) and (iii), the failure to so comply could be reasonably expected to have, individually or in the aggregate,
a Material Adverse Effect.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)
<U>Title</U>. The Company and its Subsidiaries have good and marketable title in fee simple to all real property owned by them and good
and marketable title in all personal property owned by them that is material to the business of the Company and its Subsidiaries, in
each case free and clear of all liens, encumbrances and defects (&ldquo;<U>Liens</U>&rdquo;), except as otherwise set forth in the SEC
Documents, and except for (i) Liens as do not materially affect the value of such property and do not materially interfere with the use
made and proposed to be made of such property by the Company and its Subsidiaries and (ii) Liens for the payment of federal, state or
other taxes for which appropriate reserves have been made therefor in accordance with GAAP and the payment of which is neither delinquent
nor subject to penalties. Any real property and facilities held under lease by the Company and its Subsidiaries are held by them under
valid, subsisting and enforceable leases with which the Company and its Subsidiaries are in compliance with such exceptions as are not
material and do not interfere with the use made and proposed to be made of such property and buildings by the Company and its Subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)
<U>Insurance</U>. The Company and each of its Subsidiaries are insured by insurers of recognized financial responsibility against such
losses and risks and in such amounts as management of the Company reasonably believes to be prudent and customary in the businesses in
which the Company and its Subsidiaries are engaged, including, but not limited to, directors&rsquo; and officers&rsquo; (D&amp;O) insurance
coverage. Neither the Company nor any such Subsidiary has been refused any insurance coverage sought or applied for and neither the Company
nor any such Subsidiary has any reason to believe that it will not be able to renew its existing insurance coverage as and when such
coverage expires or to obtain similar coverage from similar insurers as may be necessary to continue its business without a significant
increase in cost.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)
<U>Regulatory Permits</U>. <FONT STYLE="background-color: white">The Company and the Subsidiaries possess all certificates, authorizations
and permits issued by the appropriate federal, state, local or foreign regulatory authorities necessary to conduct their respective businesses
as described in the SEC Documents, except where the failure to possess such permits could not reasonably be expected to result in a Material
Adverse Effect (&ldquo;<U>Material Permits</U>&rdquo;), and neither the Company nor any Subsidiary has received any notice of any Proceeding
relating to the revocation or modification of any Material Permit. For all purposes of this Agreement, the term &ldquo;<U>Proceeding</U>&rdquo;
means </FONT>an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial
proceeding, such as a deposition), whether commenced or threatened.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p)
<U>Tax Status</U>. <FONT STYLE="background-color: white">Except for matters that would not, individually or in the aggregate, have or
reasonably be expected to result in a Material Adverse Effect, the Company and its Subsidiaries each (i) has made or filed all United
States federal, state and local income and all foreign income and franchise tax returns, reports and declarations required by any jurisdiction
to which it is subject, (ii) has paid all taxes and other governmental assessments and charges that are material in amount, shown or
determined to be due on such returns, reports and declarations, except for taxes, if any, as are being contested in good faith and as
to which adequate reserves have been established by the Company and (iii) has set aside on its books provision reasonably adequate for
the payment of all material taxes for periods subsequent to the periods to which such returns, reports or declarations apply. There are
no unpaid taxes in any material amount claimed to be due by the taxing authority of any jurisdiction, and the officers of the Company
or of any Subsidiary know of no basis for any such claim.</FONT> The term &ldquo;<U>taxes</U>&rdquo; means all federal, state, local,
foreign, and other net income, gross income, gross receipts, sales, use, ad valorem, transfer, franchise, profits, license, lease, service,
service use, withholding, payroll, employment, excise, severance, stamp, occupation, premium, property, windfall profits, customs, duties,
or other taxes, fees, assessments, or charges of any kind whatsoever, together with any interest and any penalties, additions to tax,
or additional amounts with respect thereto. The term &ldquo;<U>returns</U>&rdquo; means all returns, declarations, reports, statements,
and other documents required to be filed in respect to taxes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q)
<U>Transactions With Affiliates and Employees</U>. <FONT STYLE="background-color: white">Except as disclosed in the SEC Documents, none
of the officers or directors of the Company or any Subsidiary and, to the knowledge of the Company, none of the employees of the Company
or any Subsidiary is presently a party to any transaction with the Company or any Subsidiary (other than for services as employees, officers
and directors), including any contract, agreement or other arrangement providing for the furnishing of services to or by, providing for
rental of real or personal property to or from, providing for the borrowing of money from or lending of money to or otherwise requiring
payments to or from any officer, director or such employee or, to the knowledge of the Company, any entity in which any officer, director,
or any such employee has a substantial interest or is an officer, director, trustee, stockholder, member or partner, in each case in
excess of $120,000 other than for (i) payment of salary or consulting fees for services rendered, (ii) reimbursement for expenses incurred
on behalf of the Company and (iii) other employee benefits, including stock option agreements under any equity incentive plan of the
Company</FONT>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r)
<U>Application of Takeover Protections</U>. The Company and its board of directors have taken or will take prior to the Commencement
Date all necessary action, if any, in order to render inapplicable any control share acquisition, business combination, poison pill (including
any distribution under a rights agreement) or other similar anti-takeover provision under the Certificate of Incorporation or the laws
of the state of its incorporation which is or could become applicable to the Investor as a result of the transactions contemplated by
this Agreement, including, without limitation, the Company&rsquo;s issuance of the Securities and the Investor&rsquo;s ownership of the
Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(s)
<U>Disclosure</U>. Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents
that will be timely publicly disclosed by the Company, the Company confirms that neither it nor any other Person authorized to act on
its behalf has provided the Investor or its agents or counsel with any information that it believes constitutes or might constitute material,
non-public information which is not otherwise disclosed in the Registration Statement or the SEC Documents. The Company understands and
confirms that the Investor will rely on the foregoing representation in effecting purchases and sales of securities of the Company, provided
that such reliance must be reasonable under the circumstances. All of the disclosure furnished by or on behalf of the Company by a Person
authorized by the Company to the Investor regarding the Company, its business and the transactions contemplated hereby is true and correct
and does not contain any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements
made therein, in light of the circumstances under which they were made, not misleading. The press releases disseminated by the Company
during the twelve months preceding the date of this Agreement taken as a whole do not contain any untrue statement of a material fact
or omit to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the
circumstances under which they were made and when made, not misleading. The Company acknowledges and agrees that the Investor neither
makes nor has made any representations or warranties with respect to the transactions contemplated hereby other than those specifically
set forth in <U>Section 3</U> hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(t)
<U>Foreign Corrupt Practices</U>. Neither the Company nor any Subsidiary, nor, to the Company&rsquo;s Knowledge, any agent or other person
acting on behalf of the Company or any Subsidiary, has (i) directly or indirectly, used any funds for unlawful contributions, gifts,
entertainment or other unlawful expenses related to foreign or domestic political activity, (ii) made any unlawful payment to foreign
or domestic government officials or employees or to any foreign or domestic political parties or campaigns from corporate funds, (iii)
failed to disclose fully any contribution made by the Company and each Subsidiary (or made by any person acting on behalf of the Company
and each Subsidiary of which the Company is aware) which is in violation of law, or (iv) violated in any material respect any provision
of the Foreign Corrupt Practices Act of 1977, as amended (the &ldquo;<U>FCPA</U>&rdquo;). The Company has taken reasonable steps to ensure
that its accounting controls and procedures are sufficient to cause the Company to comply in all material respects with the FCPA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(u)
<U>DTC Eligibility</U>. The Company, through the Transfer Agent, currently participates in the DTC Fast Automated Securities Transfer
(FAST) Program and the Common Stock can be transferred electronically to third parties via the DTC Fast Automated Securities Transfer
(FAST) Program.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
<U>Sarbanes-Oxley Act; Internal Controls</U>. <FONT STYLE="background-color: white">The Company and the Subsidiaries are in compliance
in all material respects with all applicable requirements of the Sarbanes-Oxley Act of 2002 that are effective as of the date hereof,
and all applicable rules and regulations promulgated by the SEC thereunder that are effective as of the Commencement Date. Except as
disclosed in the SEC Documents, the Company and the Subsidiaries maintain a system of internal accounting controls sufficient to provide
reasonable assurance that: (i) transactions are executed in accordance with management&rsquo;s general or specific authorizations, (ii)
transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain asset accountability,
(iii) access to assets is permitted only in accordance with management&rsquo;s general or specific authorization, and (iv) the recorded
accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to
any differences. Except as disclosed in the SEC Documents, the Company and the Subsidiaries have established disclosure controls and
procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the Company and the Subsidiaries and designed such disclosure
controls and procedures to ensure that information required to be disclosed by the Company in the reports it files or submits under the
Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC&rsquo;s rules and forms. The
Company&rsquo;s certifying officers have evaluated the effectiveness of the disclosure controls and procedures of the Company and the
Subsidiaries as of the end of the period covered by the most recently filed periodic report under the Exchange Act (such date, the &ldquo;<U>Evaluation
Date</U>&rdquo;). The Company presented in its most recently filed periodic report under the Exchange Act the conclusions of the certifying
officers about the effectiveness of the disclosure controls and procedures based on their evaluations as of the Evaluation Date. Since
the Evaluation Date, there have been no changes in the internal control over financial reporting (as such term is defined in the Exchange
Act) of the Company and its Subsidiaries that have materially affected, or are reasonably likely to materially affect, the internal control
over financial reporting of the Company and its Subsidiaries.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(w)
<U>Certain Fees</U>. No brokerage or finder&rsquo;s fees or commissions are or will be payable by the Company to any broker, financial
advisor or consultant, finder, investment banker, bank or other Person with respect to the transactions contemplated by the Transaction
Documents, except for the cash fee payable to Dawson James Securities, Inc. (&ldquo;<U>DJS</U>&rdquo;) pursuant to the Advisory Agreement
between the Company and DJS and equal to 1.5% of the gross proceeds received by the Company from the sale of securities to the Investor
pursuant to any Regular Purchase, Add-On Purchase, or Intraday Purchase. The Investor shall have no obligation with respect to any fees
or with respect to any claims made by or on behalf of other Persons for fees of a type contemplated in this <U>Section 4(w)</U> that
may be due in connection with the transactions contemplated by the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)
<U>Investment Company</U>. <FONT STYLE="background-color: white">The Company is not, and is not an affiliate of, and immediately after
receipt of payment for the Purchase Shares will not be or be an affiliate of, an &ldquo;investment company&rdquo; within the meaning
of the Investment Company Act of 1940, as amended. The Company shall conduct its affairs in such a manner so as to reasonably ensure
that it will not be or become, at any time prior to the termination of this Agreement, an &ldquo;investment company,&rdquo; as such term
is defined in the Investment Company Act of 1940, as amended.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(y)
<U>Listing and Maintenance Requirements</U>. The Common Stock is registered pursuant to Section 12(b) of the Exchange Act, and the Company
has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration of the Common
Stock pursuant to the Exchange Act nor has the Company received any notification that the SEC is currently contemplating terminating
such registration. The issued and outstanding shares of Common Stock are listed and posted for trading on the Principal Market, and e<FONT STYLE="background-color: white">xcept
as disclosed in the SEC Documents, </FONT>the Company is in compliance in all respects with the current listing requirements of the Principal
Market; and the Securities will be listed and posted for trading on the Principal Market at or prior to Commencement, with respect to
the Commitment Shares, and prior to the time of sale to the Investor pursuant to this Agreement, with respect to the Purchase Shares.
Except as disclosed in the SEC Documents, the Company has not, in the twelve (12) months preceding the date hereof, received any notice
from any Person to the effect that the Company is not in compliance with the listing or maintenance requirements of the Principal Market.
Except as disclosed in the SEC Documents, the Company is, and has no reason to believe that it will not in the foreseeable future continue
to be, in compliance with all such listing and maintenance requirements, other than such requirements related to the bid price of the
Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(z)
<U>Accountants</U>. <FONT STYLE="background-color: white">As of the date hereof, the Company&rsquo;s independent registered public accounting
firm is </FONT>CBIZ CPAs P.C. <FONT STYLE="background-color: white">(the &ldquo;<U>Auditor</U>&rdquo;). Fahn Kanne &amp; Co., the previous
auditor, has expressed an unqualified opinion with respect to the Company&rsquo;s consolidated financial statements included in the 2024
Form 10-K filed by the Company with the SEC. To the knowledge and belief of the Company, the Auditor is an independent registered public
accounting firm as required by the Exchange Act. Neither t</FONT>he Auditor nor the prior auditor has, during the periods covered by
the financial statements included in the 2024 Form 10-K, provided to the Company any non-audit services, as such term is used in Section
10A(g) of the Exchange Act, excluding any non-audit services approved in compliance with Section 10A(h) of the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(aa)
<U>No Market Manipulation</U>. The Company has not, and to its knowledge no Person acting on its behalf has, (i) taken, directly or indirectly,
any action designed to cause or to result in the stabilization or manipulation of the price of any security of the Company to facilitate
the sale or resale of any of the Securities, (ii) sold, bid for, purchased, or, paid any compensation for soliciting purchases of, any
of the Securities, or (iii) paid or agreed to pay to any Person any compensation for soliciting another to purchase any other securities
of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(bb)
<U>Shell Company Status</U>. The Company is not currently, and has never been, an issuer identified in Rule 144(i)(1) under the Securities
Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">(cc)
<U>Office of Foreign Assets Control</U>. Neither the Company nor any Subsidiary nor, to the Company&rsquo;s knowledge, any director,
officer, agent, employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the
Office of Foreign Assets Control of the U.S. Treasury Department (&ldquo;<U>OFAC</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">(dd)
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>U.S. Real Property Holding Corporation</U>. The Company
is not and has never been a U.S. real property holding corporation within the meaning of Section 897 of the Internal Revenue Code of
1986, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ee)
<U>Bank Holding Company Act</U>. Neither the Company nor any of its Subsidiaries or affiliates is subject to the Bank Holding Company
Act of 1956, as amended (the &ldquo;<U>BHCA</U>&rdquo;) and to regulation by the Board of Governors of the Federal Reserve System (the
&ldquo;<U>Federal Reserve</U>&rdquo;). Neither the Company nor any of its Subsidiaries or affiliates owns or controls, directly or indirectly,
five percent (5%) or more of the outstanding shares of any class of voting securities or twenty-five percent (25%) or more of the total
equity of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve. Neither the Company nor any of its
Subsidiaries or affiliates exercises a controlling influence over the management or policies of a bank or any entity that is subject
to the BHCA and to regulation by the Federal Reserve.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ff)
<U>Money Laundering</U>. <FONT STYLE="background-color: white">The operations of the Company and its Subsidiaries are and have been conducted
at all times in compliance with applicable financial record-keeping and reporting requirements of the Currency and Foreign Transactions
Reporting Act of 1970, as amended, applicable money laundering statutes and applicable rules and regulations thereunder (collectively,
the &ldquo;<U>Money Laundering Laws</U>&rdquo;), and no Action or Proceeding by or before any court or governmental agency, authority
or body or any arbitrator involving the Company or any Subsidiary with respect to the Money Laundering Laws is pending or, to the knowledge
of the Company or any Subsidiary, threatened.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(gg)
<U>Labor Matters</U>. <FONT STYLE="background-color: white">No labor dispute exists or, to the knowledge of the Company, is imminent
with respect to any of the employees of the Company, which could reasonably be expected to result in a Material Adverse Effect. None
of the Company&rsquo;s or its Subsidiaries&rsquo; employees is a member of a union that relates to such employee&rsquo;s relationship
with the Company or such Subsidiary, and neither the Company nor any of its Subsidiaries is a party to a collective bargaining agreement,
and the Company and its Subsidiaries believe that their relationships with their employees are good. To the knowledge of the Company,
no executive officer of the Company or any Subsidiary, is, or is now expected to be, in violation of any material term of any employment
contract, confidentiality, disclosure or proprietary information agreement or non-competition agreement, or any other contract or agreement
or any restrictive covenant in favor of any third party, and the continued employment of each such executive officer does not subject
the Company or any of its Subsidiaries to any liability with respect to any of the foregoing matters. The Company and its Subsidiaries
are in compliance with all U.S. federal, state, local and foreign laws and regulations relating to employment and employment practices,
terms and conditions of employment and wages and hours, except where the failure to be in compliance could not, individually or in the
aggregate, reasonably be expected to have a Material Adverse Effect.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">(hh)
<U>Cybersecurity</U>. Except as would not reasonably be expected to have a Material Adverse Effect, the Company (i) has operated and
continues to operate its business in a manner compliant with all applicable United States federal, state, and local, and non-United States,
privacy, data security, and data protection laws and regulations (including, without limitation, the General Data Protection Regulation
(EU) 2016/679 and the California Consumer Privacy Act) applicable to the Company&rsquo;s collection, use, transfer, protection, disposal,
disclosure, handling, storage, and analysis of data that is defined as &ldquo;personal data&rdquo; under applicable law (&ldquo;<U>Personal
Data</U>&rdquo;), (ii) has been and is in compliance with its internal policies and procedures designed to ensure the integrity and security
of the Personal Data collected, handled or stored by the Company in connection with its business, (iii) has been and is in compliance
with its internal policies and procedures designed to ensure compliance with, to the extent applicable to the Company, health care laws
that govern privacy and data security and takes, and has taken, reasonably appropriate steps designed to assure its compliance with such
policies and procedures. Except as would not reasonably be expected to have a Material Adverse Effect, the Company has taken reasonable
steps to maintain the confidentiality of its Personal Data, protected health information, consumer information, and other confidential
information of the Company and any third parties in the possession and control of the Company (&ldquo;<U>Sensitive Company Data</U>&rdquo;).
Except as would not reasonably be expected to have a Material Adverse Effect, the Company&rsquo;s tangible or digital information technology
systems (including computers, screens, servers, workstations, routers, hubs, switches, networks, data communications lines, technical
data and hardware), software, websites, applications and telecommunications systems (the &ldquo;<U>Company IT Assets</U>&rdquo;) are
adequate in capacity and operation for, in accordance with their documentation and functional specifications, the business of the Company
as now operated as described in the Registration Statement and the Prospectus, free and clear of all Trojan horses, time bombs, malware,
and other bugs, errors, or defects that, in each case, create material risk of a security breach with respect to such Company IT Assets
or Sensitive Company Data processed thereon. Except as would not reasonably be expected to have a Material Adverse Effect, the Company
has used reasonable efforts to establish, and has established, commercially reasonable disaster recovery and security plans, procedures
and facilities for the business of the Company consistent with industry standards and practices, including, without limitation, for the
Company IT Assets and Sensitive Company Data held or used by the Company. Except as would not reasonably be expected to have a Material
Adverse Effect, (i) to the Company&rsquo;s knowledge, the Company has not suffered or incurred any security breaches, compromises or
incidents with respect to any Company IT Asset or Sensitive Company Data and (ii) to the Company&rsquo;s knowledge, there has been no
unauthorized or illegal use of, or access to, any Company IT Asset or Sensitive Company Data by any unauthorized third party. Except
as would not reasonably be expected to have a Material Adverse Effect, to the Company&rsquo;s knowledge, the Company has not been required
to notify any individual of any information security breach, compromise or incident involving Sensitive Company Data.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
<FONT STYLE="background-color: white"><U>Stock Option Plans</U>. Each stock option granted by the Company under the Company&rsquo;s stock
option plan was granted (i) in accordance with the terms of the Company&rsquo;s stock option plan and (ii) with an exercise price at
least equal to the fair market value of the Common Stock on the date such stock option would be considered granted under GAAP and applicable
law. No stock option granted under the Company&rsquo;s stock option plan has been backdated. The Company has not knowingly granted, and
there is no and has been no Company policy or practice to knowingly grant, stock options prior to, or otherwise knowingly coordinate
the grant of stock options with, the release or other public announcement of material information regarding the Company or its Subsidiaries
or their financial results or prospects.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(jj)
<U>Enforceability of Material Agreements</U>. The agreements and documents described in the SEC Documents conform to the descriptions
thereof contained therein and there are no agreements or other documents required by the Securities Act and the rules and regulations
thereunder to be described in the SEC Documents or to be filed with the SEC as exhibits to the SEC Documents, that have not been so described
or filed. Each agreement or other instrument (however characterized or described) to which the Company is a party or by which it is or
may be bound or affected and (i) that is referred to in the SEC Documents, or (ii) is material to the Company&rsquo;s business, has been
duly authorized and validly executed by the Company, is in full force and effect in all material respects and is enforceable against
the Company and, to the Company&rsquo;s knowledge, the other parties thereto, in accordance with its terms, except (x) as such enforceability
may be limited by bankruptcy, insolvency, reorganization or similar laws affecting creditors&rsquo; rights generally, (y) as enforceability
of any indemnification or contribution provision may be limited under the federal and state securities laws, and (z) that the remedy
of specific performance and injunctive and other forms of equitable relief may be subject to the equitable defenses and to the discretion
of the court before which any proceeding therefore may be brought. None of such agreements or instruments has been assigned by the Company,
and neither the Company nor, to the best of the Company&rsquo;s knowledge, any other party is in default thereunder and, to the best
of the Company&rsquo;s knowledge, no event has occurred that, with the lapse of time or the giving of notice, or both, would constitute
a default thereunder. To the best of the Company&rsquo;s knowledge, performance by the Company of the material provisions of such agreements
or instruments will not result in a violation of any existing applicable law, rule, regulation, judgment, order or decree of any governmental
agency or court, domestic or foreign, having jurisdiction over the Company or any of its assets or businesses, including, without limitation,
those relating to environmental laws and regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(kk)
<U>Smaller Reporting Company Status</U>. As of the date hereof, the Company was, and as of the Commencement Date, the Company believes
in good faith that it will be, a &ldquo;smaller reporting company&rdquo; as defined in Rule 12b-2 of the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ll)
<U>Emerging Growth Company Status</U>. As of the date of this Agreement, the Company was not, and as of the Commencement Date, the Company
will not be, an &ldquo;emerging growth company&rdquo; as defined in Section 2(a)(19) of the Securities Act, as modified by the Jumpstart
Our Business Startups Act of 2012.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(mm)
<U>Regulatory Matters</U>. As to each product subject to the jurisdiction of the U.S. Food and Drug Administration (&ldquo;<U>FDA</U>&rdquo;)
under the Federal Food, Drug and Cosmetic Act, as amended, and the regulations thereunder (&ldquo;<U>FDCA</U>&rdquo;) that is manufactured,
packaged, labeled, tested, distributed, sold, and/or marketed by the Company or any of its Subsidiaries (each such product, a &ldquo;<U>Pharmaceutical
Product</U>&rdquo;), such Pharmaceutical Product is being manufactured, packaged, labeled, tested, distributed, sold and/or marketed
by the Company in compliance with all applicable requirements under FDCA and similar laws, rules and regulations relating to registration,
investigational use, premarket clearance, licensure, or application approval, good manufacturing practices, good laboratory practices,
good clinical practices, product listing, quotas, labeling, advertising, record keeping and filing of reports, except where the failure
to be in compliance would not have a Material Adverse Effect. There is no pending, completed or, to the Company&rsquo;s knowledge, threatened,
action (including any lawsuit, arbitration, or legal or administrative or regulatory proceeding, charge, complaint, or investigation)
against the Company or any of its Subsidiaries, and none of the Company or any of its Subsidiaries has received any notice, warning letter
or other communication from the FDA or any other governmental entity, which (i) contests the premarket clearance, licensure, registration,
or approval of, the uses of, the distribution of, the manufacturing or packaging of, the testing of, the sale of, or the labeling and
promotion of any Pharmaceutical Product, (ii) withdraws its approval of, requests the recall, suspension, or seizure of, or withdraws
or orders the withdrawal of advertising or sales promotional materials relating to, any Pharmaceutical Product, (iii) imposes a clinical
hold on any clinical investigation by the Company or any of its Subsidiaries, (iv) enjoins production at any facility of the Company
or any of its Subsidiaries, (v) enters or proposes to enter into a consent decree of permanent injunction with the Company or any of
its Subsidiaries, or (vi) otherwise alleges any violation of any laws, rules or regulations by the Company or any of its Subsidiaries,
and which, either individually or in the aggregate, would have a Material Adverse Effect. The properties, business and operations of
the Company have been and are being conducted in all material respects in accordance with all applicable laws, rules and regulations
of the FDA. The Company has not been informed by the FDA that the FDA will prohibit the marketing, sale, license or use in the United
States of any product proposed to be developed, produced or marketed by the Company nor has the FDA expressed any concern as to approving
or clearing for marketing any product being developed or proposed to be developed by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(nn)
<U>Consents and Permits</U>. The Company and the Subsidiaries have made all filings, applications and submissions required by, and possess
and are operating in compliance in all material respects with all approvals, licenses, certificates, certifications, clearances, consents,
grants, exemptions, marks, notifications, orders, permits and other authorizations issued by, the appropriate federal, state or foreign
governmental authority (including the FDA, the United States Drug Enforcement Administration, the Centers for Medicare &amp; Medicaid
Services (&ldquo;<U>CMS</U>&rdquo;), or any other foreign, federal, state, provincial or local Government Authorities engaged in the
regulation of clinical trials, pharmaceuticals, biologics or biohazardous substances or materials) necessary for the ownership or lease
of their respective properties or to conduct their businesses as described in the SEC Documents (collectively, &ldquo;<U>Permits</U>&rdquo;),
except for such Permits the failure of which to possess, obtain or file would not reasonably be expected to have, individually or in
the aggregate, a Material Adverse Effect; the Company and the Subsidiaries are in compliance with the terms and conditions of all such
Permits, except where the failure to be in compliance would not reasonably be expected to have, individually or in the aggregate, a Material
Adverse Effect; all of the Permits are valid and in full force and effect, except where any invalidity would not reasonably be expected
to have, individually or in the aggregate, a Material Adverse Effect; and neither the Company nor any of the Subsidiaries has received
any notice relating to the limitation, revocation, cancellation, suspension, modification or non-renewal of any such Permit which, if
the subject of an unfavorable decision, ruling or finding, would reasonably be expected to have, individually or in the aggregate, a
Material Adverse Effect, or has any reason to believe that any such license, certificate, permit or authorization will not be renewed
in the ordinary course. To the extent required by applicable laws of the FDA, the Company or the applicable Subsidiary has submitted
to the FDA an Investigational Device Exemption Application or amendment or supplement thereto for each clinical trial it has conducted
or sponsored or is conducting or sponsoring; all such submissions were in material compliance with applicable laws when submitted and
no material deficiencies have been asserted by the FDA with respect to any such submissions. The Company and each Subsidiary possess
such valid and current certificates, authorizations or permits issued by the appropriate state, federal or foreign regulatory agencies
or bodies necessary to conduct their respective businesses, and neither the Company nor any Subsidiary has received, or has any reason
to believe that it will receive, any notice of proceedings relating to the revocation or modification of, or non-compliance with, any
such certificate, authorization or permit which, if the subject of an unfavorable decision, ruling or finding, would reasonably be expected
to have, individually or in the aggregate, a Material Adverse Effect. The Company has not applied for &ldquo;approved enterprise&rdquo;,
&ldquo;benefited enterprise&rdquo; or &ldquo;preferred enterprise&rdquo; status with respect to any of the Company&rsquo;s facilities
or operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(oo)
<U>Regulatory Filings</U>. Neither the Company nor any of the Subsidiaries has failed to file with the applicable governmental authority
(including the FDA, or any foreign, federal, state, provincial or local governmental authority performing functions similar to those
performed by the FDA) any required filing, declaration, listing, registration, report or submission, except for such failures that would
not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect. All such filings, declarations, listings,
registrations, reports or submissions were in substantial compliance with applicable laws when filed and no deficiencies have been asserted
by any applicable regulatory authority with respect to any such filings, declarations, listings, registrations, reports or submissions,
except for any deficiencies that would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect.
The Company has operated and currently is, in all material respects, in compliance with the United States Federal Food, Drug, and Cosmetic
Act, and all applicable rules and regulations of the FDA and other federal, state, local and foreign governmental authority exercising
comparable authority. The Company has no knowledge of any studies, tests or trials not described in the SEC Documents, the results of
which reasonably call into question in any material respect the results of the studies, tests and trials described in the SEC Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(pp)
<U>Healthcare Laws</U>. The Company and, to the Company&rsquo;s knowledge, its directors, officers, employees, and agents (while acting
in such capacity) are in compliance with all health care laws and regulations applicable to the Company or any of its product candidates
or activities, including development and testing of medical devices and pharmaceutical products, kickbacks, recordkeeping, documentation
requirements, the hiring of employees, quality, safety, privacy, security, licensure, accreditation or any other aspect of developing
and testing medical devices or pharmaceutical products (collectively, &ldquo;<U>Health Care Laws</U>&rdquo;), except where such noncompliance
would not, individually or in the aggregate, have a Material Adverse Effect. The Company has not received any notification, correspondence
or any other written or oral communication, including notification of any pending or threatened claim, suit, proceeding, hearing, enforcement,
investigation, arbitration or other action from any governmental or regulatory authority or third party, including, without limitation,
the FDA, CMS, the U.S. Department of Health and Human Services Office of Inspector General or Officer of Civil Rights, of potential or
actual non-compliance by, or liability of, the Company under any Health Care Laws, except for any such communication (i) that asserts
any such non-compliance that would not reasonably be expected to have a Material Adverse Effect or (ii) that the Company believes has
been resolved to the satisfaction of such governmental or regulatory authority or third party as of the date hereof. No such claim, action,
suit, proceeding, hearing, enforcement, investigation, arbitration or other action is pending or, to the Company&rsquo;s knowledge, threatened.
The Company has not received any FDA Form 483, notice including a determination of adverse finding by the FDA, warning letter, untitled
letter or other correspondence or notice from the FDA or any other governmental authority alleging or asserting noncompliance with any
Health Care Laws or any licenses, certificates, approvals, clearances, authorizations, permits and supplements or amendments thereto
required by any such Health Care Laws (&ldquo;<U>Authorizations</U>&rdquo;), except for any such letter or other correspondence or notice
(A) that asserts any such non-compliance that would not reasonably be expected to have a Material Adverse Effect or (B) that the Company
believes has been resolved to the satisfaction of the FDA or other such governmental authority as of the date hereof. The Company reasonably
believes it is not a &ldquo;covered entity&rdquo;, as defined under the Health Insurance Portability and Accountability Act of 1996,
as amended (&ldquo;<U>HIPAA</U>&rdquo;), and has not received any requests or demands from a covered entity or governmental authority
to make available its internal practices, books, and/or records relating to its use and disclosure of health information for purposes
of determining a covered entity&rsquo;s or the Company&rsquo;s compliance with HIPAA or with other applicable privacy law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(qq)
<U>Clinical Studies</U>. The preclinical studies and tests and clinical trials described in the SEC Documents were, and, if still pending,
are being conducted in all material respects in accordance with the experimental protocols, procedures and controls pursuant to, where
applicable, accepted professional and scientific standards for products or product candidates comparable to those being developed by
the Company; the descriptions of such studies, tests and trials, and the results thereof, contained in the SEC Documents are accurate
and complete in all material respects; the Company is not aware of any tests, studies or trials not described in the SEC Documents, the
results of which reasonably call into question in any material respect the results of the tests, studies and trials described in the
SEC Documents; and the Company has not received any written notice or correspondence from the FDA or any foreign, state or local governmental
authority exercising comparable authority or any institutional review board or comparable authority requiring the termination, suspension,
clinical hold or material modification of any tests, studies or trials described in the SEC Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(rr)
<U>No Disqualification Events</U>. None of the Company, any of its predecessors, any affiliated issuer, any director, executive officer,
other officer of the Company participating in the offering contemplated hereby, any beneficial owner of 20% or more of the Company&rsquo;s
outstanding voting equity securities, calculated on the basis of voting power, nor any promoter (as that term is defined in Rule 405
under the Securities Act) connected with the Company in any capacity at the time of sale (each, an &ldquo;<U>Issuer Covered Person</U>&rdquo;)
is subject to any of the &ldquo;Bad Actor&rdquo; disqualifications described in Rule 506(d)(1)(i) to (viii) under the Securities Act
(a &ldquo;<U>Disqualification Event</U>&rdquo;), except for a Disqualification Event covered by Rule 506(d)(2) or (d)(3) under the Securities
Act. The Company has exercised reasonable care to determine whether any Issuer Covered Person is subject to a Disqualification Event.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.</B></FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>COVENANTS.</B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Filing of Current Report and Registration Statement</U>. The Company agrees that it shall, within the time required under the Exchange
Act, file with the SEC a report on Form 8-K relating to the transactions contemplated by, and describing the material terms and conditions
of, the Transaction Documents (the &ldquo;<U>Current Report</U>&rdquo;). The Company shall also file with the SEC, within fifteen (15)
calendar days from the date hereof, a new registration statement (the &ldquo;<U>Registration Statement</U>&rdquo;) covering only the
resale of the total number of shares that may be purchased by the Investor pursuant to this Agreement and all of the Commitment Shares,
and shall use its reasonable best efforts to have it declared effective within forty-five (45) days thereafter, in accordance with the
terms of the Registration Rights Agreement between the Company and the Investor, dated as of the date hereof (the &ldquo;<U>Registration
Rights Agreement</U>&rdquo;). The Company shall permit the Investor to review and comment upon (1) the final pre-filing draft version
of the Current Report at least two (2) Business Days prior to its filing with the SEC, and the Company shall give due consideration to
all such comments. The Investor shall use its reasonable best efforts to comment upon the Current Report within one (1) Business Day
from the date the Investor receives the final versions thereof from the Company. The Investor shall cooperate with the Company as reasonably
requested by the Company in connection with the preparation and filing of the Current Report with the SEC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Blue Sky</U>. The Company shall take all such action, if any, as is reasonably necessary in order to obtain an exemption for or to
register or qualify (i) the issuance of the Commitment Shares and the sale of the Purchase Shares to the Investor under this Agreement
and (ii) any subsequent resale of all Commitment Shares and all Purchase Shares by the Investor, in each case, under applicable securities
or &ldquo;Blue Sky&rdquo; laws of the states of the United States in such states as is reasonably requested by the Investor from time
to time, and shall provide evidence of any such action so taken to the Investor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Listing/DTC</U>. The Company shall promptly secure the additional listing of all of the Purchase Shares and Commitment Shares to be
issued to the Investor hereunder on the Principal Market (subject to official notice of issuance) and upon each other national securities
exchange or automated quotation system, if any, upon which the Common Stock is then listed, and shall use commercially reasonable efforts
to maintain, so long as any shares of Common Stock shall be so listed, such listing of all such Securities from time to time issuable
hereunder. The Company shall use commercially reasonable efforts to maintain the listing of the Common Stock on the Principal Market
and shall comply in all respects with the Company&rsquo;s reporting, filing and other obligations under the bylaws or rules and regulations
of the Principal Market. Neither the Company nor any of its Subsidiaries shall take any action that would reasonably be expected to result
in the delisting or suspension of the Common Stock on the Principal Market. The Company shall promptly, and in no event later than the
following Business Day, provide to the Investor copies of any notices it receives from any Person regarding the continued eligibility
of the Common Stock for listing on the Principal Market; provided, however, that the Company shall not be required to provide the Investor
copies of any such notice that the Company reasonably believes constitutes material non-public information and the Company would not
be required to publicly disclose such notice in any report or statement filed with the SEC and under the Exchange Act or the Securities
Act. The Company shall pay all fees and expenses in connection with satisfying its obligations under this <U>Section 5(c)</U>. The Company
shall take all action necessary to ensure that its Common Stock can be transferred electronically as DWAC Shares. The Company shall take
all action necessary to ensure that Stockholder Approval is obtained as soon as reasonably practicable, but in no event later than November
6, 2025.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>No Shorting</U>. The Investor agrees that it will not, directly or indirectly, engage in any &ldquo;short sale&rdquo; (as such term
is defined in Rule 200 of Regulation SHO of the Exchange Act) or establish any short position, whether through put options, short sales,
or other derivative positions or instruments, with respect to the Common Stock while this Agreement is outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Issuance of Commitment Fee Shares</U>. In consideration for the Investor&rsquo;s execution and delivery of this Agreement, the Company
shall pay to the Investor a commitment fee equal to 1.5% of the total Commitment Amount (the &ldquo;<U>Commitment Fee</U>&rdquo;), payable
in cash, shares of Common Stock, Pre-Funded Warrants, or any combination thereof, at the Company&rsquo;s sole discretion. If the Commitment
Fee is paid in shares of Common Stock or Pre-Funded-Warrants (such shares, including any such shares issuable upon exercise of any Pre-Funded
Warrants, the &ldquo;<U>Commitment Shares</U>&rdquo;), the number of shares issued shall be determined based on the lower of (i) the
official closing price of the Common Stock on The Nasdaq Capital Market (as reflected on Nasdaq.com) on the trading day immediately preceding
the Commencement Date and (ii) the average official closing price of the Common Stock on The Nasdaq Capital Market (as reflected on Nasdaq.com)
for the five (5) consecutive trading days ending on the trading day immediately preceding the Commencement Date. The Commitment Fee shall
be fully earned and payable on the Commencement Date, regardless of whether any Purchase Shares are purchased by the Investor under this
Agreement or if the Agreement is subsequently terminated. In the event that any portion of the Commitment Fee is paid in shares of Common
Stock or Pre-Funded Warrants, the Investor agrees to hold all such shares and/or shares issued upon exercise of Pre-Funded Warrants for
a minimum period of three (3) months following the Commencement Date. After the expiration of this initial three-month period, the Investor
may sell up to fifty percent (50%) of the shares and/or shares issued upon exercise of Pre-Funded Warrants. The remaining fifty percent
(50%) may not be sold until six (6) months after the Commencement Date. The Company shall deliver to the Transfer Agent the Irrevocable
Transfer Agent Instructions with respect to the issuance of such shares and/or Pre-Funded Warrants, if applicable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Due Diligence; Non-Public Information</U>. The Investor shall have the right, from time to time as the Investor may reasonably deem
appropriate and upon at least two (2) business days&rsquo; advance written notice to the Company, to perform reasonable due diligence
on the Company during normal business hours. The Company and its officers and employees shall provide information and reasonably cooperate
with the Investor in connection with any reasonable request by the Investor related to the Investor&rsquo;s due diligence of the Company.
Each party hereto agrees not to disclose any Confidential Information of the other party to any third party and shall not use the Confidential
Information for any purpose other than in connection with, or in furtherance of, the transactions contemplated hereby. Each party hereto
acknowledges that the Confidential Information shall remain the property of the disclosing party and agrees that it shall take all reasonable
measures to protect the secrecy of any Confidential Information disclosed by the other party. The Company confirms that neither it nor
any other Person acting on its behalf shall provide the Investor or its agents or counsel with any information that constitutes or might
constitute material, non-public information, unless a simultaneous public announcement thereof is made by the Company in the manner contemplated
by Regulation FD. In the event of a breach of the foregoing covenant by the Company or any Person acting on its behalf (as determined
in the reasonable good faith judgment of the Investor), in addition to any other remedy provided herein or in the other Transaction Documents,
if the Investor is holding any Securities at the time of the disclosure of material, non-public information, the Investor shall have
the right to make a public disclosure, in the form of a press release, public advertisement or otherwise, of such material, non-public
information without the prior approval by the Company; provided the Investor shall have first provided notice to the Company that it
believes it has received information that constitutes material, non-public information, the Company shall have at least 24 hours to publicly
disclose such material, non-public information prior to any such disclosure by the Investor, the Company shall have failed to demonstrate
to the Investor in writing within such time period that such information does not constitute material, non-public information, and the
Company shall have failed to publicly disclose such material, non-public information within such time period. The Investor shall not
have any liability to the Company, any of its Subsidiaries, or any of their respective directors, officers, employees, stockholders or
agents, for any such disclosure. The Company understands and confirms that the Investor shall be relying on the foregoing covenants in
effecting transactions in securities of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>Purchase Records</U>. The Investor and the Company shall each maintain records showing the remaining Available Amount at any given
time and the dates and Purchase Amount for each Regular Purchase, Add-On Purchase and Intraday Purchase or shall use such other method,
reasonably satisfactory to the Investor and the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
<U>Taxes.</U> The Company shall pay any and all transfer, stamp or similar taxes that may be payable with respect to the issuance and
delivery of any shares of Common Stock to the Investor made under this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>Use of Proceeds</U>. The Company will use the net proceeds from the offering as described in the Registration Statement or the SEC
Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
<U>Other Transactions</U>. The Company shall not enter into, announce or recommend to its stockholders any agreement, plan, arrangement
or transaction in or of which the terms thereof would restrict, materially delay, conflict with or impair the ability or right of the
Company to perform its obligations under the Transaction Documents, including, without limitation, the obligation of the Company to deliver
the Purchase Shares subject to any outstanding Regular Purchase Notice, Add-On Purchase Notice or Intraday Purchase Notice and the Commitment
Shares to the Investor in accordance with the terms of the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
<U>Integration</U>. From and after the date of this Agreement, neither the Company, nor any of its affiliates will, and the Company shall
use its reasonable best efforts to ensure that no Person acting on their behalf will, directly or indirectly, make any offers or sales
of any security or solicit any offers to buy any security, under circumstances that would (i) require registration of the offer and sale
by the Company to the Investor of any of the Securities under the Securities Act, or (ii) cause this offering of the Securities by the
Company to the Investor to be integrated with other offerings by the Company in a manner that would require stockholder approval pursuant
to the rules of the Principal Market on which any of the securities of the Company are listed or designated, unless in the case of this
clause (ii), stockholder approval is obtained before the closing of such subsequent transaction in accordance with the rules of such
Principal Market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
<U>Variable Rate Prohibition</U>. From and after the date of this Agreement and while this Agreement is outstanding, the Company shall
not, without the prior written approval of the Investor, enter into any variable, reset, or otherwise adjustable equity or equity-linked
transactions, other than a future at-the-market facility with DJS. The Investor shall be entitled to seek injunctive relief against the
Company and its Subsidiaries to preclude any such issuance, which remedy shall be in addition to any right to collect damages, without
the necessity of showing economic loss and without any bond or other security being required.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)
<U>Standstill</U>. The Company shall not issue any Intraday Purchase Notice after the issuance of an Add-On Purchase Notice without the
Investor&rsquo;s consent. The Company shall not execute, close or announce any equity or debt financing arrangement during the period
commencing on the date of a Regular Purchase Share Notice, an Add-On Purchase Notice or an Intraday Purchase Notice and ending on the
Business Day following the payment for the purchase subject to each such notice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6.</B></FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TRANSFER AGENT INSTRUCTIONS.</B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
On the Commencement Date, the Company shall issue irrevocable instructions to the Transfer Agent substantially in the form attached hereto
as <B><U>Exhibit D</U></B> to issue the Commitment Shares in accordance with the terms of this Agreement (the &ldquo;<U>Irrevocable Transfer
Agent Instructions</U>&rdquo;). The certificate(s) or book-entry statement(s) representing the Commitment Shares, except as set forth
below, shall bear the following restrictive legends:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THE
SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE
SECURITIES LAWS. THE SECURITIES HAVE BEEN ACQUIRED FOR INVESTMENT AND MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED IN THE
ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES
LAWS, UNLESS SOLD PURSUANT TO: (1) RULE 144 UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (2) AN OPINION OF HOLDER&rsquo;S COUNSEL,
IN A CUSTOMARY FORM, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR APPLICABLE STATE SECURITIES LAWS.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THE
SECURITIES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO A LOCKUP AS SET FORTH IN THE PURCHASE AGREEMENT, DATED SEPTEMBER 11,
2025 (AS AMENDED, RESTATED OR OTHERWISE MODIFIED FROM TIME TO TIME, THE &ldquo;PURCHASE AGREEMENT&rdquo;), BY AND BETWEEN GLUCOTRACK,
INC. AND SIXTH BOROUGH CAPITAL FUND, LP, AND MAY NOT BE OFFERED, SOLD, TRANSFERRED, PLEDGED OR OTHERWISE DISPOSED DURING THE TERM OF
THE LOCKUP. A COPY OF SUCH PURCHASE AGREEMENT WILL BE FURNISHED WITHOUT CHARGE BY THE COMPANY TO THE HOLDER HEREOF UPON WRITTEN REQUEST.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Following the expiration of the transfer restrictions set forth in Section 5(e), or such time thereafter upon the Investor&rsquo;s request,
provided all conditions of Rule 144 under the Securities Act are met or the registration statement relating to the resale of those shares
by the Investor has been declared effective under the Securities Act by the SEC, and no stop order with respect to the Registration Statement
shall be pending or threatened by the SEC, the Company shall, no later than one (1) Business Day following the delivery by the Investor
to the Company or the Transfer Agent of one or more legended certificates or book-entry statements representing the Commitment Shares
(which certificates or book-entry statements the Investor shall promptly deliver on or prior to the first to occur of the events described
in clauses (i) and (ii) of this sentence), as directed by the Investor, issue and deliver (or cause to be issued and delivered) to the
Investor, as requested by the Investor, either: (A) a certificate or book-entry statement representing such Commitment Shares that is
free from all restrictive and other legends or (B) a number of shares of Common Stock equal to the number of Commitment Shares represented
by the certificate(s) or book-entry statement(s) so delivered by the Investor as DWAC Shares. The Company shall take all actions to carry
out the intent and accomplish the purposes of the immediately preceding sentence, including, without limitation, delivering all such
legal opinions, consents, certificates, resolutions and instructions to the Transfer Agent, and any successor transfer agent of the Company,
as may be requested from time to time by the Investor or necessary or desirable to carry out the intent and accomplish the purposes of
the immediately preceding sentence. On the Commencement Date, the Company shall issue to the Transfer Agent, and any subsequent transfer
agent, (i) irrevocable instructions in the form substantially similar to those used by the Investor in substantially similar transactions
(the &ldquo;<U>Commencement Irrevocable Transfer Agent Instructions</U>&rdquo;) and (ii) the notice of effectiveness of the Registration
Statement in the form attached as an exhibit to the Registration Rights Agreement (the &ldquo;<U>Notice of Effectiveness of Registration
Statement</U>&rdquo;), in each case to issue the Commitment Shares and the Purchase Shares in accordance with the terms of this Agreement
and the Registration Rights Agreement. All Purchase Shares and Commitment Shares to be issued from and after Commencement to or for the
benefit of the Investor pursuant to this Agreement shall be issued only as DWAC Shares. The Company represents and warrants to the Investor
that, while this Agreement is effective, no instruction other than the Commencement Irrevocable Transfer Agent Instructions and the Notice
of Effectiveness of Registration Statement referred to in this <U>Section 6(b)</U> will be given by the Company to the Transfer Agent
with respect to the Purchase Shares or the Commitment Shares from and after Commencement, and the Purchase Shares and the Commitment
Shares covered by the Registration Statement shall otherwise be freely transferable on the books and records of the Company. If the Investor
effects a sale, assignment or transfer of the Purchase Shares, the Company shall permit the transfer and shall promptly instruct the
Transfer Agent (and any subsequent transfer agent) to issue DWAC Shares in such name and in such denominations as specified by the Investor
to effect such sale, transfer or assignment. The Company acknowledges that a breach by it of its obligations hereunder will cause irreparable
harm to the Investor. Accordingly, the Company acknowledges that the remedy at law for a breach of its obligations under this <U>Section
6 </U>will be inadequate and agrees, in the event of a breach or threatened breach by the Company of the provisions of this <U>Section
6</U>, that the Investor shall be entitled, in addition to all other available remedies, to an order and/or injunction restraining any
breach and requiring immediate issuance and transfer, without the necessity of showing economic loss and without any bond or other security
being required. The Company agrees that if the Company fails to fully comply with the provisions of this <U>Section 6(b)</U> within five
(5) Business Days of the Investor providing the deliveries referred to above, the Company shall, at the Investor&rsquo;s written instruction,
purchase such shares of Common Stock containing the restrictive legend from the Investor at the greater of the (i) purchase price paid
for such shares of Common Stock (as applicable) and (ii) the Closing Sale Price of the Common Stock on the date of the Investor&rsquo;s
written instruction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>7.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CONDITIONS
                                            TO THE COMPANY&rsquo;S RIGHT TO COMMENCE SALES OF SHARES OF COMMON STOCK.</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
right of the Company hereunder to commence sales of the Purchase Shares on the Commencement Date is subject to the satisfaction of each
of the following conditions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The Investor shall have executed each of the Transaction Documents and delivered the same to the Company;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The Registration Statement covering the resale of the Purchase Shares and all of the Commitment Shares shall have been declared effective
under the Securities Act by the SEC, and no stop order with respect to the Registration Statement shall be pending or threatened by the
SEC; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
The representations and warranties of the Investor shall be true and correct in all material respects as of the date hereof and as of
the Commencement Date as though made at that time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CONDITIONS
                                            TO THE INVESTOR&rsquo;S OBLIGATION TO PURCHASE SHARES OF COMMON STOCK.</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
obligation of the Investor to buy Purchase Shares under this Agreement is subject to the satisfaction of each of the following conditions
on or prior to the Commencement Date and, once such conditions have been initially satisfied, there shall not be any ongoing obligation
to satisfy such conditions after the Commencement has occurred:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The Company shall have executed each of the Transaction Documents and delivered the same to the Investor;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The Company shall have issued or caused to be issued to the Investor, no later than one (1) Business Day following the Commencement Date,
either: (i) one or more certificates or book-entry statements representing the Commitment Shares or (ii) if such shares are free from
all restrictive and other legends, a number of shares of Common Stock equal to the number of Commitment Shares as DWAC Shares, in each
case in accordance with <U>Section 6(b)</U>;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
The Common Stock shall be listed or quoted on the Principal Market, subject only to customary listing conditions, trading in the Common
Stock shall not have been within the last 365 days suspended by the SEC, the Principal Market, and all Securities to be issued by the
Company to the Investor pursuant to this Agreement shall have been approved for listing or quotation on the Principal Market in accordance
with the applicable rules and regulations of the Principal Market, subject only to official notice of issuance and any standard listing
conditions for transactions of this nature;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
The Investor shall have received the opinions and negative assurances of the Company&rsquo;s legal counsel, dated as of the Commencement
Date, substantially in the forms heretofore agreed by the parties hereto;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
The representations and warranties of the Company shall be true and correct in all material respects (except to the extent that any of
such representations and warranties is already qualified as to materiality in Section 4 above, in which case, the portion of such representations
and warranties so qualified shall be true and correct without further qualification) as of the date hereof and as of the Commencement
Date as though made at that time (except for representations and warranties that speak as of a specific date, which shall be true and
correct as of such date) and the Company shall have performed, satisfied and complied with the covenants, agreements and conditions required
by the Transaction Documents to be performed, satisfied or complied with by the Company at or prior to the Commencement Date. The Investor
shall have received a certificate, executed by the President, CEO and CFO of the Company, dated as of the Commencement Date, to the foregoing
effect substantially in the form attached hereto as <B><U>Exhibit A</U></B>;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
The Board of Directors of the Company shall have adopted resolutions substantially in the form attached hereto as <B><U>Exhibit B</U></B>
which shall be in full force and effect without any amendment or supplement thereto as of the Commencement Date;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 29; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
As of the Commencement Date, the Company shall have reserved out of its authorized and unissued Common Stock, solely for the purpose
of effecting purchases of Purchase Shares hereunder, 20,000,000 shares of Common Stock;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
The Commencement Irrevocable Transfer Agent Instructions and the Notice of Effectiveness of Registration Statement each shall have been
delivered to and acknowledged in writing by the Company and the Company&rsquo;s Transfer Agent (or any successor transfer agent);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
The Company shall have delivered to the Investor a certificate evidencing the incorporation and good standing of the Company in the State
of Delaware issued by the Secretary of State of the State of Delaware as of a date within one (1) Business Day of the Commencement Date;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
The Company shall have delivered to the Investor a certified copy of the Certificate of Incorporation as certified by the Secretary of
State of the State of Delaware within ten (10) Business Days of the Commencement Date;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
The Company shall have delivered to the Investor a secretary&rsquo;s certificate executed by the Secretary of the Company, dated as of
the Commencement Date, substantially in the form attached hereto as <B><U>Exhibit C</U></B>;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
The Registration Statement covering the resale of the Purchase Shares and all of the Commitment Shares shall have been declared effective
under the Securities Act by the SEC, and no stop order with respect to the Registration Statement shall be pending or threatened by the
SEC. The Company shall have prepared and filed with the SEC, not later than one (1) Business Day after the effective date of the Registration
Statement, a final and complete prospectus (the preliminary form of which shall be included in the Registration Statement) and shall
have delivered to the Investor a true and complete copy thereof. Such prospectus shall be current and available for the resale by the
Investor of all of the Securities covered thereby. The Current Report shall have been filed with the SEC as required pursuant to <U>Section
5(a)</U>. All reports, schedules, registrations, forms, statements, information and other documents required to have been filed by the
Company with the SEC at or prior to the Commencement Date pursuant to the reporting requirements of the Exchange Act shall have been
filed with the SEC within the applicable time periods prescribed for such filings under the Exchange Act;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)
No Suspension Event has occurred, or any event which, after notice and/or lapse of time, would become a Suspension Event has occurred;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)
All federal, state and local governmental laws, rules and regulations applicable to the transactions contemplated by the Transaction
Documents and necessary for the execution, delivery and performance of the Transaction Documents and the consummation of the transactions
contemplated thereby in accordance with the terms thereof shall have been complied with, and all consents, authorizations and orders
of, and all filings and registrations with, all federal, state and local courts or governmental agencies and all federal, state and local
regulatory or self-regulatory agencies necessary for the execution, delivery and performance of the Transaction Documents and the consummation
of the transactions contemplated thereby in accordance with the terms thereof shall have been obtained or made, including, without limitation,
in each case those required under the Securities Act, the Exchange Act, applicable state securities or &ldquo;Blue Sky&rdquo; laws or
applicable rules and regulations of the Principal Market, or otherwise required by the SEC, the Principal Market or any state securities
regulators;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)
No statute, regulation, order, decree, writ, ruling or injunction shall have been enacted, entered, promulgated, threatened or endorsed
by any federal, state or local court or governmental authority of competent jurisdiction which prohibits the consummation of or which
would materially modify or delay any of the transactions contemplated by the Transaction Documents; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 30; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p)
No action, suit or proceeding before any federal, state, local or foreign arbitrator or any court or governmental authority of competent
jurisdiction shall have been commenced or threatened, and no inquiry or investigation by any federal, state, local or foreign governmental
authority of competent jurisdiction shall have been commenced or threatened, against the Company, or any of the officers, directors or
affiliates of the Company, seeking to restrain, prevent or change the transactions contemplated by the Transaction Documents, or seeking
material damages in connection with such transactions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q)
The Company shall have reimbursed legal fees incurred by the Investor (and offset by any amounts advanced by the Investor) not to exceed
$75,000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>9.</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INDEMNIFICATION.</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
consideration of the Investor&rsquo;s execution and delivery of the Transaction Documents and acquiring the Securities hereunder and
in addition to all of the Company&rsquo;s other obligations under the Transaction Documents, the Company shall defend, protect, indemnify
and hold harmless the Investor and all of its affiliates, stockholders, members, officers, directors, employees and direct or indirect
investors and any of the foregoing Person&rsquo;s agents or other representatives (including, without limitation, those retained in connection
with the transactions contemplated by this Agreement) (collectively, the &ldquo;<U>Indemnitees</U>&rdquo;) from and against any and all
actions, causes of action, suits, claims, losses, costs, penalties, fees, liabilities and damages, and expenses in connection therewith
(irrespective of whether any such Indemnitee is a party to the action for which indemnification hereunder is sought), and including reasonable
attorneys&rsquo; fees and disbursements (the &ldquo;<U>Indemnified Liabilities</U>&rdquo;), incurred by any Indemnitee as a result of,
or arising out of, or relating to (a) any misrepresentation or breach of any representation or warranty made by the Company in the Transaction
Documents or any other certificate, instrument or document contemplated hereby or thereby, (b) any breach of any covenant, agreement
or obligation of the Company contained in the Transaction Documents or any other certificate, instrument or document contemplated hereby
or thereby, or (c) any cause of action, suit or claim brought or made against such Indemnitee and arising out of or resulting from the
execution, delivery, performance or enforcement of the Transaction Documents or any other certificate, instrument or document contemplated
hereby or thereby, other than, in the case of clause (c), with respect to Indemnified Liabilities which directly and primarily result
from the fraud, gross negligence or willful misconduct of an Indemnitee. The indemnity in this <U>Section 9</U> shall not apply to amounts
paid in settlement of any claim if such settlement is effected without the prior written consent of the Company, which consent shall
not be unreasonably withheld, conditioned or delayed. To the extent that the foregoing undertaking by the Company may be unenforceable
for any reason, the Company shall make the maximum contribution to the payment and satisfaction of each of the Indemnified Liabilities
which is permissible under applicable law. Payment under this indemnification shall be made within thirty (30) days from the date Investor
makes written request for it; provided, however, that the Indemnitee must undertake to repay any amounts paid to it hereunder if it is
ultimately determined, by a final and non-appealable order of a court of competent jurisdiction, that the Indemnitee is not entitled
to be indemnified against such Indemnified Liabilities by the Company pursuant to this Agreement. A certificate containing reasonable
detail as to the amount of such indemnification submitted to the Company by Investor shall be conclusive evidence, absent manifest error,
of the amount due from the Company to Investor. If any action shall be brought against any Indemnitee in respect of which indemnity may
be sought pursuant to this Agreement, such Indemnitee shall promptly notify the Company in writing, and the Company shall have the right
to assume the defense thereof with counsel of its own choosing reasonably acceptable to the Indemnitee. Any Indemnitee shall have the
right to employ separate counsel in any such action and participate in the defense thereof, but the fees and expenses of such counsel
shall be at the expense of such Indemnitee, except to the extent that (i) the employment thereof has been specifically authorized by
the Company in writing, (ii) the Company has failed after a reasonable period of time to assume such defense and to employ counsel or
(iii) in such action there is, in the reasonable opinion of such separate counsel, a material conflict on any material issue between
the position of the Company and the position of such Indemnitee, in which case the Company shall be responsible for the reasonable fees
and expenses of no more than one such separate counsel.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 31; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.</B></FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SUSPENSION EVENTS.</B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
&ldquo;<U>Suspension Event</U>&rdquo; shall be deemed to have occurred at any time as any of the following events occurs:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
the effectiveness of a registration statement registering the resale of the Securities lapses for any reason (including, without limitation,
the issuance of a stop order or similar order) or such registration statement (or the prospectus forming a part thereof) is unavailable
to the Investor for resale of any or all of the Securities to be issued to the Investor under the Transaction Documents, and such lapse
or unavailability continues for a period of ten (10) consecutive Business Days or for more than an aggregate of thirty (30) Business
Days in any 365-day period, but excluding a lapse or unavailability where (i) the Company terminates a registration statement after the
Investor has confirmed in writing that all of the Securities covered thereby have been resold or (ii) the Company supersedes one registration
statement with another registration statement, including (without limitation) by terminating a prior registration statement when it is
effectively replaced with a new registration statement covering Securities (provided in the case of this clause (ii) that all of the
Securities covered by the superseded (or terminated) registration statement that have not theretofore been resold are included in the
superseding (or new) registration statement);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
the suspension of the Common Stock from trading on the Principal Market for a period of one (1) Business Day, provided that the Company
may not direct the Investor to purchase any shares of Common Stock during any such suspension;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
the delisting of the Common Stock from The Nasdaq Capital Market (or any nationally recognized successor thereto), provided, however,
that the Common Stock is not immediately thereafter trading on The Nasdaq Global Market, The Nasdaq Global Select Market, the New York
Stock Exchange, the NYSE American, the NYSE Arca, or The OTCQX Best Market or The OTCQB Venture Market operated by OTC Markets Group,
Inc. (or any nationally recognized successor to any of the foregoing);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
the failure for any reason by the Transfer Agent to issue Purchase Shares to the Investor within two (2) Business Days after the Regular
Purchase Date, Add-On Purchase Date or Intraday Purchase Date, as applicable, on which the Investor is entitled to receive such Purchase
Shares;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
the Company breaches any representation, warranty, covenant or other term or condition under any Transaction Document if such breach
would reasonably be expected to have a Material Adverse Effect and except, in the case of a breach of a covenant which is reasonably
curable, only if such breach continues for a period of at least five (5) Business Days;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
if any Person commences a proceeding against the Company pursuant to or within the meaning of any Bankruptcy Law;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
if the Company, pursuant to or within the meaning of any Bankruptcy Law, (i) commences a voluntary case, (ii) consents to the entry of
an order for relief against it in an involuntary case, (iii) consents to the appointment of a Custodian of it or for all or substantially
all of its property, or (iv) makes a general assignment for the benefit of its creditors or is generally unable to pay its debts as the
same become due;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 32; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
a court of competent jurisdiction enters an order or decree under any Bankruptcy Law that (i) is for relief against the Company in an
involuntary case, (ii) appoints a Custodian of the Company or for all or substantially all of its property, or (iii) orders the liquidation
of the Company or any Subsidiary;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
if at any time the Company is not eligible to transfer its Common Stock electronically as DWAC Shares or DTC places the Company&rsquo;s
Common Stock on &ldquo;chill&rdquo;;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
if at any time after the Commencement Date, the Exchange Cap is reached (to the extent such Exchange Cap is applicable pursuant to <U>Section
2(e)</U> hereof), and the Stockholder Approval referred to in <U>Section 2(e)(i)</U> has not been obtained in accordance with the applicable
rules of The Nasdaq Stock Market; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
if at any time the Investor&rsquo;s broker is unable to accept Commitment Shares or Purchase Shares for deposit for reasons not within
the Investor&rsquo;s control.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to any other rights and remedies under applicable law and this Agreement, so long as a Suspension Event has occurred and is
continuing, or if any event which, after notice and/or lapse of time, would reasonably be expected to become a Suspension Event has occurred
and is continuing, the Company shall not deliver to the Investor any Regular Purchase Notice, Add-On Purchase Notice or Intraday Purchase
Notice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>11.</B></FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TERMINATION</B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Agreement may be terminated only as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
If pursuant to or within the meaning of any Bankruptcy Law, the Company commences a voluntary case or any Person commences a proceeding
against the Company which is not discharged within 90 days, a Custodian is appointed for the Company or for all or substantially all
of its property, or the Company makes a general assignment for the benefit of its creditors (any of which would be a Suspension Event
as described in <U>Sections 10(f)</U>, <U>10(g)</U> and <U>10(h)</U> hereof), this Agreement shall automatically terminate without any
liability or payment to the Company (except as set forth below) without further action or notice by any Person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
In the event that (i) the Company fails to file the Registration Statement with the SEC within the period specified in <U>Section 5(a)</U>
hereof in accordance with the terms of the Registration Rights Agreement or (ii) the Commencement shall not have occurred on or before
November 27, 2025, due to the failure to satisfy the conditions set forth in <U>Sections 7</U> and <U>8</U> above with respect to the
Commencement, then, in the case of clause (i) above, this Agreement may be terminated by the Investor at any time prior to the filing
of the Registration Statement and, in the case of clause (ii) above, this Agreement may be terminated by either party at the close of
business on November 27, 2025 or thereafter, in each case without liability of such party to the other party (except as set forth below);
provided, however, that the right to terminate this Agreement under this <U>Section 11(b)</U> shall not be available to any party if
such party is then in breach of any covenant or agreement contained in this Agreement or any representation or warranty of such party
contained in this Agreement fails to be true and correct such that the conditions set forth in <U>Section 7(c)</U> or <U>Section 8(e)</U>,
as applicable, could not then be satisfied.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 33; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
At any time after the Commencement Date, the Company shall have the option to terminate this Agreement for any reason or for no reason
by delivering notice (a &ldquo;<U>Company Termination Notice</U>&rdquo;) to the Investor electing to terminate this Agreement without
any liability whatsoever of any party to any other party under this Agreement (except as set forth below). The Company Termination Notice
shall not be effective until one (1) Business Day after it has been received by the Investor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
This Agreement shall automatically terminate on the date that the Company sells and the Investor purchases the full Available Amount
as provided herein, without any action or notice on the part of any party and without any liability whatsoever of any party to any other
party under this Agreement (except as set forth below).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
If, for any reason or for no reason, the full Available Amount has not been purchased in accordance with <U>Section 2</U> of this Agreement
by the Maturity Date, this Agreement shall automatically terminate on the Maturity Date, without any action or notice on the part of
any party and without any liability whatsoever of any party to any other party under this Agreement (except as set forth below).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as set forth in <U>Sections 11(a)</U> (in respect of a Suspension Event under <U>Sections 10(f)</U>, <U>10(g)</U> and 10(h)), <U>11(d)</U>
and <U>11(e)</U>, any termination of this Agreement pursuant to this <U>Section 11</U> shall be effected by written notice from the Company
to the Investor, or the Investor to the Company, as the case may be, setting forth the basis for the termination hereof. The representations
and warranties and covenants of the Company and the Investor contained in <U>Sections 3</U>, <U>4</U>, <U>5</U>, and <U>6</U> hereof,
the indemnification provisions set forth in <U>Section 9</U> hereof and the agreements and covenants set forth in <U>Sections 10</U>,
<U>11</U> and <U>12</U> shall survive the execution and delivery of this Agreement and any termination of this Agreement. No termination
of this Agreement shall (i) affect the Company&rsquo;s or the Investor&rsquo;s rights or obligations under (A) this Agreement with respect
to pending Regular Purchases, Add-On Purchases or Intraday Purchases and the Company and the Investor shall complete their respective
obligations with respect to any pending Regular Purchases, Add-On Purchases and Intraday Purchases under this Agreement and (B) the Registration
Rights Agreement, which shall survive any such termination, or (ii) impact in any way the Company&rsquo;s obligation to issue the Commitment
Shares, or (iii) be deemed to release the Company or the Investor from any liability for intentional misrepresentation or willful breach
of any of the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>12.</B></FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>MISCELLANEOUS.</B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Governing Law; Jurisdiction; Jury Trial</U>. The corporate laws of the State of Delaware shall govern all issues concerning the relative
rights of the Company and its stockholders. All other questions concerning the construction, validity, enforcement and interpretation
of this Agreement, the Registration Rights Agreement and the other Transaction Documents shall be governed by the internal laws of the
State of Florida, without giving effect to any choice of law or conflict of law provision or rule (whether of the State of Florida or
any other jurisdictions) that would cause the application of the laws of any jurisdictions other than the State of Florida. Each party
hereby irrevocably submits to the exclusive jurisdiction of the state courts sitting in the State of Florida, Palm Beach County and federal
courts sitting in the Southern District of Florida, for the adjudication of any dispute hereunder or under the other Transaction Documents
or in connection herewith or therewith, or with any transaction contemplated hereby or discussed herein, and hereby irrevocably waives,
and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of any such
court, that such suit, action or proceeding is brought in an inconvenient forum or that the venue of such suit, action or proceeding
is improper. Each party hereby irrevocably waives personal service of process and consents to process being served in any such suit,
action or proceeding by mailing a copy thereof to such party at the address for such notices to it under this Agreement and agrees that
such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to
limit in any way any right to serve process in any manner permitted by law. <B>EACH PARTY HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY
HAVE, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION HEREWITH OR ARISING OUT
OF THIS AGREEMENT OR ANY TRANSACTION CONTEMPLATED HEREBY.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 34; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Counterparts</U>. This Agreement may be executed in two or more identical counterparts, all of which shall be considered one and the
same agreement and shall become effective when counterparts have been signed by each party and delivered to the other party; provided
that a facsimile signature or signature delivered by e-mail in a &ldquo;.pdf&rdquo; format data file, including any electronic signature
complying with the U.S. federal ESIGN Act of 2000, e.g., www.docusign.com, www.echosign.adobe.com, etc., shall be considered due execution
and shall be binding upon the signatory thereto with the same force and effect as if the signature were an original signature.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Headings</U>. The headings of this Agreement are for convenience of reference and shall not form part of, or affect the interpretation
of, this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Severability</U>. If any provision of this Agreement shall be invalid or unenforceable in any jurisdiction, such invalidity or unenforceability
shall not affect the validity or enforceability of the remainder of this Agreement in that jurisdiction or the validity or enforceability
of any provision of this Agreement in any other jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Entire Agreement</U>. The Transaction Documents supersede all other prior oral or written agreements between the Investor, the Company,
their affiliates and Persons acting on their behalf with respect to the subject matter thereof, and this Agreement, the other Transaction
Documents and the instruments referenced herein contain the entire understanding of the parties with respect to the matters covered herein
and therein and, except as specifically set forth herein or therein, neither the Company nor the Investor makes any representation, warranty,
covenant or undertaking with respect to such matters. The Company acknowledges and agrees that is has not relied on, in any manner whatsoever,
any representations or statements, written or oral, other than as expressly set forth in the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Notices</U>. Any notices, consents or other communications required or permitted to be given under the terms of this Agreement must
be in writing and will be deemed to have been delivered: (i) upon receipt when delivered personally; (ii) upon receipt when sent by facsimile
or email (provided confirmation of transmission is mechanically or electronically generated and kept on file by the sending party); or
(iii) one Business Day after deposit with a nationally recognized overnight delivery service, in each case properly addressed to the
party to receive the same. The addresses for such communications shall be:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
to the Company:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Glucotrack,
Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">301
Rte 17 North, Ste. 800</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rutherford,
NJ 07070</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E-mail:</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">pvgoode@glucotrack.com</FONT></TD></TR>

<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Paul Goode, Chief Executive
  Officer</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 35; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
a copy to (which shall not constitute notice or service of process):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nelson
Mullins Riley &amp; Scarborough LLP</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">301
Hillsborough Street, Suite 1400</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Raleigh,
NC 27603</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Telephone:
(919) 329-3804</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E-mail:</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">david.mannheim@nelsonmullins.com</FONT></TD></TR>

<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">W. David Mannheim</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
to the Investor:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sixth
Borough Capital Fund, LP</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1515
N Federal Highway, #300</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Boca
Raton, FL 33432</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Telephone:
(561) 864-5500</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E-mail:</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">bob@6bcap.com and mmaclaren@6bcap.com</FONT></TD></TR>

<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Robert D. Keyser, Jr and
  Monique MacLaren</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
a copy to (which shall not constitute notice or service of process):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ArentFox
Schiff LLP</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1717
K Street NW</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Washington,
DC 20006</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Telephone:
(202) 724-6848</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Facsimile:
(202) 778-6460</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E-mail:</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ralph.demartino@afslaw.com</FONT></TD></TR>

<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ralph V. De Martino, Esq.</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
to the Transfer Agent:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">VStock
Transfer, LLC</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18
Lafayette Place</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Woodmere,
NY 11598</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E-mail:</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">action@vstocktransfer.com</FONT></TD></TR>

<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operations</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">or
at such other address and/or facsimile number and/or email address and/or to the attention of such other Person as the recipient party
has specified by written notice given to each other party three (3) Business Days prior to the effectiveness of such change. Written
confirmation of receipt (A) given by the recipient of such notice, consent or other communication, (B) mechanically or electronically
generated by the sender&rsquo;s facsimile machine or email account containing the time, date, and recipient facsimile number or email
address, as applicable, and an image of the first page of such transmission or (C) provided by a nationally recognized overnight delivery
service, shall be rebuttable evidence of personal service, receipt by facsimile or receipt from a nationally recognized overnight delivery
service in accordance with clause (i), (ii) or (iii) above, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>Successors and Assigns</U>. This Agreement shall be binding upon and inure to the benefit of the parties and their respective successors
and assigns. The Company shall not assign this Agreement or any rights or obligations hereunder without the prior written consent of
the Investor, including by merger or consolidation. The Investor may not assign its rights or obligations under this Agreement without
the prior written consent of the Company, which consent shall not be unreasonably withheld.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 36; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
<U>No Third-Party Beneficiaries</U>. This Agreement is intended for the benefit of the parties hereto and their respective permitted
successors and assigns and, except as set forth in Section 9, is not for the benefit of, nor may any provision hereof be enforced by,
any other Person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>Publicity</U>. The Company shall afford the Investor and its counsel with the opportunity to review and comment upon, shall consult
with the Investor and its counsel on the form and substance of, and shall give due consideration to all such comments from the Investor
or its counsel on, any press release, SEC filing or any other public disclosure by or on behalf of the Company relating to the Investor,
its purchases hereunder or any aspect of the Securities, the Transaction Documents or the transactions contemplated thereby, not less
than 24 hours prior to the issuance, filing or public disclosure thereof. The Investor must be provided with a final version of any portion
of such press release, SEC filing or other public disclosure relating to the Investor, its purchases hereunder or any aspect of the Securities,
the Transaction Documents or the transactions contemplated thereby at least 24 hours prior to any release, issuance, filing or use by
the Company thereof. The Company agrees and acknowledges that its failure to fully comply with this <U>Section 12(i)</U> may constitute
a Material Adverse Effect, subject to the materiality standards set forth in the definition of Material Adverse Effect in this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
<U>Further Assurances</U>. Each party shall do and perform, or cause to be done and performed, all such further acts and things, and
shall execute and deliver all such other agreements, certificates, instruments and documents, as the other party may reasonably request
in order to consummate and make effective, as soon as reasonably possible, the Commencement, and to carry out the intent and accomplish
the purposes of this Agreement and the consummation of the transactions contemplated hereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
<U>No Financial Advisor, Placement Agent, Broker or Finder</U>. The Company represents and warrants to the Investor that except as disclosed
in Section 4(w) it has not engaged any financial advisor, placement agent, broker or finder in connection with the transactions contemplated
hereby. The Investor represents and warrants to the Company that it has not engaged any financial advisor, placement agent, broker or
finder in connection with the transactions contemplated hereby. Except as disclosed in <U>Section 4(w)</U>, the Company shall be responsible
for the payment of any fees or commissions, if any, of any financial advisor, placement agent, broker or finder relating to or arising
out of the transactions contemplated hereby. The Company shall pay, and hold the Investor harmless against, any liability, loss or expense
(including, without limitation, reasonable and documented attorneys&rsquo; fees and out-of-pocket expenses) arising in connection with
any such claim.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
<U>No Strict Construction</U>. The language used in this Agreement will be deemed to be the language chosen by the parties to express
their mutual intent, and no rules of strict construction will be applied against any party. In addition, each and every reference to
share prices and shares of Common Stock in this Agreement shall be subject to adjustment as provided in this Agreement for reverse and
forward stock splits, stock dividends, stock combinations and other similar transactions of the Common Stock that occur after the date
of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 37; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)
<U>Remedies, Other Obligations, Breaches and Injunctive Relief</U>. The Investor&rsquo;s remedies provided in this Agreement, including,
without limitation, the Investor&rsquo;s remedies provided in Section 9, shall be cumulative and in addition to all other remedies available
to the Investor under this Agreement, at law or in equity (including a decree of specific performance and/or other injunctive relief),
no remedy of the Investor contained herein shall be deemed a waiver of compliance with the provisions giving rise to such remedy and
nothing herein shall limit the Investor&rsquo;s right to pursue actual damages for any failure by the Company to comply with the terms
of this Agreement. The Company acknowledges that a breach by it of its obligations hereunder will cause irreparable harm to the Investor
and that the remedy at law for any such breach may be inadequate. The Company therefore agrees that, in the event of any such breach
or threatened breach, the Investor shall be entitled, in addition to all other available remedies, to an injunction restraining any breach,
without the necessity of showing economic loss and without any bond or other security being required.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)
<U>Enforcement Costs</U>. If: (i) this Agreement is placed by the Investor in the hands of an attorney for enforcement or is enforced
by the Investor through any legal proceeding; (ii) an attorney is retained to represent the Investor in any bankruptcy, reorganization,
receivership or other proceedings affecting creditors&rsquo; rights and involving a claim under this Agreement; or (iii) an attorney
is retained to represent the Investor in any other proceedings whatsoever in connection with this Agreement, then the Company shall pay
to the Investor, as incurred by the Investor, all reasonable costs and expenses including reasonable attorneys&rsquo; fees incurred in
connection therewith, in addition to all other amounts due hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)
<U>Amendment and Waiver; Failure or Indulgence Not Waiver</U>. No provision of this Agreement may be amended or waived by the parties
from and after the date that is one (1) Business Day immediately preceding the initial filing of the Registration Statement with the
SEC, except as may be required by applicable law or regulation. Subject to the immediately preceding sentence, (i) no provision of this
Agreement may be amended other than by a written instrument signed by both parties hereto and (ii) no provision of this Agreement may
be waived other than in a written instrument signed by the party against whom enforcement of such waiver is sought. No failure or delay
in the exercise of any power, right or privilege hereunder shall operate as a waiver thereof, nor shall any single or partial exercise
of any such power, right or privilege preclude other or further exercise thereof or of any other right, power or privilege.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>**
Signature Page Follows **</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 38; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IN
WITNESS WHEREOF,</B> the Investor and the Company have caused this Agreement to be duly executed as of the date first written above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>THE COMPANY:</U></B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>GLUCOTRACK,
  INC.</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="padding-bottom: 1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">/s/ <FONT STYLE="font-size: 10pt">Paul
  V. Goode</FONT></FONT></TD></TR>

<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Paul V. Goode</FONT></TD></TR>

<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 211.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 211.5pt; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>INVESTOR:</U></B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SIXTH BOROUGH
  CAPITAL FUND, LP</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="padding-bottom: 1pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">/s/ Robert
  D. Keyser, Jr.</FONT></TD></TR>

<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Robert D. Keyser, Jr</FONT></TD></TR>

<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">President</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 211.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 211.5pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 39; Value: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>EXHIBITS</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit</FONT>
  <FONT STYLE="font-family: Times New Roman, Times, Serif">A</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Officer&rsquo;s Certificate</FONT></TD></TR>

<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit B</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Form of Resolutions of Board of Directors
  of the Company</FONT></TD></TR>

<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit C</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Form of Secretary&rsquo;s Certificate</FONT></TD></TR>

<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit D</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Form of Letter to Transfer Agent</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: -1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: -1.5in"></P>

<!-- Field: Page; Sequence: 40 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>EXHIBIT
A</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FORM
OF OFFICER&rsquo;S CERTIFICATE</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Officer&rsquo;s Certificate (&ldquo;<B>Certificate</B>&rdquo;) is being delivered pursuant to <U>Section 8(e)</U> of that certain Purchase
Agreement dated as of September 11, 2025 (the &ldquo;<B>Purchase Agreement</B>&rdquo;), by and between <B>GLUCOTRACK, INC.</B>,
a Delaware corporation (the &ldquo;<B>Company</B>&rdquo;), and <B>SIXTH BOROUGH CAPITAL FUND, LP </B>(the &ldquo;<B>Investor</B>&rdquo;).
Capitalized terms used herein and not otherwise defined shall have the meanings ascribed to them in the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned, Paul V. Goode, Chief Executive Officer and President of the Company, hereby certifies, on behalf of the Company and not
in his individual capacity, as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: .75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
I am the Chief Executive Officer and President of the Company and make the statements contained in this Certificate;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
The representations and warranties of the Company are true and correct in all material respects (except to the extent that any of such
representations and warranties is already qualified as to materiality or Material Adverse Effect in Section 4 of the Purchase Agreement,
in which case, such representations and warranties are true and correct without further qualification) as of the date when made and as
of the Commencement Date as though made at that time (except for representations and warranties that speak as of a specific date, in
which case such representations and warranties are true and correct as of such date);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
The Company has performed, satisfied and complied in all material respects with covenants, agreements and conditions required by the
Transaction Documents to be performed, satisfied or complied with by the Company at or prior to the Commencement Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
The Company has not taken any steps, and does not currently expect to take any steps, to seek protection pursuant to any Bankruptcy Law
nor does the Company or any of its Subsidiaries have any knowledge or reason to believe that its creditors intend to initiate involuntary
bankruptcy or insolvency proceedings. The Company is financially solvent and is generally able to pay its debts as they become due.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, I have hereunder signed my name on this ___ day of ___________.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
  <TD STYLE="text-align: justify; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Paul V. Goode</FONT></TD></TR>

<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer and
  President</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 2.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned as Chief Financial Officer and Secretary of <B>GLUCOTRACK, INC.</B>, a Delaware corporation, hereby certifies that Paul V.
Goode is the duly elected, appointed, qualified and acting Chief Executive Office and President of <B>GLUCOTRACK, INC.</B> and that the
signature appearing above is his genuine signature.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
  <TD STYLE="text-align: justify; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Peter Wulff</FONT></TD></TR>

<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Chief Financial Officer and Secretary</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 41 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>EXHIBIT
B</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>RESOLUTIONS
OF THE BOARD OF DIRECTORS OF GLUCOTRACK, INC.</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Approval
of Purchase Agreement</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
there has been presented to the Board a draft of the Purchase Agreement in substantially the form attached hereto as <U>Exhibit A</U>
(the &ldquo;<B><I>Purchase Agreement</I></B>&rdquo;), by and between the Company and Sixth Borough Capital Fund, LP (the &ldquo;<B><I>Investor</I></B>&rdquo;),
providing for the purchase by Investor of up to Twenty Million Dollars ($20,000,000) (the &ldquo;<B><I>Commitment Amount</I></B>&rdquo;)
of the Company&rsquo;s common stock, par value $0.001 per share (the &ldquo;<B><I>Common Stock</I></B>&rdquo;), from time to time at
the direction of the Company; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
after careful consideration of the Purchase Agreement, the documents incident thereto and other factors deemed relevant by the Board,
the Board has determined that it is advisable and in the best interests of the Company to engage in the transactions contemplated by
the Purchase Agreement, including, but not limited to, the payment of a commitment fee equal to 1.5% of the total Commitment Amount,
payable in cash, Common Stock, or any combination thereof, at the Company&rsquo;s option (the &ldquo;<B><I>Commitment Fee</I></B>&rdquo;),
and the sale of shares of Common Stock to the Investor up to the &ldquo;<B><I>Available Amount</I></B>&rdquo; (as such term is defined
in Purchase Agreement) under the Purchase Agreement (the &ldquo;<B><I>Purchase Shares</I></B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Transaction
Documents</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOW,
THEREFORE, BE IT RESOLVED</B>, that the transactions described in the Purchase Agreement are hereby approved and each of Paul V. Goode
and Peter C. Wulff (the &ldquo;<B><I>Authorized Officers</I></B>&rdquo;) are severally authorized to execute and deliver the Purchase
Agreement, and any other agreements or documents contemplated thereby including, without limitation, a registration rights agreement
in substantially the form attached hereto as <U>Exhibit B</U> (the &ldquo;<B><I>Registration Rights Agreement</I></B>&rdquo;), providing
for the registration of the shares of the Company&rsquo;s Common Stock issuable in respect of the Purchase Agreement on behalf of the
Company, with such amendments, changes, additions and deletions as the Authorized Officers may deem to be appropriate and approve on
behalf of, the Company, such approval to be conclusively evidenced by the signature of an Authorized Officer thereon; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FURTHER
RESOLVED</B>, that the terms and provisions of the Registration Rights Agreement by and among the Company and the Investor are hereby
approved and the Authorized Officers are authorized to execute and deliver the Registration Rights Agreement (pursuant to the terms of
the Purchase Agreement), with such amendments, changes, additions and deletions as the Authorized Officer may deem appropriate and approve
on behalf of, the Company, such approval to be conclusively evidenced by the signature of an Authorized Officer thereon; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FURTHER
RESOLVED</B>, that the terms and provisions of the forms of Irrevocable Transfer Agent Instructions and Notice of Effectiveness of Registration
Statement (each as defined in the Purchase Agreement and referred to herein collectively as the &ldquo;<B><I>Instructions</I></B>&rdquo;)
are hereby approved and the Authorized Officers are authorized to execute and deliver the Instructions on behalf of the Company in accordance
with the Purchase Agreement, with such amendments, changes, additions and deletions as the Authorized Officers may deem appropriate and
approve on behalf of, the Company, such approval to be conclusively evidenced by the signature of an Authorized Officer thereon; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 42 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Execution
of Purchase Agreement</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FURTHER
RESOLVED</B>, that the Company be and it hereby is authorized to execute the Purchase Agreement providing for the purchase by the Investor
of up to Twenty Million Dollars ($20,000,000) of the Company&rsquo;s Common Stock, from time to time at the direction of the Company;
and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Issuance
of Common Stock</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FURTHER
RESOLVED</B>, that the Company is hereby authorized to pay to the Investor the Commitment Fee, payable in cash, common stock, or any
combination thereof, at the Company&rsquo;s option, and that upon issuance of any shares of Common Stock as part of the Commitment Fee
pursuant to the Purchase Agreement, such shares shall be duly authorized, validly issued, fully paid and nonassessable with no personal
liability attaching to the ownership thereof; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FURTHER
RESOLVED</B>, that the Company is hereby authorized to issue shares of Common Stock upon the purchase of Purchase Shares up to the Available
Amount under the Purchase Agreement in accordance with the terms of the Purchase Agreement and that, upon issuance of the Purchase Shares
pursuant to the Purchase Agreement, the Purchase Shares will be duly authorized, validly issued, fully paid and nonassessable with no
personal liability attaching to the ownership thereof; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FURTHER
RESOLVED</B>, that the Company shall initially reserve 20,000,000 shares of Common Stock (which number shall be no less than the maximum
number of shares issuable under the Purchase Agreement) for issuance as Purchase Shares under the Purchase Agreement, and shall maintain
such reserve as required under the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Approval
of Actions</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FURTHER
RESOLVED</B>, that, without limiting the foregoing, the Authorized Officers are, and each of them hereby is, authorized and directed
to proceed on behalf of the Company and to take all such steps as deemed necessary or appropriate, with the advice and assistance of
counsel, to cause the Company to consummate the agreements referred to herein and to perform its obligations under such agreements; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FURTHER
RESOLVED</B>, that the Authorized Officers be, and each of them hereby is, authorized, empowered and directed on behalf of and in the
name of the Company, to take or cause to be taken all such further actions and to execute and deliver or cause to be executed and delivered
all such further agreements, amendments, documents, certificates, reports, schedules, applications, notices, letters and undertakings
and to incur and pay all such fees and expenses as in their judgment shall be necessary, proper or desirable to carry into effect the
purpose and intent of any and all of the foregoing resolutions, and that all actions heretofore taken by any officer or director of the
Company in connection with the transactions contemplated by the agreements described herein are hereby approved, ratified and confirmed
in all respects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 43 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>EXHIBIT
C</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FORM
OF SECRETARY&rsquo;S CERTIFICATE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Secretary&rsquo;s Certificate (&ldquo;Certificate&rdquo;) is being delivered pursuant to <U>Section 8(k)</U> of that certain Purchase
Agreement, dated as of September 11, 2025 (&ldquo;Purchase Agreement&rdquo;), by and between <B>GLUCOTRACK, INC.</B>, a Delaware
corporation (the &ldquo;Company&rdquo;), and <B>SIXTH BOROUGH CAPITAL FUND, LP</B> (the &ldquo;Investor&rdquo;), pursuant to which the
Company may sell to the Investor up to Twenty Million Dollars ($20,000,000) of the Company&rsquo;s common stock, par value $0.001 per
share (the &ldquo;Common Stock&rdquo;). Capitalized terms used herein and not otherwise defined shall have the meanings ascribed to them
in the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned, Peter Wulff, Secretary of the Company, hereby certifies, on behalf of the Company and not in his individual capacity, as
follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
I am the Secretary of the Company and make the statements contained in this Secretary&rsquo;s Certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
Attached hereto as <U>Exhibit A</U> and <U>Exhibit B</U> are true, correct and complete copies of the Company&rsquo;s Amended and Restated
Bylaws, as amended through the date hereof (the &ldquo;Bylaws&rdquo;), and the Company&rsquo;s Amended and Restated Certificate of Incorporation,
as amended through the date hereof (the &ldquo;Charter&rdquo;), and no action has been taken by the Company, its directors, officers
or stockholders, in contemplation of the filing of any further amendment relating to or affecting the Bylaws or Charter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
Attached hereto as <U>Exhibit C</U> are true, correct and complete copies of the resolutions duly adopted by the Board of Directors of
the Company on September 9, 2025, at which a quorum was present and acting throughout. Such resolutions have not been amended,
modified or rescinded and remain in full force and effect and such resolutions are the only resolutions adopted by the Company&rsquo;s
Board of Directors, or any committee thereof, or the stockholders of the Company relating to or affecting (i) the entering into and performance
of the Purchase Agreement, the Registration Rights Agreement and the other Transaction Documents, or the issuance, offering and sale
of the Purchase Shares and the Commitment Shares, and (ii) and the performance of the Company of its obligations under each of the Transaction
Documents as contemplated therein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
As of the date hereof, the authorized, issued and reserved capital stock of the Company is as set forth on <U>Exhibit D</U> hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 44 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IN
WITNESS WHEREOF</B>, I have hereunder signed my name on this _______ day of ________, 202_.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
  <TD STYLE="text-align: justify; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Peter Wulff</FONT></TD></TR>

<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Secretary</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned as _____________ of <B>GLUCOTRACK, INC.</B>, a Delaware corporation, hereby certifies that Peter Wulff is the duly elected,
appointed, qualified and acting Secretary of <B>GLUCOTRACK, INC.</B>, and that the signature appearing above is his genuine signature.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
  <TD STYLE="text-align: justify; width: 45%"></TD></TR>

<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
  <TD STYLE="text-align: justify"></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 45 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>EXHIBIT
D</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FORM
OF LETTER TO THE TRANSFER AGENT FOR THE ISSUANCE OF THE COMMITMENT SHARES ON THE COMMENCEMENT DATE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[COMPANY
LETTERHEAD]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;],
2025</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">____________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">____________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
[&#9679;]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Re:
Issuance of Common Stock to Sixth Borough Capital Fund, LP</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dear
[&#9679;],</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
behalf of <B>GLUCOTRACK, INC.</B>, a Delaware corporation (the &ldquo;Company&rdquo;), you are hereby instructed to issue <B><U>as soon
as possible</U></B> a book-entry statement representing the number of shares of our common stock to be issued to <B><U>Sixth Borough
Capital Fund, LP</U></B> as part of the Commitment Fee, as determined in accordance with the Purchase Agreement. The book-entry statement
should be dated [&#9679;]. The book-entry statement should bear the following restrictive legends:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THE
SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE
SECURITIES LAWS. THE SECURITIES HAVE BEEN ACQUIRED FOR INVESTMENT AND MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED IN THE
ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES
LAWS, UNLESS SOLD PURSUANT TO: (1) RULE 144 UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (2) AN OPINION OF HOLDER&rsquo;S COUNSEL,
IN A CUSTOMARY FORM, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR APPLICABLE STATE SECURITIES LAWS.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THE
SECURITIES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO A LOCKUP AS SET FORTH IN THE PURCHASE AGREEMENT, DATED SEPTEMBER 11,
2025 (AS AMENDED, RESTATED OR OTHERWISE MODIFIED FROM TIME TO TIME, THE &ldquo;PURCHASE AGREEMENT&rdquo;), BY AND BETWEEN GLUCOTRACK,
INC. AND SIXTH BOROUGH CAPITAL FUND, LP, AND MAY NOT BE OFFERED, SOLD, TRANSFERRED, PLEDGED OR OTHERWISE DISPOSED DURING THE TERM OF
THE LOCKUP. A COPY OF SUCH PURCHASE AGREEMENT WILL BE FURNISHED WITHOUT CHARGE BY THE COMPANY TO THE HOLDER HEREOF UPON WRITTEN REQUEST.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 46 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
book-entry statement should be sent <B><U>as soon as possible via overnight mail</U></B> to the following address:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">____________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">____________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
[&#9679;]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thank
you very much for your help. Please call me at [&#9679;] if you have any questions or need anything further.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>GLUCOTRACK, INC.</B></FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 47; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>ex10-2.htm
<DESCRIPTION>EX-10.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><B>Exhibit 10.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>REGISTRATION
RIGHTS AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>REGISTRATION
RIGHTS AGREEMENT</B> (this &ldquo;<U>Agreement</U>&rdquo;), dated as of September 11, 2025, by and between <B>GLUCOTRACK, INC.</B>,
a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), and <B>SIXTH BOROUGH CAPITAL FUND, LP</B>, a Delaware limited partnership
(together with its permitted assigns, the &ldquo;<U>Investor</U>&rdquo;). Capitalized terms used herein and not otherwise defined herein
shall have the respective meanings set forth in the Purchase Agreement by and between the parties hereto, dated as of the date hereof
(as amended, restated, supplemented or otherwise modified from time to time, the &ldquo;<U>Purchase Agreement</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A. Upon
the terms and subject to the conditions of the Purchase Agreement, (i) the Company has agreed to issue to the Investor, and the Investor
has agreed to purchase, up to Twenty Million Dollars ($20,000,000) of the Company&rsquo;s common stock, par value $0.001 per share (the &ldquo;<U>Common
Stock</U>&rdquo;), pursuant to the Purchase Agreement (such shares, the &ldquo;<U>Purchase Shares</U>&rdquo;), and (ii) the Company has
agreed to issue to the Investor such number of shares of Common Stock or Pre-Funded Warrants (and the shares of Common Stock issuable
upon exercise thereof) as consideration for its commitment to purchase shares of Common Stock under the Purchase Agreement at such time
and otherwise in accordance with the terms set forth in Section 5(e) of the Purchase Agreement (the &ldquo;<U>Commitment Shares</U>&rdquo;);
and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B. To
induce the Investor to enter into the Purchase Agreement, the Company has agreed to provide certain registration rights under the Securities
Act of 1933, as amended, and the rules and regulations thereunder, or any similar successor statute (collectively, the &ldquo;<U>Securities
Act</U>&rdquo;), and applicable state securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOW,
THEREFORE,</B> in consideration of the promises and the mutual covenants contained herein and other good and valuable consideration,
the receipt and sufficiency of which are hereby acknowledged, the Company and the Investor hereby, intending to be legally bound, agree
as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1. <U>DEFINITIONS</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
used in this Agreement, the following terms shall have the following meanings:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a. &ldquo;<U>Investor</U>&rdquo;
means the Investor, any transferee or assignee thereof to whom the Investor assigns its rights under this Agreement in accordance with
Section 9 and who agrees to become bound by the provisions of this Agreement, and any transferee or assignee thereof to whom a transferee
or assignee assigns its rights under this Agreement in accordance with Section 9 and who agrees to become bound by the provisions of
this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b. &ldquo;<U>Person</U>&rdquo;
means any individual or entity including but not limited to any corporation, a limited liability company, an association, a partnership,
an organization, a business, an individual, a governmental or political subdivision thereof or a governmental agency.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c. &ldquo;Pre-Funded
Warrants&rdquo; means any pre-funded warrants to purchase shares of Common Stock issued by the Company to the Investor as all or part
of the Commitment Fee pursuant to Section 5(e) of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d. &ldquo;<U>Register</U>,&rdquo;
&ldquo;<U>registered</U>,&rdquo; and &ldquo;<U>registration</U>&rdquo; refer to a registration effected by preparing and filing one or more
Registration Statements of the Company in compliance with the Securities Act and pursuant to Rule 415 under the Securities Act or any
successor rule providing for offering securities on a continuous basis (&ldquo;<U>Rule 415</U>&rdquo;), and the declaration or ordering
of effectiveness of such Registration Statement(s) by the United States Securities and Exchange Commission (the &ldquo;<U>SEC</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e. &ldquo;<U>Registrable
Securities</U>&rdquo; means all of the Commitment Shares, all of the Purchase Shares, and all of the Warrant Shares that may, from time
to time, be issued or become issuable to the Investor under the Purchase Agreement (without regard to any limitation or restriction on
purchases under the Purchase Agreement or this Agreement), and any and all shares of capital stock issued or issuable with respect to
the Purchase Shares, the Commitment Shares, the Pre-Funded Warrants, the Warrant Shares or the Purchase Agreement as a result of any
stock split, stock dividend, recapitalization, exchange or similar event or otherwise, without regard to any limitation on purchases
under the Purchase Agreement</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f. &ldquo;<U>Registration
Statement</U>&rdquo; means one or more registration statements of the Company covering only the resale of the Registrable Securities,
including, for the avoidance of doubt, any New Registration Statement (as defined below).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g. &ldquo;<U>Warrant
Shares</U>&rdquo; means the shares of Common Stock issuable upon exercise of the Pre-Funded Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2. <U>REGISTRATION</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a. <U>Mandatory
Registration.</U> The Company shall, within fifteen (15) calendar days after the date of this Agreement, file with the SEC an initial
Registration Statement covering the maximum number of Registrable Securities, which shall include all of the Commitment Shares, all of
the Warrant Shares and such number of additional Registrable Securities as shall be permitted to be included thereon in accordance with
applicable SEC rules, regulations and interpretations so as to permit the resale of such Registrable Securities by the Investor under
Rule 415 under the Securities Act at then prevailing market prices (and not fixed prices), as mutually determined by both the Company
and the Investor in consultation with their respective legal counsel. The initial Registration Statement shall register only the Registrable
Securities. The Investor and its counsel shall have a reasonable opportunity to review and comment upon such Registration Statement and
any amendment or supplement to such Registration Statement and any related prospectus prior to its filing with the SEC, and the Company
shall give due consideration to all such comments. The Investor shall furnish all information reasonably requested by the Company for
inclusion therein. The Company shall use its reasonable best efforts to have the Registration Statement and any amendment declared effective
by the SEC within forty-five (45) days after its filing date. The Company shall use reasonable best efforts to keep the Registration
Statement effective pursuant to Rule 415 promulgated under the Securities Act and available for the resale by the Investor of all of
the Registrable Securities covered thereby at all times until the date on which the Investor shall have resold all the Registrable Securities
covered thereby and no Available Amount remains under the Purchase Agreement (the &ldquo;<U>Registration Period</U>&rdquo;). The Registration
Statement (including any amendments or supplements thereto and prospectuses contained therein) shall not contain any untrue statement
of a material fact or omit to state a material fact required to be stated therein, or necessary to make the statements therein, in light
of the circumstances in which they were made, not misleading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b. <U>Rule
424 Prospectus</U>. The Company shall, as required by applicable securities regulations, from time to time file with the SEC, pursuant
to Rule 424 promulgated under the Securities Act, the prospectus and prospectus supplements, if any, to be used in connection with sales
of the Registrable Securities under the Registration Statement. The Investor and its counsel shall have a reasonable opportunity to review
and comment upon such prospectus prior to its filing with the SEC, and the Company shall give due consideration to all such comments.
The Investor shall use its reasonable best efforts to comment upon such prospectus within one (1) Business Day from the date the Investor
receives the final pre-filing version of such prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c. <U>Sufficient
Number of Shares Registered</U>. In the event the number of shares available under the Registration Statement is insufficient to cover
all of the Registrable Securities, the Company shall amend the Registration Statement or file a new Registration Statement (a &ldquo;<U>New
Registration Statement</U>&rdquo;), so as to cover all of such Registrable Securities (subject to the limitations set forth in Section
2(a)) as soon as practicable, but in any event not later than fifteen (15) Business Days after the necessity therefor arises, subject
to any limits that may be imposed by the SEC pursuant to Rule 415 under the Securities Act. The Company shall use its reasonable best
efforts to cause such amendment and/or New Registration Statement to become effective as soon as practicable following the filing thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d.
<U>Offering</U>. If the staff of the SEC (the &ldquo;<U>Staff</U>&rdquo;) or the SEC seeks to characterize any offering pursuant to a
Registration Statement filed pursuant to this Agreement as constituting an offering of securities that does not permit such Registration
Statement to become effective and be used for resales by the Investor under Rule 415 at then-prevailing market prices (and not fixed
prices), or if after the filing of the initial Registration Statement with the SEC pursuant to Section 2(a), the Company is otherwise
required by the Staff or the SEC to reduce the number of Registrable Securities included in such initial Registration Statement, then
the Company shall reduce the number of Registrable Securities to be included in such initial Registration Statement (after consulting
with the Investor and its legal counsel as to the specific Registrable Securities to be removed therefrom) until such time as the Staff
and the SEC shall so permit such Registration Statement to become effective and be used as aforesaid. In the event of any reduction in
Registrable Securities pursuant to this paragraph, the Company shall file one or more New Registration Statements in accordance with
Section 2(c) until such time as all Registrable Securities have been included in Registration Statements that have been declared effective
and the prospectus contained therein is available for use by the Investor. Notwithstanding any provision herein or in the Purchase Agreement
to the contrary, the Company&rsquo;s obligations to register Registrable Securities (and any related conditions to the Investor&rsquo;s
obligations) shall be qualified as necessary to comport with any requirement of the SEC or the Staff as addressed in this Section 2(d).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3. <U>RELATED
OBLIGATIONS</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
respect to the Registration Statement and whenever any Registrable Securities are to be registered pursuant to Section 2 including on
any New Registration Statement, the Company shall use its reasonable best efforts to effect the registration of the Registrable Securities
in accordance with the intended method of disposition thereof and, pursuant thereto, the Company shall have the following obligations:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a. The
Company shall prepare and file with the SEC such amendments (including post-effective amendments) and supplements to any Registration
Statement and the prospectus used in connection with such Registration Statement, which prospectus is to be filed pursuant to Rule 424
promulgated under the Securities Act, as may be necessary to keep the Registration Statement or any New Registration Statement effective
at all times during the Registration Period, and, during such period, comply with the applicable provisions of the Securities Act with
respect to the disposition of all Registrable Securities of the Company covered by the Registration Statement or any New Registration
Statement until such time as all of such Registrable Securities shall have been disposed of in accordance with the intended methods of
disposition by the seller or sellers thereof as set forth in such Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b. The
Company shall permit the Investor to review and comment upon the Registration Statement or any New Registration Statement and all amendments
and supplements thereto at least two (2) Business Days prior to their filing with the SEC, and not file any such document in a form to
which the Investor reasonably objects. The Investor shall use its reasonable best efforts to comment upon the Registration Statement
or any New Registration Statement and any amendments or supplements thereto within two (2) Business Days from the date the Investor receives
the final version thereof. The Company shall furnish to the Investor, without charge any correspondence from the SEC or the staff of
the SEC to the Company or its representatives relating to the Registration Statement or any New Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c. Upon
request of the Investor, the Company shall furnish to the Investor, (i)&nbsp;promptly after the same is prepared and filed with the SEC,
at least one copy of any Registration Statement and any amendment(s) thereto, including financial statements and schedules, all documents
incorporated therein by reference and all exhibits, (ii) upon the effectiveness of any Registration Statement, a copy of the prospectus
included in such Registration Statement and all amendments and supplements thereto (or such other number of copies as the Investor may
reasonably request) and (iii) such other documents, including copies of any preliminary or final prospectus, as the Investor may reasonably
request from time to time in order to facilitate the disposition of the Registrable Securities owned by the Investor. For the avoidance
of doubt, any filing available to the Investor via the SEC&rsquo;s live EDGAR system shall be deemed &ldquo;furnished to the Investor&rdquo;
or &ldquo;delivered&rdquo; to the Investor hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d. The
Company shall use reasonable best efforts to (i) register and qualify the Registrable Securities covered by a Registration Statement
under such other securities or &ldquo;blue sky&rdquo; laws of such jurisdictions in the United States as the Investor reasonably requests,
(ii) prepare and file in those jurisdictions, such amendments (including post-effective amendments) and supplements to such registrations
and qualifications as may be necessary to maintain the effectiveness thereof during the Registration Period, (iii) take such other actions
as may be necessary to maintain such registrations and qualifications in effect at all times during the Registration Period, and (iv)
take all other actions reasonably necessary or advisable to qualify the Registrable Securities for sale in such jurisdictions; provided,
however, that the Company shall not be required in connection therewith or as a condition thereto to (x) qualify to do business in any
jurisdiction where it would not otherwise be required to qualify but for this Section 3(d), (y) subject itself to general taxation in
any such jurisdiction, or (z) file a general consent to service of process in any such jurisdiction. The Company shall promptly notify
the Investor who holds Registrable Securities of the receipt by the Company of any notification with respect to the suspension of the
registration or qualification of any of the Registrable Securities for sale under the securities or &ldquo;blue sky&rdquo; laws of any
jurisdiction in the United States or its receipt of actual notice of the initiation or threatening of any proceeding for such purpose.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e. As
promptly as practicable after becoming aware of such event or facts, the Company shall notify the Investor in writing of the happening
of any event or existence of such facts as a result of which the prospectus included in any Registration Statement, as then in effect,
includes an untrue statement of a material fact or omits to state a material fact required to be stated therein or necessary to make
the statements therein, in light of the circumstances under which they were made, not misleading, and promptly prepare a supplement or
amendment to such Registration Statement to correct such untrue statement or omission, and deliver a copy of such supplement or amendment
to the Investor (or such other number of copies as the Investor may reasonably request). The Company shall also promptly notify the Investor
in writing (i) when a prospectus or any prospectus supplement or post-effective amendment has been filed, and when a Registration Statement
or any post-effective amendment has become effective (notification of such effectiveness shall be delivered to the Investor by email
or facsimile on the same day of such effectiveness and by overnight mail), (ii) of any request by the SEC for amendments or supplements
to any Registration Statement or related prospectus or related information, and (iii) of the Company&rsquo;s reasonable determination that
a post-effective amendment to a Registration Statement would be appropriate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f. The
Company shall use its reasonable best efforts to prevent the issuance of any stop order or other suspension of effectiveness of any Registration
Statement, or the suspension of the qualification of any Registrable Securities for sale in any jurisdiction and, if such an order or
suspension is issued, to obtain the withdrawal of such order or suspension at the earliest possible moment and to notify the Investor
of the issuance of such order and the resolution thereof or its receipt of actual notice of the initiation or threat of any proceeding
for such purpose.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g. The
Company shall (i) cause all the Registrable Securities to be listed on the Principal Market if the listing of such Registrable Securities
is then permitted under the rules of the Principal Market, or (ii) secure designation and quotation of all the Registrable Securities
on the Principal Market. The Company shall pay all fees and expenses in connection with satisfying its obligation under this Section.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h. The
Company shall cooperate with the Investor to facilitate the timely issuance of the Registrable Securities to be offered pursuant to any
Registration Statement, it being agreed that such Registrable Securities shall be issued as DWAC Shares and in such denominations or
amounts as the Investor may reasonably request and registered in such names as the Investor may request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i. The
Company shall at all times provide a transfer agent and registrar with respect to its Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">j. If
reasonably requested by the Investor, the Company shall (i) as soon as practicable incorporate in a prospectus supplement or post-effective
amendment such information as the Investor believes should be included therein relating to the sale and distribution of Registrable Securities,
including, without limitation, information with respect to the number of Registrable Securities being sold, the purchase price being
paid therefor and any other terms of the offering of the Registrable Securities; (ii) make all required filings of such prospectus supplement
or post-effective amendment as soon as practicable upon notification of the matters to be incorporated in such prospectus supplement
or post-effective amendment; and (iii) supplement or make amendments to any Registration Statement or New Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">k.
The Company shall use its reasonable best efforts to cause the Registrable Securities covered by any Registration Statement to be registered
with or approved by such other governmental agencies or authorities as may be necessary to consummate the disposition of such Registrable
Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">l. Within
one (1) Business Day after any Registration Statement which includes the Registrable Securities is declared effective by the SEC, the
Company shall deliver, and shall cause legal counsel for the Company to deliver, to the transfer agent for such Registrable Securities
(with copies to the Investor) confirmation that such Registration Statement has been declared effective by the SEC in the form attached
hereto as <U>Exhibit A</U>. Thereafter, if requested by the Investor at any time, the Company shall require its counsel to deliver to
the Investor a written confirmation whether or not the effectiveness of such Registration Statement has lapsed at any time for any reason
(including, without limitation, the issuance of a stop order) and whether or not the Registration Statement is current and available
to the Investor for sale of all of the Registrable Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">m. The
Company shall take all other reasonable actions necessary to expedite and facilitate disposition by the Investor of Registrable Securities
pursuant to any Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4. <U>OBLIGATIONS
OF THE INVESTOR</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a. The
Company shall notify the Investor in writing of the information the Company reasonably requires from the Investor in connection with
any Registration Statement hereunder. The Investor shall promptly furnish to the Company such information regarding itself, the Registrable
Securities held by it and the intended method of disposition of the Registrable Securities held by it as shall be reasonably required
to effect the registration of such Registrable Securities and shall execute such documents in connection with such registration as the
Company may reasonably request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b. The
Investor agrees to cooperate with the Company as reasonably requested by the Company in connection with the preparation and filing of
any Registration Statement hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c. The
Investor agrees that, upon receipt of any notice from the Company of the happening of any event or existence of facts of the kind described
in Section 3(f) or the first sentence of Section 3(e), the Investor will immediately discontinue disposition of Registrable Securities
pursuant to any Registration Statement(s) covering such Registrable Securities until the Investor&rsquo;s receipt of the copies of the supplemented
or amended prospectus contemplated by Section 3(f) or the first sentence of Section 3(e). Notwithstanding anything to the contrary, the
Company shall cause its transfer agent to promptly deliver shares of Common Stock without any restrictive legend in accordance with the
terms of the Purchase Agreement in connection with any sale of Registrable Securities with respect to which an Investor has entered into
a contract for sale prior to the Investor&rsquo;s receipt of a notice from the Company of the happening of any event of the kind described
in Section 3(f) or the first sentence of Section 3(e) and for which the Investor has not yet settled.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5. <U>EXPENSES
OF REGISTRATION</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
reasonable expenses, other than sales or brokerage commissions and fees and disbursements of counsel for the Investor, incurred in connection
with registrations, filings or qualifications pursuant to Sections 2 and 3, including, without limitation, all registration, listing
and qualifications fees, printers and accounting fees, and fees and disbursements of counsel for the Company, shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6. <U>INDEMNIFICATION</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a. To
the fullest extent permitted by law, the Company will, and hereby does, indemnify, hold harmless and defend the Investor, each Person,
if any, who controls the Investor, the members, the directors, officers, partners, employees, agents, representatives of the Investor
and each Person, if any, who controls the Investor within the meaning of the Securities Act or the Securities Exchange Act of 1934, as
amended (the &ldquo;<U>Exchange Act</U>&rdquo;) (each, an &ldquo;<U>Indemnified Person</U>&rdquo;), against any losses, claims, damages,
liabilities, judgments, fines, penalties, charges, costs, attorneys&rsquo; fees, amounts paid in settlement or expenses, joint or several,
(collectively, &ldquo;<U>Claims</U>&rdquo;) incurred in investigating, preparing or defending any action, claim, suit, inquiry, proceeding,
investigation or appeal taken from the foregoing by or before any court or governmental, administrative or other regulatory agency, body
or the SEC, whether pending or threatened, whether or not an indemnified party is or may be a party thereto (&ldquo;<U>Indemnified Damages</U>&rdquo;),
to which any of them may become subject insofar as such Claims (or actions or proceedings, whether commenced or threatened, in respect
thereof) arise out of or are based upon: (i) any untrue statement or alleged untrue statement of a material fact in the Registration
Statement, any New Registration Statement or any post-effective amendment thereto or in any filing made in connection with the qualification
of the offering under the securities or other &ldquo;blue sky&rdquo; laws of any jurisdiction in which Registrable Securities are offered
(&ldquo;<U>Blue Sky Filing</U>&rdquo;), or the omission or alleged omission to state a material fact required to be stated therein or necessary
to make the statements therein not misleading, (ii) any untrue statement or alleged untrue statement of a material fact contained in
the final prospectus (as amended or supplemented, if the Company files any amendment thereof or supplement thereto with the SEC) or the
omission or alleged omission to state therein any material fact necessary to make the statements made therein, in light of the circumstances
under which the statements therein were made, not misleading, (iii) any violation or alleged violation by the Company of the Securities
Act, the Exchange Act, any other law, including, without limitation, any state securities law, or any rule or regulation thereunder relating
to the offer or sale of the Registrable Securities pursuant to the Registration Statement or any New Registration Statement or (iv) any
material violation by the Company of this Agreement (the matters in the foregoing clauses (i) through (iv) being, collectively, &ldquo;<U>Violations</U>&rdquo;).
The Company shall reimburse each Indemnified Person within thirty (30) days of receiving documented evidence of such expenses, as such
expenses are incurred and are due and payable, for any reasonable legal fees or other reasonable expenses incurred by them in connection
with investigating or defending any such Claim. Notwithstanding anything to the contrary contained herein, the indemnification agreement
contained in this Section 6(a): (i) shall not apply to a Claim by an Indemnified Person arising out of or based upon a Violation which
occurs in reliance upon and in conformity with information about the Investor furnished in writing to the Company by such Indemnified
Person expressly for use in connection with the preparation of the Registration Statement, any New Registration Statement or any such
amendment thereof or supplement thereto, if such prospectus was timely made available by the Company pursuant to Section 3(c) or Section
3(e); (ii) with respect to any superseded prospectus, shall not inure to the benefit of any such Person from whom the Person asserting
any such Claim purchased the Registrable Securities that are the subject thereof (or to the benefit of any Person controlling such Person)
if the untrue statement or omission of material fact contained in the superseded prospectus was corrected in the revised prospectus,
as then amended or supplemented, if such revised prospectus was timely made available by the Company pursuant to Section 3(c) or Section
3(e), and the Indemnified Person was promptly advised in writing not to use the incorrect prospectus prior to the use giving rise to
a violation and such Indemnified Person, notwithstanding such advice, used it; (iii) shall not be available to the extent such Claim
is based on a failure of the Investor to deliver or to cause to be delivered the prospectus made available by the Company, if such prospectus
was timely made available by the Company pursuant to Section 3(c) or Section 3(e); and (iv) shall not apply to amounts paid in settlement
of any Claim if such settlement is effected without the prior written consent of the Company, which consent shall not be unreasonably
withheld. Such indemnity shall remain in full force and effect regardless of any investigation made by or on behalf of the Indemnified
Person and shall survive the transfer of the Registrable Securities by the Investor pursuant to Section 9.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b. In
connection with the Registration Statement or any New Registration Statement, the Investor agrees to indemnify, hold harmless and defend,
to the same extent and in the same manner as is set forth in Section 6(a), the Company, each of its directors, each of its officers who
signs the Registration Statement or any New Registration Statement, each Person, if any, who controls the Company within the meaning
of the Securities Act or the Exchange Act (collectively and together with an Indemnified Person, an &ldquo;<U>Indemnified Party</U>&rdquo;),
against any Claim or Indemnified Damages to which any of them may become subject, under the Securities Act, the Exchange Act or otherwise,
insofar as such Claim or Indemnified Damages arise out of or are based upon any Violation, in each case to the extent, and only to the
extent, that such Violation occurs in reliance upon and in conformity with written information about the Investor set forth on <U>Exhibit
B</U> attached hereto and furnished to the Company by the Investor expressly for use in connection with such Registration Statement;
and, subject to Section 6(d), the Investor will reimburse any legal or other expenses reasonably incurred by them in connection with
investigating or defending any such Claim; provided, however, that the indemnity agreement contained in this Section 6(b) and the agreement
with respect to contribution contained in Section 7 shall not apply to amounts paid in settlement of any Claim if such settlement is
effected without the prior written consent of the Investor, which consent shall not be unreasonably withheld; provided, further, however,
that the Investor shall be liable under this Section 6(b) for only that amount of a Claim or Indemnified Damages as does not exceed the
net proceeds to the Investor as a result of the sale of Registrable Securities pursuant to such Registration Statement. Such indemnity
shall remain in full force and effect regardless of any investigation made by or on behalf of such Indemnified Party and shall survive
the transfer of the Registrable Securities by the Investor pursuant to Section 9.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c. Promptly
after receipt by an Indemnified Person or Indemnified Party under this Section 6 of notice of the commencement of any action or proceeding
(including any governmental action or proceeding) involving a Claim, such Indemnified Person or Indemnified Party shall, if a Claim in
respect thereof is to be made against any indemnifying party under this Section 6, deliver to the indemnifying party a written notice
of the commencement thereof, and the indemnifying party shall have the right to participate in, and, to the extent the indemnifying party
so desires, jointly with any other indemnifying party similarly noticed, to assume control of the defense thereof with counsel mutually
satisfactory to the indemnifying party and the Indemnified Person or the Indemnified Party, as the case may be; provided, however, that
an Indemnified Person or Indemnified Party shall have the right to retain its own counsel with the fees and expenses to be paid by the
indemnifying party, if, in the reasonable opinion of counsel retained by the indemnifying party, the representation by such counsel of
the Indemnified Person or Indemnified Party and the indemnifying party would be inappropriate due to actual or potential differing interests
between such Indemnified Person or Indemnified Party and any other party represented by such counsel in such proceeding. The Indemnified
Party or Indemnified Person shall cooperate fully with the indemnifying party in connection with any negotiation or defense of any such
action or claim by the indemnifying party and shall furnish to the indemnifying party all information reasonably available to the Indemnified
Party or Indemnified Person which relates to such action or claim. The indemnifying party shall keep the Indemnified Party or Indemnified
Person fully apprised at all times as to the status of the defense or any settlement negotiations with respect thereto. No indemnifying
party shall be liable for any settlement of any action, claim or proceeding effected without its written consent, provided, however,
that the indemnifying party shall not unreasonably withhold, delay or condition its consent. No indemnifying party shall, without the
consent of the Indemnified Party or Indemnified Person, consent to entry of any judgment or enter into any settlement or other compromise
which does not include as an unconditional term thereof the giving by the claimant or plaintiff to such Indemnified Party or Indemnified
Person of a release from all liability in respect to such claim or litigation. Following indemnification as provided for hereunder, the
indemnifying party shall be subrogated to all rights of the Indemnified Party or Indemnified Person with respect to all third parties,
firms or corporations relating to the matter for which indemnification has been made. The failure to deliver written notice to the indemnifying
party within a reasonable time of the commencement of any such action shall not relieve such indemnifying party of any liability to the
Indemnified Person or Indemnified Party under this Section 6, except to the extent that the indemnifying party is prejudiced in its ability
to defend such action.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d. The
indemnification required by this Section 6 shall be made by periodic payments of the amount thereof during the course of the investigation
or defense, as and when bills are received or Indemnified Damages are incurred.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e. The
indemnity agreements contained herein shall be in addition to (i) any cause of action or similar right of the Indemnified Party or Indemnified
Person against the indemnifying party or others, and (ii) any liabilities the indemnifying party may be subject to pursuant to the law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7. <U>CONTRIBUTION</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the extent any indemnification by an indemnifying party is prohibited or limited by law, the indemnifying party agrees to make the maximum
contribution with respect to any amounts for which it would otherwise be liable under Section 6 to the fullest extent permitted by law;
provided, however, that: (i) no seller of Registrable Securities found by a court of competent jurisdiction to have committed fraudulent
misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any seller of Registrable
Securities who was not found to have committed fraudulent misrepresentation; and (ii) contribution by any seller of Registrable Securities
shall be limited in amount to the net amount of proceeds received by such seller from the sale of such Registrable Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8. <U>REPORTS
AND DISCLOSURE UNDER THE SECURITIES ACT</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
a view to making available to the Investor the benefits of Rule 144 promulgated under the Securities Act or any other similar rule or
regulation of the SEC that may at any time permit the Investor to sell securities of the Company to the public without registration (&ldquo;<U>Rule
144</U>&rdquo;), the Company agrees, at the Company&rsquo;s sole expense, to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a. make
and keep public information available, as those terms are understood and defined in Rule 144;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b. file
with the SEC in a timely manner all reports and other documents required of the Company under the Securities Act and the Exchange Act
so long as the Company remains subject to such requirements and the filing of such reports and other documents is required for the applicable
provisions of Rule 144;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c. furnish
to the Investor so long as the Investor owns Registrable Securities, promptly upon request, (i) a written statement by the Company that
it has complied with the reporting and or disclosure provisions of Rule 144, the Securities Act and the Exchange Act, (ii) a copy of
the most recent annual or quarterly report of the Company and such other reports and documents so filed by the Company, and (iii) such
other information as may be reasonably requested to permit the Investor to sell such securities pursuant to Rule 144 without registration;
and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d. take
such additional action as is requested by the Investor to enable the Investor to sell the Registrable Securities pursuant to Rule 144,
including, without limitation, delivering all such legal opinions, consents, certificates, resolutions and instructions to the Company&rsquo;s
Transfer Agent as may be requested from time to time by the Investor and otherwise fully cooperate with Investor and Investor&rsquo;s
broker to effect such sale of securities pursuant to Rule 144.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company agrees that damages may be an inadequate remedy for any breach of the terms and provisions of this Section 8 and that Investor
shall, whether or not it is pursuing any remedies at law, be entitled to equitable relief in the form of a preliminary or permanent injunctions,
without having to post any bond or other security, upon any breach or threatened breach of any such terms or provisions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>ASSIGNMENT OF REGISTRATION RIGHTS</U>.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company shall not assign this Agreement or any rights or obligations hereunder without the prior written consent of the Investor; provided,
however, that any transaction, whether by merger, reorganization, restructuring, consolidation, financing or otherwise, whereby the Company
remains the surviving entity immediately after such transaction shall not be deemed an assignment. The Investor may not assign its rights
under this Agreement without the prior written consent of the Company, in which case the assignee must agree in writing to be bound by
the terms and conditions of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10. <U>AMENDMENT
OF REGISTRATION RIGHTS</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
provision of this Agreement may be amended or waived by the parties from and after the date that is one (1) Business Day immediately
preceding the initial filing of the Registration Statement with the SEC. Subject to the immediately preceding sentence, no provision
of this Agreement may be (i) amended other than by a written instrument signed by both parties hereto or (ii) waived other than in a
written instrument signed by the party against whom enforcement of such waiver is sought. Failure of any party to exercise any right
or remedy under this Agreement or otherwise, or delay by a party in exercising such right or remedy, shall not operate as a waiver thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11. <U>MISCELLANEOUS</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a. A
Person is deemed to be a holder of Registrable Securities whenever such Person owns or is deemed to own of record such Registrable Securities.
If the Company receives conflicting instructions, notices or elections from two or more Persons with respect to the same Registrable
Securities, the Company shall act upon the basis of instructions, notice or election received from the registered owner of such Registrable
Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b. Any
notices, consents, waivers or other communications required or permitted to be given under the terms of this Agreement must be in writing
and will be deemed to have been delivered: (i) upon receipt, when delivered personally; (ii) upon receipt, when sent by facsimile or
email during normal business hours of the recipient, with confirmation of transmission electronically generated and retained by the sending
party; or (iii) one (1) Business Day after deposit with a nationally recognized overnight delivery service, in each case properly addressed
to the party to receive the same. The addresses, email addresses and facsimile numbers for such communications shall be:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
to the Company:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Glucotrack, Inc.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">301 Rte 17 North, Ste. 800</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rutherford, NJ 07070</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E-mail:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">pvgoode@glucotrack.com
    </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Paul
    Goode, Chief Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
a copy to (which shall not constitute notice or service of process):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nelson Mullins Riley &amp; Scarborough LLP</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">301 Hillsborough Street, Suite 1400</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Raleigh, NC 27603</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Telephone:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(919)
    329-3804</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E-mail:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">david.mannheim@nelsonmullins.com</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">W.
    David Mannheim</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
to the Investor:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sixth Borough Capital Fund, LP</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1515 N Federal Highway, #300</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Boca Raton, FL 33432</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Telephone:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(561)
    864-5500 </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E-mail:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">bob@6bcap.com
    and mmaclaren@6bcap.com</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Robert
    D. Keyser, Jr and Monique MacLaren</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
a copy to (which shall not constitute notice or service of process):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ArentFox Schiff LLP</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1717 K Street NW</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Washington, DC 20006</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Telephone:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(202)
    724-6848</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Facsimile:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(202)
    778-6460</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E-mail:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ralph.demartino@afslaw.com</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ralph
    V. De Martino Esq.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">or
at such other address and/or facsimile number and/or to the attention of such other Person as the recipient party has specified by written
notice given to each other party three (3) Business Days prior to the effectiveness of such change. Written confirmation of receipt (A)
given by the recipient of such notice, consent, waiver or other communication, (B) mechanically or electronically generated by the sender&rsquo;s
facsimile machine or email account containing the time, date, recipient facsimile number or email address, as applicable, and an image
of the first page of such transmission or (C) provided by a nationally recognized overnight delivery service, shall be rebuttable evidence
of personal service, receipt by facsimile or receipt from a nationally recognized overnight delivery service in accordance with clause
(i), (ii) or (iii) above, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c. The
corporate laws of the State of Delaware shall govern all issues concerning the relative rights of the Company and its stockholders. All
other questions concerning the construction, validity, enforcement and interpretation of this Agreement shall be governed by the internal
laws of the State of Florida, without giving effect to any choice of law or conflict of law provision or rule (whether of the State of
Florida or any other jurisdictions) that would cause the application of the laws of any jurisdictions other than the State of Florida.
Each party hereby irrevocably submits to the exclusive jurisdiction of the state courts sitting in Palm Beach County, Florida and the
United States District Court for the Southern District of Florida, for the adjudication of any dispute hereunder or in connection herewith
or with any transaction contemplated hereby or discussed herein, and hereby irrevocably waives, and agrees not to assert in any suit,
action or proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such suit, action or proceeding
is brought in an inconvenient forum or that the venue of such suit, action or proceeding is improper. Each party hereby irrevocably waives
personal service of process and consents to process being served in any such suit, action or proceeding by mailing a copy thereof to
such party at the address for such notices to it under this Agreement and agrees that such service shall constitute good and sufficient
service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any
manner permitted by law. If any provision of this Agreement shall be invalid or unenforceable in any jurisdiction, such invalidity or
unenforceability shall not affect the validity or enforceability of the remainder of this Agreement in that jurisdiction or the validity
or enforceability of any provision of this Agreement in any other jurisdiction. <B>EACH PARTY HEREBY IRREVOCABLY WAIVES ANY RIGHT IT
MAY HAVE, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION HEREWITH OR ARISING
OUT OF THIS AGREEMENT OR ANY TRANSACTION CONTEMPLATED HEREBY.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d. This
Agreement and the Purchase Agreement constitute the entire agreement among the parties hereto with respect to the subject matter hereof
and thereof. There are no restrictions, promises, warranties or undertakings among the parties hereto, other than those set forth or
referred to herein and therein. This Agreement and the Purchase Agreement supersede all prior agreements and understandings among the
parties hereto with respect to the subject matter hereof and thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e. This
Agreement is intended for the benefit of the parties hereto and, subject to the requirements of Section 9, their successors and permitted
assigns and, except as set forth in Section 6 with respect to those Persons entitled to indemnity thereunder, is not for the benefit
of, nor may any provision hereof be enforced by, any other Person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f. The
headings in this Agreement are for convenience of reference only and shall not limit or otherwise affect the meaning hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g. This
Agreement may be executed in two or more identical counterparts, all of which shall be considered one and the same agreement and shall
become effective when counterparts have been signed by each party and delivered to the other party; provided that a facsimile signature
or signature delivered by e-mail in a &ldquo;.pdf&rdquo; format data file, including any electronic signature complying with the U.S.
federal ESIGN Act of 2000 and Florida&rsquo;s Electronic Signature Act of 1996 (Florida Statutes &sect; 668.001 et seq.), shall be considered
due execution and shall be binding upon the signatory thereto with the same force and effect as if the signature were an original signature.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h. Each
party shall do and perform, or cause to be done and performed, all such further acts and things, and shall execute and deliver all such
other agreements, certificates, instruments and documents, as the other party may reasonably request in order to carry out the intent
and accomplish the purposes of this Agreement and the consummation of the transactions contemplated hereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i. The
language used in this Agreement will be deemed to be the language chosen by the parties to express their mutual intent and no rules of
strict construction will be applied against any party.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 12; Options: NewSection; Value: 12 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IN
WITNESS WHEREOF,</B> the parties have caused this Registration Rights Agreement to be duly executed as of day and year first above written.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>THE
    COMPANY:</U></B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>GLUCOTRACK, INC.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Paul V. Goode</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Paul
    V. Goode</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>BUYER:</U></B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SIXTH BOROUGH CAPITAL FUND, LP</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Robert D. Keyser, Jr.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Robert
    D. Keyser, Jr.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 211.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Value: 12 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>EXHIBIT
A</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>TO
REGISTRATION RIGHTS AGREEMENT</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FORM
OF NOTICE OF EFFECTIVENESS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>OF
REGISTRATION STATEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;],
202[&#9679;]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">VStock
Transfer, LLC</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18
Lafayette Place</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Woodmere,
NY 11598</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
Operations</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Re:
<U>Glucotrack, Inc.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ladies
and Gentlemen:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are counsel to Glucotrack, Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), and have represented the Company in connection
with that certain Purchase Agreement, dated as of September 11, 2025 (the &ldquo;<U>Purchase Agreement</U>&rdquo;), entered into
by and between the Company and Sixth Borough Capital Fund, LP (the &ldquo;<U>Investor</U>&rdquo;), pursuant to which the Company has
issued to the Investor an aggregate of [&#9679;] shares of the Company&rsquo;s common stock, par value $0.001 per share (the &ldquo;<U>Common
Stock</U>&rdquo;), as payment of a commitment fee for its commitment to purchase shares of Common Stock under the Purchase Agreement,
and may in the future issue and sell to the Investor up to Twenty Million Dollars ($20,000,000.00) of Common Stock from time to time
at the direction of the Company, upon the terms and subject to the conditions set forth in the Purchase Agreement. In connection with
the transactions contemplated by the Purchase Agreement, the Company has registered with the U.S. Securities and Exchange Commission
(the &ldquo;<U>SEC</U>&rdquo;) under the Securities Act of 1933, as amended (the &ldquo;<U>Securities Act</U>&rdquo;), for resale by
the Investor an aggregate of [&#9679;] shares of Common Stock, consisting of:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]
                                            shares of Common Stock that have been issued to the Investor upon execution of the Purchase
                                            Agreement as payment of a commitment fee (the &ldquo;<U>Commitment Shares</U>&rdquo;);</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]
                                            shares of Common Stock to be issued to the Investor upon exercise of Pre-Funded Warrants
                                            (the &ldquo;<U>Warrant Shares</U>&rdquo;); and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9679;]
                                            shares of Common Stock to be issued to the Investor upon purchase by the Investor from the
                                            Company at the Company&rsquo;s direction from time to time in accordance with the terms of
                                            the Purchase Agreement (the &ldquo;<U>Purchase Shares</U>&rdquo;).</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Purchase Agreement, the Company also has entered into a Registration Rights Agreement, dated as of September 11, 2025,
with the Investor (the &ldquo;<U>Registration Rights Agreement</U>&rdquo;) pursuant to which the Company has agreed, among other things,
to register under the Securities Act the Purchase Shares and the Commitment Shares for resale by the Investor. In connection with the
Company&rsquo;s obligations under the Purchase Agreement and the Registration Rights Agreement, on [&#9679;], 2025, the Company filed
a Registration Statement on Form S-1 (File No. 333-[&#9679;]) (the &ldquo;<U>Registration Statement</U>&rdquo;) with the SEC for the
purpose of registering under the Securities Act the resale of the Purchase Shares and the Commitment Shares by the Investor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the foregoing, we advise you that the SEC has entered an order declaring the Registration Statement effective under the
Securities Act at [&#9679;] [A.M./P.M.] on [&#9679;], 2025 and we have no knowledge, after review of the stop order notification website
maintained by the SEC, that any stop order suspending its effectiveness has been issued or that any proceedings for that purpose are
pending before, or threatened by, the SEC. Therefore, you may issue the Purchase Shares and the Commitment Shares in accordance with
instructions from the Company from time to time without any restrictive legend or stop transfer orders maintained against them.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very truly yours,</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Law Firm Name]</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[Address]</FONT></TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[State
    Bar Number]</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">cc:</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;Sixth
    Borough Capital Fund, LP</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>EXHIBIT
B</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>TO
REGISTRATION RIGHTS AGREEMENT</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Information
About The Investor Furnished To The Company By The Investor</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expressly
For Use In Connection With The Registration Statement</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Information
With Respect to Sixth Borough Capital Fund, LP</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of the date of the Purchase Agreement, Sixth Borough Capital Fund, LP, beneficially owned [&#9679;] shares of our common stock. Robert
D. Keyser, Jr., the Managing Member of Sixth Borough Capital Fund, LP, is deemed to be a beneficial owner of all of the shares of common
stock owned by Sixth Borough Capital Fund, LP. Mr. Keyser has voting and investment power over the shares being offered under the prospectus
filed with the SEC in connection with the transactions contemplated under the Purchase Agreement. Sixth Borough Capital Fund, LP is not
registered as a broker-dealer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 16; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>gctk-20250911.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWaeBKbP9z5Z8OekhvWBwbUn6Hy8tfnJTRCaoiky2kSQP -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:srt-types="http://fasb.org/srt-types/2024" xmlns:GCTK="http://glucotrack.com/20250911" elementFormDefault="qualified" targetNamespace="http://glucotrack.com/20250911">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://glucotrack.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="gctk-20250911_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="gctk-20250911_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" />
    <import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" />
    <import namespace="http://fasb.org/us-types/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2024" schemaLocation="https://xbrl.sec.gov/country/2024/country-2024.xsd" />
    <import namespace="http://fasb.org/srt/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd" />
    <import namespace="http://fasb.org/srt-types/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>gctk-20250911_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>gctk-20250911_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="gctk-20250911.xsd#Cover" roleURI="http://glucotrack.com/role/Cover" />
    <link:presentationLink xlink:type="extended" xlink:role="http://glucotrack.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001493152-25-013094-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001493152-25-013094-xbrl.zip
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M\0>-SX?GGC__?Q<_)T]>O7GUZT\_)Z<GKY]?G+Q(GOWZ\BD,X\7KSFL6Q;+
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M#\PJ?$S9MNG:M4!51XJS3#876:W>#:*JN^G<27U7VY\6>-N+XF91G 6BR Y
MW+E-,C35)^0QAD;1J*X0(#!-IM5UJ;9\F:-0M.@#@&6$(1]"N1PDF-8U0 MX
M05OD&%6JQI)+!G$DDQPO=G5JC3 G\[IJK/V@8\J*KJF#+BZ*>D1,([9'D">A
M<)OUC<SK^RVRHFG6&Y^YE_W[)/MS3_:?9.7;>KUJ)S?)B^RZ*_P710LJ^O@X
M37X]/#\$:WO*_CV:W.H@SG)$,RS([6]15A;9M8FSU/FBR&<H-]-\#-+9[-W!
M>SZET64@(;UQOTVJT5-VYS!^U&H2I^%8\B@>3I^)= 6!#,+(W"J2@;$/T.PP
MHGUXXR\MSX4OSTY$+B+1('G3[ 9WGXW':(@2!( "LZ3DV!5'<W6R6-/EO?DA
MPT'_4UCZ-3B-KCR:H1AG0-ED^W8"RP83Q_01_'$O?O=\2J/?//'K1I,CGH_J
MP"8'552 X\,% RQ7Z-A0]"D#(W,BCVOP<:R,3>[-?+LW8 Z/W98PV<O7/9_2
MZ*TO7U4YP[L0/6=P"4 8EG1;QE5=83\ EVA#J182A;R@2Q)+-TQRO[*_2O4#
M'(Y=W%"4$N8H/Q*6%C$#I!FK&KUXO$['^$H*%2N\-BOG!48!*K(%&DQZB!KE
MT'*U=E/?*7A:DS7>N[ BJ[IJJ_9FA:O39,O5 O^Q6F3H5%%.Z_=UL:([6B,!
MH'&G>0.[HU4XLF[NHJ6Z2O*WUY1NR5M0N/H7/& 5Z&4U(?29,,!#=\TY:;<N
MBPF]3Y9!XQ &" Q_ZMNUI)CQ678WJB  \JRHEPQ EG7&^8QS_$??TX8#7%$,
MD\334];8D="+RL2ZS@_[Q[B$JRY;-)7<@'F/5*&9IS_"*(<#%B[2.T7-94)%
MWFQXD0G"I\EE=8W&76K>&4HS;SBZT==98]./B)XN*?]'28EY7N:T*R Q)B E
M<23^#@C<$MQS/UU'MS*Z-&9Y5'W:^?%!><R^]#@'2<AO.0[>CNWOT%$1B/S*
M^?5E7:WGE[!@B=BWE ?))BZV/?@2C1<-)A"R;%'GV?3&K$?5-" J_=\UYW7B
M;B#&0N!>HG<*S&3WY8/EP-P+KI5\(GBG*1V9%7#\:4'A$U4]W9!L[;X>9WUU
M0 :9$XSQ7J?B2LBGS!%9.^TLP?CVA&(^=&B=#YEQ5B  <X;QX.?<I2IH^7D<
M>%V ;8A_@>%/0=878"M:,%3?TJ\Y50Z3)>0@YBQTVN':FB'UG;<T<1??*%Y<
MY.& +P.0ZE6.@:XD)P]L8DY/WSY9*2(].KHJ:+XU*NN:UQW#!YS.\ZZDR%/!
M*X1+ -\\9=\MMC2(L&KB!P>^O(2+.P"WZ?;)F,@K-0)$?W$$ERHV8#Y-FQ'\
M$J;/,L2.0$))&KJJ'#R<JZA(H%376'6[CYG=(Q-KX9M8Z("!9NFQJ5C^\&YJ
M:P1G(-ZD00,!_[4H0*; AL<PA(U!&*R+E)O!4_S W-X*O^=3&BT]$7EZ<1J)
MI<+)?PKN5E/ ]M\D%R@=MGI27;[U!-&AF&_*:]02Y-VMQZA?.!O&L.\,[K#9
MNN1[58.M\K"]M'R<*>T #WCX.'FUHMO]>QR(I (?)__".E;X\U\</1#C$_$0
M!0_<Q=5E?9Q<@)?W?7)29^-B\CAY"<+/2_^RP@5]Z&7\]5OXEP=[;,)?[(S>
MG48O?8W^[Y/3Q%9U^YJ]K\ <35+*$Y.12VE2Q'0N0"O450D&'RKXE%W$69VC
MIX*!8/;^L)X7<Q-@QC/2'G^C=K[K5<'_AQ\S^0[Y;^3CP-,F8%(7<;2<FS*V
MW@DXB*T&2?+<_-ZIQI ;[,M_PTBF=78-5@O,TMA$R0A7ZH!*(A!,0?! N [%
MM,&G/\/ Y<D:@]@XM',.4X+K#U<BSS<9/3LYOSA(7M?5O,Z6G8SCBG\_'""X
M@MWD;%JM9*+XMMTOS_UE><^G-*J\@WCV;G*9E: X3R9=T!!G&ZU N1_&XWG\
MW5=?DUL+$H# #4MS4:]M_ !QF.RAHX.X7LQ)3EO#![$7F7L^I='*$YGG)6G5
MF_>H"TVZW]V,9IY$T,QNE-5/"AK,CCB-%-662,/#+848WF.1>.D*%GD:&3!#
M?X<#DQCJ?B12P_9G8GCV(G][D?]]B\C?IG3T0X4>'O%I%(]V)_I!Y:,]CQL.
MY'GO5T Z^6,*2+>LQ>U+2+L/["TBC6OHI%]C4?8O"/SVR3Q%J1=H#HABR_G+
MC0;A[6H/!X]&2U[N<;ZH]G&W^SZE4;U%[=VB8O4NKGHX#UE[BZ)5J3%T06B,
MXGCO0E8XVSV5K-9\V'I0[Z".DU)WT5K6Y"Y*6?O&W"UF'0XV&5$?>QG"<M;A
MH*>>]8-G;4#;78B17Z_*T8GA0-[K6:>]2=,>#7W+&M6[079^,(@SO+SV:OZ>
M3VG4;%'SMR]2?3]MSR$GH2CX:&6J?9:,7ZA*7#_AB]MJGM/1,+;.!C/9M>=P
M='RH^MX>KX)U>1KP5L,XONH;+:V?9H6$-IVBU:TWG" )Z (=/0K!2BMTF:?J
M).C?A@/48AS%WVP4>BJS$PC%*PJ=EJF,W<(V_%7S1"3_\ZB6/G']L5MR[:M]
M'NVCYM&^VN?1/JN*]H]^*[?>K?P+>CYHZ)],N>Z&>>OC*)FE?CB3#TL( RGI
M12GGB)*:Y""K"T*Q,P#^PC'UG@HF+16&!(9_->M%2WX].!S,LML0!"='T/!8
M+Q$LE"S*K&2.&270#IBIZ9; G-7Y>MP48!C7!2Y(F[W-*8:4P85<+=!'P)L3
M7<"LW#@],DYYB'"WP"VZ@/%<H9E,4;'1R0%]7;(6<@/^6E(.[QR+ZWC@<+9@
MHQ/D_JN6!?^R,6D/, S<R2WI.D5,H>),>1C3"KZ(ESD18!(V%^UVN-I@(=!0
MMEOR/DLR>G+ E#0R&7JG ;J"43XCP#?CX:8@L35!36UP?-,+96_SW68R''S@
M5$Z];8'/D8/%?-&EW/]D<.49& :_K^$)#8*4X1@N:$M2A. V9+%=9S7BU4'W
M$>M0C5RD=06/7.(/2_P"AO98Q!M-?>8-7!"9HGB->%U7(%R$-93C01YCY\5)
M^%X2D<TOSM\5C>+*Y520^Z0&\.@I+XJZ7;1J@3V;TO+"5L/#57CQ-QR[*&KD
MU!.\4V.@E/.RB5)E.DX>4W#GR]4B,Q:D3_<Z.A,E(AL_"\Z5XU0OLFL^,I*S
MQCES.O"/."881G[FBA?ZPZ@?J!P,E0*'+YW,#''7=KQ8650J*U@O!5UJ^6)V
M7SH<$8/ G?D8RUC5,4;C.<FNWH,12MTW1'PK$F&<-0AK;GT$M,4[QM0Z>TO#
M@;S'-$YQ/?EICLM12/7%9W6]?HX6PSJT&+A"+9J/%>^O;EJNIA0R_@II%=PX
ME</JC*).5"$/9M4:Q/CAUP?RA:PL$91+61-^TG!PZL0A:0A[^;GG4QI=>?+S
M^NPD>4WQ[[CP2&Q<XLT.R^.FP/BLF(&\C![]</[KZQ_;RQ^^Q/\>](9)L03!
MB9/B36=OXQ5<Q ]RT[Z)4">JV?#3;_(Y7++2;8+L._KK*$,,UHP*43AA>8!:
MF=:I]QMTE_+MP(5N,]NA(GC3&^P\YP9 O;CY#FO4&S,V9U'R(7;NJK _I679
MZX-[/J71M:\/0,''2UW1Q<!4PIIY2K#8J;UQ2O;'ZY9L/.U9)J3P^B.87V+V
M3!2OG[E]S1#SD/Q6%2!R5_#L=8TY&;?/&OY(Y2!XTL#L@3?+'ZDPU*9#V I.
MYA5<5J6:=53XG>/[S&_ D9H(G&%/ZW[OIS1ZY\MIG3]XQLQ1_\YJL'QC01)T
MV&K)1!C<2P_2&''&)7AL>3TI##D4?*C;.*NJ12%RK!_#!R6&*0S(8TGQ<_R*
M!,![PO-N4;5[ \@@#(:YSK%^%H:\;A&&2Z<-G:P%..4R7M+&L_5BL9?C>SZE
MT4T@Q[Y,Q&N>7F;--/L].>4<KV9W1J+7V'.CD!!6[LY!$8) V#(H4G%M=?#8
M('YL]3<%W$RB*+\B$R+BLWIG!>05OPPZO6'E2XDI_%?I#O>G134VHTTC?SDG
M'+]^@,T=7,G_K>JW\BJ%'W.V\.7_GI\E)TM8V@DNM?U5/<G(Z\9WO+HX_9__
MESQ!4(C" .P?GB3_XMO%_(VC8'1(X0/R:[!Y?JJK]2I-GI>3P]U7FN\\\;,P
MQCB'&VU^0$/E)=YMZSE-B +@Z9JEF4^NL.PJ$N_KW34:1;AK>Y5QSZ<T^H^O
M,GRRS1V;\X3<R&FT98_(>4]FW\#W4X(FV0!@*O0&M1LQ"_E)MV;N[QT)Z%Y6
M;R^KF=].*A2[>"K+&&?9=%HC%F+:009D^R9,G]"41N/Q1C'8N7RDR^F^&6.4
M1;J@W*IXA)%N7_=5CJ"7:Z)5WV",9^?Z$G1PN<"DCZ?>@+4[']A7EWSJ4QI-
M)IM/Q"VJ2[JW^<X'PJ\K&0[NKK $6UJ'8%OQB2/ N4ZMPW#0F1,#;S.G&*6#
M!91:E"X@.]X^L/> [8_/G\;W\/4>DO91(6E?[R%I^^-X]PV/IIMOL]V+AB*7
MV6U,/(X:=1K=-1C*<HJ&OJ6BH>_]5G>1F@Z]2J+WAP([8EW/<!RW;7N6[-KU
MS,N/QJ\V+2,9#MZ_CN1N6YU):'%?1_)936F4^UUH-K PDXA1C-'A52;VD'@*
MIJ^*:Q/'LE*![^7FGD]I-/-;QIR?1?C="*J+73(< A+,@!D2$I27@K@O]QM^
MSZ<TFOM]4NR61LP"M*\9RH+,U]T*_"8UUV;!&7SU(X5\IIL/WK=)N>]3&EU>
M]DC(3LQ$EI#HJSTAT><O+(7?A"36$"<N,I)S_J4HB^5ZR9\D@5'@,V<;POAJ
M:(:8I"J)U7 P^O,M;$+7#P=["_NSFM+H-[_?"1G'E]4"<?XG*&U7V2*.%= @
M*'U$74W^)G<_@5G^5M52"D:<"@ZDR+/*71C!<'!5M=P5P:5FK!($YLVX3H/?
MFE/7O-TJ)O)HP4+C=@&BPJ8&HP 3;ASE/-VY"(07$H>QJMI<>0KIFT+/XP>K
M;1Z;QFLA6RZ'>A!0-I<)%I?8VT1&T_%9%#%BL2$,F-P?O_L^I=%;OQV,J3[J
MZ77%B%DO+8%U28N;!]4U%Y^A[-?5HDFY>T07KY.Z36 2IP<,Z/9K C*&YU8.
M)%\4#@VZ_+[ X'&.4%F77(2+L:ZK]6+JM 8@Z7:#;<_AH";?'!V/Q@>CA\<'
M=/#>&)%/SA_\T[.AN "I:YOM!?V>3VFT\$GYH^IX!U_-JZ!3V[N97.938W_G
M[RZ+,5:N,1(Q[10.@(0%E0/;GM3JH^BWTC.$KC2REC)]3N,U/)I@4F9&W83X
M>44)0Y"N')1R0<8[.#X5%0FOZ[)H+NU]( UV9!JQZM7-%Q]^;WRC4\-_[T_)
M/9_2:+GLGA(D6#Z9YS'0^;_8.M*/I<F+%Z<A 99<&7!-&%!FD]=74BEL1&B6
M<Y6"82JC>KL5]VFR):+=C,)>J.[YE$:E3XV.V:BN*/F;'(%"<4XJQ'!2.HAL
M\A@-DK"=>>A-SJ$)J=!UCIH8[6G);ZWZ^,_Z O:I%['OY6:C7G99R4<"/KYN
M&0?25##67+ D3?)D455(OS2'HW3X>B_:?QI0X]$>J/%1@1J/]D"->WD<=Q/(
M)Z_>/#U[X\JF)X#;S@;];M<U^^)''-8F ?Y"-\H*K0SGPQ:MLT8@E_BFGL-A
M]NU.7AX[QD]^? A7PI,?;S>@.Q["ZU_?G/Y\<GZ6O'J6G+[ZY9=7+^')KT[_
MV1D9'6'8.SG$*%[WEF\K/E7=?F=>G\-%?,ZTXF ("5$.$<2@$65XK3:2=Z=>
M_.=2K/@:+2EB!\\7BS ,:?-4)C IWQL.'*Y$MW0U1.>F75AM(_P!S?>?U?[<
M'T/I#BMEP 6@=M,.A0I8V1TK/X#)H)]PF/RZ$KNZ 3%I9K8CK1,B[Q-=BZ9K
MDF^9DA5%$7[]#Y<F?^27*[KC='T5E6)--X4#(CO>&4K_4Y%YU*L*.;"1$DIK
M^:>,\QY$*64.6VIH""@49(X1X>$XK!H<0NRG3?V:%DAN@X!W]H;,H8R[7B]=
MO#QL-)WN8LG .W-@URO\\8+X=)*+RVK=$&?JPZ/TZ.CHH(MQB'8WX Z^9@.)
M5=]H(!<6*<T4EMD[2G3VLM:F3L;#)BPC,_%V2I9@. @8@U\@P8.[::F"^WL
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M<V'\=0HM.H9.YN9=?:ZA?6>F>SXE[<S$(D'[]IHS(S:V:(N4&G&G-<CLQ'I
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M6.'T#)"C&I.BGJR7N.=$8%ZX_0PQ?(BL<:*#.%H*_ZSQ9D=Z*#;0Z/D%S_A
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ML];[ _FQ.A4ZGN@+N'[F#NW8;F[@K>!*=<ZHPT1;LC5@#A.K*%H^-ZD#0S:
MU]1M/4%W(/*-R$A-% 5[WHG5X5S" 5%K>XGQDYQ2? )],B4%%&GT/AU I>W]
MWS$*';"Q1',8FQQ%_J8^_A$?.UW"W<\8OBMT_@PDTL4^&F3PR$?B4LN/$BUJ
M1N-6M6)V#]"_M;EHG)&3=#Z9='E/.)Z)GGW&OC5:U+P^?*<C(C OYV(:+?)Y
MQL;\E;!\D['M<\]ZI$K]Y(E!$([ASP<,VL5@)&T.K"SE,:E=^BR[JFJR$,!]
M)'J>](Z0O;UE&.0&6ID@E/T.<L?>K/7KQ-FSH F;UR>KF]*^PF<GR\>[)<D7
MCHHS3M\[*U+Z8;PL<16T, B3/%'X,$[-/@[O"F9;GA73]82D?[K&;98R+MT3
MGL!P\(?LR86)-:EW8NC7O=4/.0,]Q=,Z"L/#_6K-@JM;Q.U"-6;6/>82B!<B
M)V^)P!S9; I=Z&[[PQ+B77AV)$P COQ*<=:V$ 9_;-:-SH#BTZR[P'Q&!TQD
MQ44$V[B/ C]VJR#I1M*[9_1DTNX#SY_&E+1=[8EQ#LFW>V-R.\KB92*'F$E?
M1Q!KGGM)T27T%(VG&30Z9EIOL.%SPXL]'$RR53;1JZ%>FE?BS8*A4 F_U=&
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M(3%R9="+*5"-DN9E5_6:,"ET?\#:5D0-(@K>B=#BE7.+DRD0@[#[>1(V/U<
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ME-.)%H*V#55A'QK#:JSAHZMG$_Q-Z]7K'1YDBM(%$\H%EL<XE=*Z--094\Z
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M35QB:(-DB0-D_=NN';*-FWZ\)KVE%<IP,2DT/T<O0[2\\9*!U9(R3ZZ;:-7
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M>U7!L@H8[9JLQLU1CH,Z*/9$ND3R<'4]0FD]0AF5&8?JB9%#7+M)-+5C\]1
M! #<A-,Q.#]#F6C7ZE=0+"$H!A5SIB8W$"Z(FX$ZO\R8Q6F.6G-(<I*N>,]J
M[6,KX$C"<C>H<>\8PA:D'[GA?+(R/-(PNBH7G+K9]0:8"K':JAM#P$;%2:;9
M.)1C+ M/S8TC2&I6G+5B%*$.O?AR)3,I[^B'F,XJ+,?B1"K&0$RC. @*FX#D
M=2O887&F-@&:\-FPX3(\(!'LX#N<F_ C)89]"U*%&3?\I3%Z&08UUDD:W0AX
M=[[!>>2'VX$-4C0Y;$@H?; 81+@1,LJ=+[#KXZN0=F7!:2P91 O_8@%!*!O'
MRDX9KE8E#:^9,5##%]5<S8E@OWF[3N%MO%A0P>PL@1V/("=DC?$ZG_) 9M^3
M(  S!-$!Y<O)&&L!+J3>H5 U+4%XK2\2OI<H$@\?6?^2[1K7;5PJ,09>,?45
MPE8/IG(VTDDX349PU5WA<4XD6_ #>$9XJ)8"R>P#A@\S!^R%S#XA7$R!921;
M:?%FP\5>&SY-=1&QA6T3B7*\2_+G2E=O/:2;4_AQMIS)D6^32FNB2:>M<H^M
MIT.46[9PL3E)? ,E-"2G*EAMX2#(K")M<O,%=2++H)L[33UXW12.DB5JJL,X
M.I.)H;Y19%F/50]H-F2>$Z8WS<+IY)GU*_V@!YHTS9)1O<"^:=*TDC>BLX/Q
MC<2V1+ALT6T2T:FV&ZH%VO,7JV_O(9X#6\D\5?R@^U.P] 8?5T+W2;O20X3'
MUX,]'1%GW?2;L+'J"LFWU5HPV7:=E]MX!21L+> DDG*H63 ^GT6X=T=IB'<_
MS"^=_^*\6:Q\^4T4Q@&2BHM^./X#.2>7TZM@P05;VNU#A?!X#$M% %-$A^<>
M16B%F*.L>)+Q(<KT?7CDA@3<^P.68S9FA0#QP.8BOIZ5W@2HAXX?:S;8R%%H
MO>G*FR5CF LF=YX&*\]B2;S--6=.MKKB_KL"15X^KX$B]PH4>?F\!HK\J$"M
MN[N;YGPW\>&)<?%(HBK)*&0^?%X;)9>&+U<&,X.'T&PO2.'H3P.A[,>OW.8^
M:3:<"Z7$U*?@SMB-:NJ0:12C5;7B:Q.#:*HRN_3**VF]W42P]3:X\S9OXE6
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MSV 41T%L_RH=!92ZQW?TA@?_^A]O'_,NIJ)/_6'?^QVF< FGN_K;'*%>?*'
M!^37F?<N399S'^V"T>[F(YN4XI+JR^"Q=XED(&C.P*[$U9'S+VS OJ$<Q 0L
M)0ORU#5YXUSED3\G7NM%GG3+$+?TJ4@Q;3;T\Y@YJ3T>/^O%GO-;7-3=&#=>
ML/)RGP_LPG74GI,$A-,FA"9(JI9SS,2>SE>'>A[L0NK0=DWV-J[?<,=-VS'^
M*LQ*(&.^!HSY&IAE,))H03-3OP!)%)8"GE/F66K4"[]159E:>=E+3F..%E;P
M)X!S5M)M[?$G-*J%7%3RHYC9+(", AM59IJN 2#FG<T&^ MJ\2/9F-/&-8XN
M7'W3$$65)K@76J]S>W6[%LTV[@/DY(\XCL)@8%T?1G!34V)74AWF8"&L4QL1
M3&$0BU6&']P/XH_I<KX8K;R3X/-V#>$VKHHK7A4.N.XK)]NG0).]J#XETV5,
MK(BL;T,A#$6&HN$9)'N([(B8K*>H(T?^IE$XT8LQ8AT?U(,M>6K)8^&:!P-S
MH;&(W@%JS8&%'C-:1H7E*)B2NA2,K)@HH!K8&7 *+@0 &WW:\1C+%GA@Z6 )
M)V(W8,[H30JB< E_FD2:HWR4PM:2&DH\C^6;</XN8P7+02 ;?G8<7K(B.P=6
M4(94V)?&RYIN]#MB%E[4F(7[Q2R\J#$+]8:\%Z;_&W&[3%N#/H%)?#$+CF7D
MN]>= 11&6=F-E8,*!C'5:97=B')59?E+RG["FMO*J[ZL\.G,+T8/FT9_+J-Q
MX)!J62_ _QK DR-H0+K:KF6PC2L[$HO>0@DXBTY0Y]"H2$%_590&UXHK[HSQ
MQC2)%>S5D7#&Q7$X// HR965U5H2*:IY&OQ#(!"CZV@Z%<##=@W_-JZH/XHK
MRL3@*F1Z-*7=03"76 ,QEK=<^#5%&?*?M<I0JDA_7[1"(OT53<H=@YX?F!I:
MKTU*RB3N"<M;^'OAU+6JF/!!L&7X60'O#9?_KX(]T#2RV6">/3@ZK9 ]+WF.
MCO\*6V6KEL0VKO*/Y>=FH9+],DT^<D6M\=*XE**$<AV.R'RL>T)&!"'@Q4#
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M&$0)SNAE"$? CG[89)F2_:E8(;3!)[P[O#9J)^*1=XG0MET^&]B(=RK5U8I
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M48#K4S(BJ#/K6)@*]"]*I\(I"91FL"0]U0_"5$3L;$3E;_:]\V Z\_8I^7N
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MZD*A1[6GOSNC[=.^YZ\5JPI>Y^GXV3DY$?MT28^B((W"\ML>2<!1:P:-5T4
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M@P+XY(8C, W-?68.6D\DJHF4X$AA(QG9E#B[0LC(.!SA79LR,9()^?O&HD
MY$BQX6418C;(7D 781EGX93(F4;!,@OS*$@$=BYGR#_&3S((DY*TC;172,2(
MS"BYA'D..&<A-#B48=#/J6_X)]"E#6[XLMUQN?'F\+UP-D\^$U&VO4_<O6'@
MNW"]$X=2CJ17;19DK./53 DLX2Y3.TBQ2 96FK,BYY=[D'QD;'\&-W/QT7I]
M^TY>3V.R?,7[@"RO\%,:SI,4?YTA<FHYI=S??#X5CDOX*:9$+/QC2CHFW&S:
M4M ]9!\3T"T2F(V67'*+ 073MC#D+R%%&^QZ.D1X.*,45M+XBMP+8UJI@X7
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M+<S4BT/"::\6I.@@#!-UW=9]0J=OMFDW;Z9CHMX$7RTS=TL@SG=KSI4%W4O
MIP^.C5XW&#FL]+U"I>^D$&K3M]PU[/M;1_H.E]K^:AVF^49W]-O&Y&'^_R/?
M-@^ ZK^'';*E(UB)\G\B0ZA+#&KK8U/K8UTH[^VO7H_$ K._>B=!MJ@C>[>,
M[&TKA/ZG_=[A!]IPQ\/3D]_^/U!+ P04    " #LABM;^?B=__]#   $]@$
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M3WY!5P15( /7VM+4'K[@_/,<U+=(=>JR#$O1N0:%< _%?'8'F!I$MPO:3=>
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M3%SCCV'F*[<64R8@([HY3+VCWY6AW_&&CK#7.[-4:,FVV[B&XVQIRV<+]!3
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MSZT8^[6]&FO6UU:W9@O7>I)US I2FG /SR\_&')$U!?0V-BJKY(U5:WN>^8
M-7&T6K^8D:47VWS?=YW#]MIX__2=@X!-J9)O)57RY)P+.YO5DZP*'NW!G,9^
M!Z2 QH U7AZ<71F7!Q?GEU<SN'& X\7 #P;<#8W0@\=,]+*QQ@KS?-986[26
MF-=A85?,)NZ [\"W0UL$QL'(['(7-*A=,T2<&ULKJS.(]$R>5#27#=BS2]'W
M_) MXN^XAX*#<22"D(E; (;Y]+6PEK995FYL9N3&!1G;!](2+Q8@H[]6]EOV
MZ<F1M_(@ 2)]V6\6[%&X;<'H/7BV:_'Q&* 5;EK -.I% B8%W (0<1]&:0LX
ML(T*PZE*!<],[?JLD;)6;,IT&NGRNQ37=H!!D1"]K<6DN3I:^=0(WX_W=ZVI
M=1O\/>MN3,^]L'-T^G'O_.IR=^^D8AR?[=5>CL*S>#""=3)P@9#1^-'",!ZP
MH"],]"I:S(9]# ,&D@7XCK\T8XM0= !#WG8$ .$X\*F)T=H%X&'X>Y];EO[]
MP8@GO"R1\P30<G@_ '#T3^0I?!WZ#Q__5OBA;7)'KV+H]97;\75H93PZVFG3
M+G+:W&^ZH@U3**XT_WQ4)6<B,SEV3<\'H4BQU58(XF1/!A_W/*N$M[SO';W?
M;W@'&_]^G5;L8=@7/>.AZ/O>+9ZAG-QKYIG/1%A!!Q .'X($O4OVA59N7Q]E
MWQYWVS)'JP#H62#&1HH8#VU'P*Z!(E-,>6\_[7\Z7]WDG\SN]%)M)4]8\;P8
M(VI45QN-U<:<C'X?,CI(D=$5'QVKN)Y)O&(239V9-V?N\._3U=8/:$H%@=D2
M(!9VMC:K]?7U33(N[Z0P^,-_6I'V(]O[J/H4,71T.IR'7;!DWH-9'E@V>2.>
MZLP][T'[52!=W/-Z/3L(Y@O[V M[?-EB![V^XXV%_S)/,5A"*2UMZ7?8M]^'
MPE!185*0S%?V42%-RVIVYM66"D_P,IFW.W/;?6Z[%^FYZ^M/JN=NI/3<7<OR
M11"HOTYM5S2*==S/_)^U_8/>;O_OK>EUW+6\CEL P,+.2KU!2W\9BAIK;,!1
M\L-NB:I;R;GAU^_ L%F,X6W][2=_K_Z/9_+I,5R_#X;-A9T68K99K]\;J:TB
MI/;@QW/_RANZQ2BY8CC\T#IVNZO-Z5':*$4IGGYAYW* *G<'#LB]4=HL0HE4
M^'/_PO=N;=<L<1_5-PX;W\/^.WMK;7J\-DOQRL"PL'/V?F[)_SZ6_%X175UX
M0<B=?^U^N5.R8?/QV^/KSN?+ASDE4U2U54I5*0@6=NH;\._<?$_:/FJA,!;2
M]^'DV7WN,#$2YB"T;P6![75 OQ+!7'-]W)4'JF1(EB]18?WMD8H#JO_[/YO-
MQL:KP B%(_I=SQ7,)4NOPN X.0-4OQGW!0=^9HE\ L.NXIPHV'?AL7)>.1:[
MGX;^8?!/=W-J7ME,Y24DYP2*;-8;2R7<,0=V78%]"JJ;<X%H3_+6?G#^XH=7
MG[^MA0]+N4B!GHIK9^==V-E<;58W-AKS'(K?%ZFSY=T9PVCQT/.!#%6^@4_!
M5.$S+J4NL(@.D]EK()]0[V4.#W2^TTO(.G@:I+X.@M#NC)\%J[VN,&\,,,08
M[_=]#Y0HC(>TO1%K"\<;X@[CET@';+-ZPCJV@Q+!#D \A,*U8.=##S:_-W!"
M[@IO$#AC%O#0#CIC>E.]X+4!-^GEDHF=R=P50!"(C+MC_5W'<V!R? \C]38&
M#0*V& C!CH0K?-#QCEUX=R"S1G=KS9H$=VG[!1#=++O+'@QNO=9<L]VGM W?
M*E7A;]\.@>(QC#5PE<<V*-87_FE^=P[-[][9ZO74*9IMSW,$=ZF8-Z-)I))4
M"L%"PMG:6%U]]81.B,=<<X4$+$X2"]97*>+(8K#4C*TVUR2S0"Y!@,>9U)1
MO=C88'N'EZRY4J_!P\7&R4^GWE_39'Q:J&9S]<OLBI;GV":0I7O] >0I"%6G
MF%.TC@]:*]\V3J[\A^46W9-3I+*.\C#];FPBQ@#$M$0ASR,:J[S::&;81*K*
M(F(2J_6:?'K.)WX9J&9S]<L<SA>^0,F-#2NHA \U:O^\TRGS1 R_7WS<['V[
M_+S;>0I^D<HH*X?M=^,;@$G53*!RIY[16+6JS<7V$@$?<9))7$0^/^<COPQ4
ML[GZ99G,F;-Z' 0#X=_)379'Q^?K[W:/;IKF4W"3M0G<) ?A[/.4%5%=733O
MSU/4\_, R^_H5TM4^$I'E_"%E2**J.89!8=V? $1S%U8O[<+ZWGR(>J/FP_1
MWKG"1HPJ8,X$-[O,='@0I&HHYRDK#T'J\;?(YW@VI-]KW&M[SB*F-<PW:#JD
M5A\Y:[*]@]7)J2,DM' '/@^,%3Z)A4%VXWX=A?6I<T<*:LWWM=],BLUQH]DF
MAE2LMUZVS]I;M\=;WWQG^GA\*N\R.^_"#BJKL&NMT#-O[E-?_@OGZOP^644%
ME*$M',7\)-\K(8N_@JY_='[UO6M/3Q:IW-74I L[V )X3@L_CQ;>9KB$MIW*
M.U(,W^__T_QWM=U9G;I9"E6-(R,O*AAO;A9QD21<"SM7H->?\<#BWR0W81^X
M?R-"6O?3T[U[$M1S67Z1D40?VBY6J( "L%5KK&';R;E!.&VICVNA;T 8[3$S
M,>D" ;R!>005GF8R(NR P;P"*.(:HQT VS#LHHNACUD2/&"6Z-BN[/0A(Z/U
M-6U#9D*BLJ?42N1;P.7=>&50A+2^MH1I/=(_T6Q7FP5C%#6HR@PF_17X_E+M
M!5BO3X.4;U]WG^> '2BR,C)D-;G:0K]U1"_MR7>*N>Y5_=W[SSX_VQC=/(5?
ML2!AOA"X>[L4YZ3Z"_/-CE'."3%)6;)5EF:K=B['K M,4SC"#(%INAYYX :!
MH*< ,Y7)AG=^V.25DUW/D2)I+F>,YV5HP]1X4EP '[[QQ:T=P'O BKEK8C2:
MFW2+!D**%ZY8W+<"F<-FE;G_5A9YY/Y+\MH:BZAWMG9T-NDTC<_/:/.=\(\4
MMOE.M %/0O_+M/G^R328VC1$]A6\_6V \1UXBS G2RF_!Z7=U#,;NDYTTD_O
M/RU)LH6YZI:?F\L7_*;:%L"1 )X^P9>DH(</GMSA)]C<WYIE/+(A>QR*GM&H
MU1LU=H"MP]BQ"R* ,YV(Q?91G;>Q9HWM7ON"(HJUY^I?^ 0XSRB/A_VPL7$Q
M2.E &-%.@7ZY\\R;]8SXZKW\"3BF?! RU?M9$#]WC7QWVPH[BF[_JF##F1I;
M1*4-2^B:L$#)V0EP2YBJ(<VV#/CCY7+D64;=52TDO=UXM<3(4""+GEA#7U$9
MXYK*IINMB%K3$X.:"O-I59F44K)%@Q^=^C(YY*4<L@R*"B/EN@6F7Y>]]6![
MK[O&'N_;(7#'0QBTPDXOI@/CV+T50>CYN1F3ZKB,SN#P^G&R&#"I U/3J<HE
MVI)!'W_]HUFOU1D0F".K6JB*1FVN+JND 3P$TT.BZ7.?W7)G(-@?\&Z]@68&
MH^MYIB:E1) B@UXP:'\%(P-!-84?<MMEC@W8R 05 [==%NIP,UF7 P:Z9<L<
MED"$: '!CL"[^)TFII20>@'\X">(LY^%ZD>JQ<+-!G;4"X@[)"CIX11288ES
M08>*+'-D!Q76'H32&H>/XA*Q"M64"<<QU(SZ3%8(G-0IM0/]8OJ05DI.*2LZ
MI<ES](-LMJ4NVTH=QAIK#8"]!-P1U*L@-5][G(2)BBKI[R' S-KBCG.<[OJ<
MW(*8X].J]?B8>:8Y\%G']WHL!#*@#86_85G#PG4!.T8PRPY,7\A]L08^^C;P
MV>9JE5K(:U=)&[B]ZU*MGX1#+6$RZ\_ SO$UM2KL2LX8I]!1_WQ;$HA%?1EU
MV)S#4B3(+D,6$;P1ATZ4&\:I=@4+T^6@<;>%<!4KA&5,%KZ3=ZC305?-K7!5
MHXF,K*2&PC18QW9@%]+;*<4:?O"QUJHE_.K$?R-_3]P<<3KR:QWL9<6ZZ=V*
M:+. )('V$'IUUZ6-^9<6HP,$0A#3L3*+.G'AXH.HZSNUP\VA@X@>,0<=7TB=
MX2"(EP$@K6  P\=[7K,Y<?C 1*WA><7-;$J6YS <;%3^!@[W#4T[@30@7H $
M?4'*PB%($F)DO!,J7I%CZ&GY#U*H@BQRJ"H^0?C;)FB_F"X%?&$:&P/)C)W1
M.#D=V (68X8IOF;D-?EFO5*OUS5KS,IG@@VD,/P1*Q?30ZH/1!I6Y*<5)?C&
ML=S#^K6((0,J N10H-FD1EPM\8\"1+LUR8K@%A*<5"@P @UJ@=U&B4>= A9I
MA7I\9/<&/4,VD<&UC(:7FA$Q?]1%0+.1 Z*XR&LDCX(13<E.45O*:62H?>C]
M-/H^4B%&>VBS<P--:_^F1[GP\S2*5"?U/!"((#.5% 1%,9#K!RJ5",?5 .\2
M0ET+(XK&XM;&GQ@UVF:+]A*]<.LY UB_H4")"4L*BHV/3EV)V53P?_I[]R(+
M;:Q QP=$Z7LJQT4;[3++A68V'JQ-1[V\Y"@Y*-Q81\P<!L361NITX*CXTB9(
MJ36/LY4%9^65@:/;:C_T^JL%"[N@P;#%E24&9P6OAC(=+Z P(>IEM$D!T5_9
MZF:79'J6N2=G-EHX<R%))K1\Y-&+C?H2QD9))0;VA!%-&T'U4HN?6AMYOB8=
M2$7X@)4O\ @B'UXC/ISA&#J8J^!F,=R3J)'W^XYMDF);"" 2"5J>>-#@!5BZ
M/U9J]7I%^D4(M,[ I]P<#2(BO%)_%A"-$A#7 $2YM#G;)W95Y8P?%+P(5]%:
M2%1Q&C$R!;S]QUJ=<)Q[=GYK_7O7LJKG[ES]GF546U(WTUZRV&&7<)4H_E/D
ME[-=[.0E\UU@"*DK4],E330%^ANJ;TF3G6N68DCAFU;W)7?A3N!)5\O]7'\%
M6GO*_\Y9J7J)Z95*]E/GPJRAD=,&E!1U'RQ&Y0&+YR^T0&KL /7)XF=1#39^
M %>=QZ08=TIMU(JAUCI"(BU\)!Y.V3MZ*LO(NF( ;WB@C\0$:YE6LBI,:SLK
M]3\C+4<I"4H9G2#[+'55)A4]IE='$=)TBEIVI:7"L=O#K*R))@#+F #9@1X#
M&B.I;542EA\K-#%_F":G-#4ZF(806QIK&4L#S8+H3E/M[LRIIUJ7S7F'><BV
MME?JV_4&X[5>K0(G! NB7&7WE>I&1EI]>Q3J*+1X 7#:"4\F9J-5VA\ @S*=
M,>R)"Y1D3L!;Q3>HZ[#-'</K"QEVD$=#.DZ%/%&KVW58ASKK%ZW#O:#(S$96
MA4A,A\N)PQB)]2Q:!$F%]S9>\GIN4'C8TX:$089$>P"OHD9+EH3=ZPD+>PX"
M6BFKH@C*F@X9:%>29O5X5DIX;);A>ZXS-FQ%SK;,"\7&AT B8W1V*!V:9VU*
M19<!=L(L-"@J*L\3$8Z(/XI'= H9N8H6Q><1W@/YS*4SC;O%]E72B(('7!3D
M,DH!2,5->[%08!""(@'P1S8,.MZ#@4-B7GI=P#Q/$$>1!>,K(HS]/T%!<"#6
M+)8RU)2*J"LGED4AG:SP3CJ;'$<11!;_ (3V*!FAR2U0CUM"4W[Q9BV1&VHH
M4#D)$G-EM69"Y-C%TP34EH @48(!2R-L%X@)$[AXF \!35JK%VME34RW;,[3
M+5]4NN5S&<7Z),_-XEE&]=@UDG;M7=9L',C@;>_V_@:LAT8EZP&#T+)::TF>
M:7+J66PH!0A'2NH]/V;]*MQ 8RB)6*5M8&4!&YE0V\.MBYP<++9Y(\F+CTZ9
ML9>=J$!1E\I@Z(6@9.=LVNR*I/*4R-@J0P:WX%K69$8Y"[GA4SDWU+<:7S#*
MQ@P2BF52CR1*R#E@"^QX+/_0"K;6S2T.AR-K<6NSS"@S3Q(:.9EYBVM9C;R/
M&EJD6R6_2ROHQ9N45OV,"5YJ"7^Z+_@?#?0\DX<]%4YD_!H4)LSQ8IQ,^>GB
M@WF0)[D'C +W0)RO&3D*"$ZJ'%-YE(]$\O?P%21FQ;C%CT]Z/X>!ME"*/08L
M[S%05F,"7!5PO=.+D"#7'W<DY- UI-WVJ 8_>[#!;T3P$A23 &8/ ?B^OH'$
MC 4<K, [\+ H5XJ#E)K[Q7N3-_@E(T7I5<9LR<+'@)P=3@X$1_,W<4LN:A]J
M*0I2\">-X[0()\D@I]3RH,3#"G.T8U9B%62QFJ LD%T-\@3E-1&])[<GI[26
MKHK,9HGUD')YA&)+AP0S+%[5JH)*$^K%&\>X&!G;-A4*B,SH\HG1!4#YEFBC
MS[/Y?@NLP'"BV]&-*PPP/;O%-)O[]K.,(V =1IR;+-.J0]]SI)/6[DESQ5)Z
M%CDNT0PJS%S/<=1,_*C W97*73 L3T6QTK85OJ_R@U/,1E4%,&68%2CZTK J
MJPG0+Z'11T86B?5DW4[EQVH=7JPW;U91Q=,"&BLJO^I D.B6QV3BV=#5&Y;
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MM&[J;^2*++<]:XQ_=\.>L_/_ 5!+ P04    " #LABM;(\. Z2P#  #H"P
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M#)\TP?PI.#;L$5.0#[YI!.I.HJ:/?P!02P,$%     @ [(8K6]% 2'']"@
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M.-A<OJC5N5PF#6QL3>\3GI;M+GXJ<; (F0X'4I2'(17GB:3:;8@>AEI*U_0
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MTA0!7DBPRUP/_3:3YO!?UP2!0(>QUDE)*45:Z^.%A,.4M>Y?!*R]+0+6/8N
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MEWL/JSWR/U!+ 0(4 Q0    ( .R&*UNVS2,;(=@  *",!0 *
M  "  0    !E>#$P+3$N:'1M4$L! A0#%     @ [(8K6_GXG?__0P  !/8!
M  H              ( !2=@  &5X,3 M,BYH=&U02P$"% ,4    " #LABM;
M=J*H4%(H  ""& $ "P              @ %P' $ 9F]R;3@M:RYH=&U02P$"
M% ,4    " #LABM;(\. Z2P#  #H"P  $0              @ 'K1 $ 9V-T
M:RTR,#(U,#DQ,2YX<V102P$"% ,4    " #LABM;T4!(<?T*  !_A@  %0
M            @ %&2 $ 9V-T:RTR,#(U,#DQ,5]L86(N>&UL4$L! A0#%
M  @ [(8K6VVIVD=<!P  V%<  !4              ( !=E,! &=C=&LM,C R
C-3 Y,3%?<')E+GAM;%!+!08     !@ & &X!   %6P$    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>form8-k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="gctk-20250911.xsd" xlink:type="simple"/>
    <context id="AsOf2025-09-11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506983</identifier>
        </entity>
        <period>
            <startDate>2025-09-11</startDate>
            <endDate>2025-09-11</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2025-09-11" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2025-09-11" id="Fact000004">0001506983</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2025-09-11" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2025-09-11" id="Fact000010">2025-09-11</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2025-09-11" id="Fact000011">GLUCOTRACK, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2025-09-11" id="Fact000012">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2025-09-11" id="Fact000013">001-41141</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2025-09-11" id="Fact000014">98-0668934</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2025-09-11" id="Fact000015">301     Rte. 17 North</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="AsOf2025-09-11" id="Fact000016">Ste. 800</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="AsOf2025-09-11" id="Fact000017">Rutherford</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2025-09-11" id="Fact000018">NJ</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2025-09-11" id="Fact000019">07070</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2025-09-11" id="Fact000020">(201)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2025-09-11" id="Fact000021">842-7715</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2025-09-11" id="Fact000022">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2025-09-11" id="Fact000023">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2025-09-11" id="Fact000024">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2025-09-11" id="Fact000025">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="AsOf2025-09-11" id="Fact000026">Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2025-09-11" id="Fact000027">GCTK</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2025-09-11" id="Fact000028">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2025-09-11" id="Fact000029">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Sep. 11, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 11,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-41141<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">GLUCOTRACK,
INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001506983<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">98-0668934<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">301
    Rte. 17 North<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Ste. 800<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Rutherford<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NJ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">07070<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(201)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">842-7715<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">GCTK<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="form8-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://glucotrack.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="form8-k.htm">form8-k.htm</File>
    <File>gctk-20250911.xsd</File>
    <File>gctk-20250911_lab.xml</File>
    <File>gctk-20250911_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>22
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "form8-k.htm": {
   "nsprefix": "GCTK",
   "nsuri": "http://glucotrack.com/20250911",
   "dts": {
    "inline": {
     "local": [
      "form8-k.htm"
     ]
    },
    "schema": {
     "local": [
      "gctk-20250911.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "gctk-20250911_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "gctk-20250911_pre.xml"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 23
   },
   "report": {
    "R1": {
     "role": "http://glucotrack.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2025-09-11",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form8-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-09-11",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form8-k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CountryRegion",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Extension",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12gTitle",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://glucotrack.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
